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Abstract	
 
Slits are large secreted proteins which mediate their functions by binding to single pass 
transmembrane receptors called Robo. This signalling axis was first identified as a pivotal 
guidance mechanism in the development of the nervous system. A repulsive activity of Slit 
proteins controls the projection and movement of Robo expressing neurons in Drosophila 
and vertebrates. Slit and Robo expression is not limited to the nervous system or 
development only, they were found to be expressed in many different tissues both in 
embryo and adult organism. Correspondingly, the Slit-Robo signalling axis now is 
implicated in many other biological and pathological processes such as angiogenesis, 
cancer and tissue remodelling. This study sought to investigate two different aspects of the 
Slit-Robo signalling system: Robo1 transmembrane signalling mechanism and possible 
Slit-Robo roles within the immune system. 
Robos and other type I transmembrane receptors are unable to transmit signal across the 
membrane within a single molecule because a single transmembrane α-helix restricts 
propagation of conformational changes between extracellular and intracellular parts of the 
protein. Therefore, the type I receptors usually act as homo- or heterooligomers, formation 
or dissociation of which is controlled by ligand binding. Based on indirect evidence a 
similar transmembrane signalling mechanism was suggested for Robo receptors. It was 
hypothesized that Slit binding induces changes in oligomeric state of Robo which in turn 
initiates downstream signalling events. In order to test this hypothesis and determine 
details of the transmembrane signalling mechanism, the oligomeric state of Robo1 receptor 
was assessed in live cells using two different fluorescence resonance energy transfer 
(FRET) based methods. A strong FRET signal was observed between differently tagged 
Robo1 proteins, indicating that the receptor forms oligomers in the resting state. However, 
contrary to the initial hypothesis, the addition of Slit2 protein did not have an observable 
effect on the FRET signal and thus on receptor oligomeric state. Moreover, Robo1 proteins 
were found to form higher density domains within the cell membrane. This property could 
be abolished by removing the intracellular part of the protein indicating constant Robo1 
association with intracellular structures. These data show that the Robo1 transmembrane 
signalling mechanism might be more complicated than initially expected and likely 
involves structural changes within the Robo1 oligomer or Robo1 complexes with other 
proteins.  
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The Slit-Robo signalling axis was linked to the immune system when it was demonstrated 
that Slit2 is able to inhibit chemotactic leukocyte migration and reduce inflammatory 
responses in mice. However, the precise role of these proteins remained unknown. In order 
to gain further insight into possible Slit-Robo functions within the immune system 
promoter analysis was performed with the aim to identify transcription factors responsible 
for the control of these proteins. Among many putative transcription factors discovered, 
Foxn1 was the most prominent as its binding site was identified both in Slit2 and Slit3 
promoters. Development and functions of thymus, a primary lymphoid organ responsible 
for T cell development, is regulated by Foxn1 and since thymic activity includes active and 
abundant leukocyte movement into, out-of and within the organ, a hypothesis was 
suggested that Slits contribute to regulation of these processes. Quantitative Slit2-Slit3 
expression studies and assessment of embryonic thymus cellular composition in Slit2 
knockout mouse were employed to test this hypothesis. Quantitative PCR revealed that 
both Slit2 and Slit3 are downregulated four-fold in thymic epithelial cells starting 
embryonic stage E13, however no differences in cellular composition of embryonic thymi 
were detected between wild type and Slit2 knockout animals using flow cytometry. 
Possible Slit2 and Slit3 redundancy might be the reason for the lack of observable effects, 
unfortunately a Slit3 knockout model was unavailable for these studies. Interestingly, flow 
cytometry also revealed that in addition to thymic epithelial cells, Slit2 is expressed by 
pericyte type cells surrounding the thymic vasculature. It seems that Slit proteins have 
intricate and regulated expression patterns within the thymus, however their precise role 
remains an open question.  
In summary, data collected during this study illuminates two different aspects of the Slit-
Robo signalling system. Both of them, despite Slits being secreted proteins, hint at short-
range, possibly even juxtacrine, ligand – receptor interactions. Given Robo receptor 
evolutionary connections to cell adhesion molecules and Slit affinity to heparan sulphate it 
is not a completely unexpected finding.   
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1 Introduction	
1.1 General	Introduction	
One of the great evolutionary events in the history of life was rise of multicellular 
organisms. While carrying obvious advantages, multicellularity creates the need for 
intercellular communication systems. One can imagine that molecules which initially were 
utilised only for mechanical cell-to-cell adhesion soon developed additional signalling 
roles. As organisms became more and more complex, this primordial intercellular 
signalling network was constantly expanding and accommodating new functions: 
development, tissue repair and immune responses. So it is hardly surprising that many cell 
adhesion molecules, initially considered mainly as a "sticky coat" of the cell, turned out to 
be crucial receptors for intercellular communication, in some cases literally determining 
life and death of the cell.  
There are four main classes of cell adhesion molecules: cadherins, integrins, 
immunoglobulin like cell adhesion molecules (IgCAMs) and selectins. Among them 
IgCAMs are the biggest, the most ancient and the most diverse group. Recent advances 
revealed a new subgroup of IgCAM molecules, the so called Robo receptors. Together 
with their cognate ligands Slits, Robo proteins form the Slit-Robo signalling axis which 
possesses unique structural and functional features setting Robos apart from other IgCAM 
molecules and making them compelling research subjects.  
1.2 Slits	‐	guidance	cues		
The Slit locus was first identified by genetic screens for mutations affecting development 
in Drosophila (Nusslein-Volhard et al, 1984). Further studies showed that it corresponds to 
the gene coding a large secreted protein crucial for the correct wiring of commissural 
neurons (Rothberg et al, 1988; Rothberg et al, 1990). Exact Slit functions remained vague 
until it was shown that Slit is a repulsive guidance cue during development of the nervous 
system. It was demonstrated that Slit acts as a ligand for the so called Robo receptors and 
repels neuron growth cones both in Drosophila and mammals (Brose et al, 1999; Kidd et 
al, 1999; Li et al, 1999; Yuan et al, 1999). Currently, it seems that the Slit-Robo signalling 
axis is preserved in the majority if not all bilateral organisms.  
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Drosophila has a single Slit gene while three different Slit orthologs were identified in 
vertebrates - Slit1, Slit2 and Slit3 (Banfi et al, 1996; Holmes et al, 1998; Itoh et al, 1998; 
Nakayama et al, 1998). All three share a highly similar sequence and identical domain 
organisation. The defining feature of Slits is a unique tandem of four leucine-rich repeat 
(LRR) domains followed by six epidermal growth factor-like (EGF) domains, a laminin G 
domain, an additional three EGF domains (only one in invertebrates) and a C-terminal 
cysteine knot domain (Figure 1.1A and B). Because of this complex domain composition, a 
typical full-length Slit protein consists of 1500 amino acids and has molar mass of 
approximately 170 kDa. 
Little is known about the tertiary or quaternary organisation of Slit proteins. Three-
dimensional structures were successfully solved only for separate leucine-rich domains: 
LRR2, LRR3 and LRR4 (Howitt et al, 2004; Morlot et al, 2007b; Seiradake et al, 2009). 
Differently from all other LRR type proteins, these domains contain an additional 
disulphide bridge restricting flexibility of the interdomain linker (Figure 1.1C). This 
structural hindrance most likely enforces complex and compact structure of the N-terminal 
LRR tandem (Hohenester et al, 2006). The Slit LRR4 domain forms dimers both in 
solution and crystals (Howitt et al, 2004; Seiradake et al, 2009). Additionally, C-terminal 
cysteine knot domains are known as protein modules for dimerisation, so one could expect 
that full-length Slit proteins form homodimers. However, the LRR1-LRR4 tandem is 
monomeric in solution, as is full-length Slit1 in native PAGE (Hohenester, 2008; Tanno et 
al, 2004). The possibility exists that Slit dimerisation depends on heparan sulphate 
Figure 1.1 Organisation of Slit proteins 
Schematic illustration of mammalian (A) and Drosophila (B) Slit proteins. Red arrows indicates site of 
proteolytic cleavage. Structure of human LRR2 domain (C; pdb id: 2V9T) shows typical horseshoe 
conformation. Cysteine residues forming disulphide bridges and restricting interdomain linker flexibility 
are marked in yellow.  
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(Seiradake et al, 2009), but overall, the existence and biological relevance of Slit dimers 
remains to be determined. 
Biochemical experiments with truncated Slit forms show that the LRR2 domain is 
sufficient for Robo binding and activation in vitro (Howitt et al, 2004). This fact naturally 
begs a question – what functions do the other Slit domains possess? Slit binds heparan 
sulphate (HS) with high affinity and binding sites are mapped to LRR2, LRR4 and the C-
terminal part of the protein (Hussain et al, 2006; Ronca et al, 2001; Seiradake et al, 2009). 
Some additional information can be inferred from Slit domain composition. Both LRR and 
EGF domains are usually found among extracellular proteins and receptors. LRR and EGF 
domains are known to mediate protein-protein interactions (Rothberg & Artavanis-
Tsakonas, 1992). The laminin G domain is found in laminin, agrin and other extracellular 
matrix (ECM) proteins and thus is likely responsible for recognising and binding ECM 
components (Rothberg & Artavanis-Tsakonas, 1992). The C-terminal cysteine knot is an 
unusual structural element often shared by proteins that otherwise have very little sequence 
homology. They appear to be required for protein secretion and/or oligomerisation (Isaacs, 
1995). Interestingly, in vivo, Slits are subjected to partial but specific proteolysis which 
separates the Robo binding LRR tandem (140 kDa N-terminal fragment, Slit-N) from 
laminin G and cysteine knot domains (40-60 kDa C-terminal fragment, Slit-C). The 
responsible proteases remain unknown, although the mechanism seems to be shared among 
species as different as Drosophila and Bos taurus (Brose et al, 1999; Patel et al, 2001; 
Wang et al, 1999; Whitford et al, 2002). The N-terminal fragment retains biological 
activity, however, it has far lower affinity for heparan sulphate than the full-length protein 
or its C-terminal part, and thus is expected to be more diffusible within tissues (Ronca et 
al, 2001). This led to proposals that the elaborate Slit composition coupled with proteolysis 
is necessary for diffusion control and gradient formation. Nevertheless, the uncleavable 
Slit form was able to fully rescue Slit knockout mutations in Drosophila, showing that at 
least in this system, Slit proteolysis is not critical for its functions (Coleman et al, 2010). 
Other experiments indicate that proteolytic Slitforms might have different biological 
effects. Both human Slit2 and Slit2-N can repulse axons, however only Slit2-N causes 
collapse of growth cones (Ba-Charvet et al, 2001). In another study, human Slit1-N failed 
to repel axons, yet similarly to full-length protein, was able to induce dendritic growth and 
branching (Whitford et al, 2002). In both cases, the mode of Slit action strongly depended 
on neuron type and the assay employed and since there were no systematic follow-up 
studies, the biological significance of Slit proteolysis remains largely unknown.  
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In addition to ECM binding, the complex Slit structure might be necessary for interaction 
with other secreted proteins or even with alternative receptors. Brose et al, 1999 reported 
high affinity interactions between human Slit2 and another neuron guidance molecule 
netrin, although the functional relevance of this observation remains unknown. Yeast two-
hybrid screens revealed that Slit2 also binds a Gremlin/Drm protein (Chen et al, 2004). 
This protein belongs to the Dan protein family, members of which directly bind and 
antagonise bone morphogenic proteins (Gazzerro & Canalis, 2006). Interestingly, like Slit, 
Dan proteins contain a cysteine knot domain, however, the biological relevance of Slit-
Gremlin binding remains vague. 
The concept that Slits have additional, Robo-independent receptors cannot be discarded 
completely. The phenotype of the cumulative Slit1/Slit2/Slit3 knockout was considerably 
different from that of the Robo1/Robo2 knockout implying that Slits have Robo-
independent functions (Jaworski et al, 2010). One of the candidates as an alternative Slit 
receptor could be a protein called Eva-1 (putative mammalian homolog is C21orf63), 
which was shown to bind Slit and act as its receptor/co-receptor in C. elegans (Fujisawa et 
al, 2007). The extracellular part of Eva-1 contains two carbohydrate binding lectin 
domains. Bioinformatical analysis predicts many putative glycosylation sites in Slits. In 
accordance, full-length proteins and some of the separate domains migrate more slowly on 
SDS-PAGE then would be expected from their molecular mass suggesting some kind of 
posttranslational modification (Brose et al, 1999; Rothberg et al, 1990). Furthermore, an N-
acetylglucosamine residue can be identified in the crystal structure of the LRR3 domain 
(Morlot et al, 2007a). So it seems that Slits are heavily N-glycosylated and thus could 
serve as ligands for the lectin-like receptor Eva-1.  
Another alternative, Robo-independent Slit signalling mechanism was suggested by 
Seiradake et al, 2009. They observed that, even though the Slit domain LRR4 does not 
bind Robo receptors, it affects axon growth in a somewhat similar way as LRR2. This 
effect was also HS dependent. The authors speculated that Slit was able to signal via LRR4 
- syndecan interactions (Seiradake et al, 2009). However, this idea is not compatible with 
the finding that, while total syndecan knockout is detrimental, removal of the cytoplasmic 
syndecan domain does not affect Slit signalling in Drosophila (Chanana et al, 2009; Schulz 
et al, 2011).  
1.3 Robos	–	receptors	for	Slit	
Like Slits, Robos were first identified in Drosophila by a genetic screen for mutations 
affecting development of neuronal pathways in CNS (Seeger et al, 1993). One of 
Chapter 1  18 
 
theidentified mutations caused circular axon misrouting and hence was called roundabout, 
shortened to robo. Kidd et al, 1998a cloned and characterised the corresponding gene 
showing that it encodes a cell surface receptor belonging to the immunoglobulin (Ig) 
superfamily of cell adhesion molecules. Three different Robo genes have been identified in 
Drosophila (Robo, Robo2, Robo3) and four in mammals (Robo1/Dutt1, Robo2, 
Robo3/Rig1, Robo4/Magic Roundabout) (Huminiecki et al, 2002; Kidd et al, 1998a; 
Rajagopalan et al, 2000a; Simpson et al, 2000b; Sundaresan et al, 1998; Yuan et al, 1999). 
It must be stressed however, that those two families were created by independent 
duplications and invertebrate Robo2 is not an ortholog of mammalian Robo2. Typical 
Robo is a single pass membrane protein and contains an N-terminal tandem of 5 Ig 
domains followed by 3 fibronectin type III domains (FnIII), a transmembrane helix and a 
poorly conserved intracellular part (Figure 1.2A). The exception is Robo4 receptor which 
has only two Ig and two FNIII domains in the extracellular part of the protein.  
Crystal structures are available for the first two Ig domains of human and Drosophila 
Robo1, however, the overall folding of Robo proteins remains unknown (Figure 1.3A) 
(Fukuhara et al, 2008; Morlot et al, 2007b). Some structural information can be gleaned by 
analysing other, better described IgCAM family members. Neural cell adhesion molecule 
(NCAM, 5 Ig domans and 2 FnIII domains) most likely adopts a relatively extended, rod-
like form (Kulahin et al, 2011; Soroka et al, 2010). Deleted in colorectal carcinoma (DCC, 
4 Ig domains and 6 FnIII domains), L1 (6 Ig domains and 5 FNIII domains) and axonin (6 
Figure 1.2 Organisation of Robo proteins 
Schematic illustration of Robo structure (A) and table listing cytoplasmic fragments in different Robo 
proteins (B). Robo4 CC sequences are marked in a different colour because their identity is debatable. In 
Figure A, green colour represents Ig domains, blue - FNIII domains, brown – transmembrane domains, and 
dark green – conserved cytoplasmic motifs.  
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Ig domains and 4 FNIII domains) form “hooks” where the linker between Ig2 and Ig3 is 
severely bent and Ig1 and Ig2 adjoin Ig3 and Ig4 respectively (Freigang et al, 2000; Pocock 
et al, 2008). An even more complicated conformation is observed in DSCAM molecule (10 
Ig domains and 6 FnIII domains), which assumes a complex folded shape (Vidi et al, 2011) 
(Figure 1.3B, D and C respectively). Intriguingly, some structural Robo features hint at the 
possible overall folding of this receptor. Drosophila and human Ig1-Ig2 fragments adopt 
two different conformations during crystallisation – one is fully extended, while the other 
is significantly bent via an interdomain linker (Figure 1.3A) (Fukuhara et al, 2008; Morlot 
et al, 2007b). Moreover, the fragment of linker between Ig2 and Ig3 seen in the human 
Robo1 structure makes a sharp turn, which might be necessary for Ig2 packing against the 
Ig3 and IgCAM “hook” formation (Morlot et al, 2007b). Taking all facts into account, 
Robo proteins are likely to accommodate at least a partially packed, non-extended 
structure, which in turn might depend on receptor signalling state. 
Robo receptors were shown to interact with Slit proteins genetically and biochemically by 
many independent studies. A partial Slit-Robo complex structure shows the second LRR 
domain from Slit protein binding to the first Ig domain of Robo (Figure 1.4) (Morlot et al, 
2007b). This interaction mode is in a good agreement with biochemical data, which 
identified the same domains as determinants for Slit-Robo interaction using truncations 
Figure 1.3 Structure of Robo Ig domains and conformations adopted by various IgCAM proteins  
Human and Drosophila Robo1 Ig1-2 domains can be crystallised in two different conformations indicating 
that Robo ectodomain might adopt a non-extended structure (A). In agreement, extracellular domains of 
IgCAM family proteins are known to adopt several different conformations: extended like NCAM (B), 
“hook” like axonin (C) or complex “S” like structure like DSCAM (D). Cytoplasmic domains are omitted 
for clarity. Figure A was adapted from Fukuhara et al, 2008. 
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and deletions (Howitt et al, 2004; Liu et al, 2004). It is generally believed that structural 
and functional details of Slit-Robo interactions are the same for all family members, since 
the Slit-Robo interface consists of well conserved amino acids. This assumption is 
indirectly confirmed by promiscuous interactions where all Slits bind all Robos (Kd 5-50 
nM) with the only exception being Robo4 (Ba-Charvet et al, 2001; Brose et al, 1999; 
Camurri et al, 2005). Conserved amino acids responsible for Slit binding in Robo1-Robo3 
are not preserved in Robo4. While some groups observed Slits directly binding to Robo4 
by co-immunoprecipitation (Park et al, 2003; Zhang et al, 2009), many others failed to 
replicate these experiments using Biacore assays (Hohenester et al, 2006; Koch et al, 2011; 
Suchting et al, 2005). Similarly, Sheldon et al, 2009 showed that the soluble extracellular 
part of Robo1, but not Robo4, was able to quench chemotactic effects of recombinant 
Slit2. On the other hand, functional and genetic studies demonstrate that Slit2 plays an 
important role in the vasculature and mammary glands by acting through the Robo4 
receptor (Jones et al, 2008; Jones et al, 2009; London et al, 2010; Marlow et al, 2010). 
Consolidation of these observations led to a hypothesis that a co-receptor is required for 
Slit mediated Robo4 activation, with Robo1 and syndecans suggested for this role so far 
(Kaur et al, 2008; Sheldon et al, 2009).  
Syndecans, or more precisely their polysaccharide chains, heparan sulphate and 
chondroitin sulphate, are extremely important in Slit-Robo interactions and signalling. It is 
well established that biochemical or genetic HS removal diminishes Slit-Robo interactions 
and disrupts associated biological functions in vivo (Hu, 2001; Johnson et al, 2004; Piper et 
Figure 1.4 Structure of Slit-Robo complex 
LRR2 domain from Slit (orange) binds Ig1 domain (green) from Robo forming signalling competent 
complex.  
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al, 2006; Ronca et al, 2001; Steigemann et al, 2004). Biochemical and structural data 
indicate that HS binds to a second LRR domain from Slit and a first Ig domain from Robo 
i.e. the same domains that mediate Slit-Robo interactions (Fukuhara et al, 2008; Hussain et 
al, 2006). Fukuhara et al, 2008 suggests that upon association, Slit and Robo form a 
continuous positively charged surface which in turn binds a HS chain forming a ternary 
complex. It appears that heparan sulphate has multiple roles in Slit-Robo signalling. First 
of all, as described above it might be necessary for Slit concentration and presentation. 
Second, it takes part in stabilising a productive signalling complex. Unexpectedly, recent 
genetic experiments in Drosophila indicate that negative syndecan Slit-Robo interactions 
are possible as well (Schulz et al, 2011). The authors demonstrated that the syndecan 
knockout phenotype in tracheal cells is caused by a gain in Slit-Robo2 signalling. How 
syndecan suppresses its target remains unknown. Syndecan’s effects were independent of 
its cytoplasmic domain and thus unlikely to be mediated by signalling. The authors 
speculate that syndecans affect Robo levels by interfering with its delivery or retraction 
from the cell surface (Schulz et al, 2011). Obviously, an even bigger unanswered question 
is what factors determine syndecan’s mode of action and its switching from enhancement 
to suppression. 
In addition to interactions with Slit and heparan sulphate, Robo’s ectodomain was recently 
shown to associate with other membrane proteins. Banerjee et al, 2010 demonstrated that 
in Drosophila the single pass transmembrane protein Neurexin IV displays dose dependent 
genetic interactions with Slit and Robo proteins. Neurexin IV knockout altered cellular 
Robo distribution in neurons and caused mild abnormalities in nervous system 
development somewhat resembling that of the Robo knockout. Biochemical experiments 
revealed a direct interaction between Robo and Neurexin IV. Slit appears to facilitate 
complex formation, but generally it was expendable and Robo-Neurexin IV binding was 
observed without it (Banerjee et al, 2010). The Neurexin IV cytoplasmic domain was also 
expendable as its ectodomain was sufficient for Robo binding and knockout phenotype 
rescue (Banerjee et al, 2010). Neurexin IV is a molecular component of Drosophila septate 
junctions (tight junction-like structures in invertebrates) (Baumgartner et al, 1996). Its 
mammalian homologue, CNTNAP2, functions in cell-cell adhesion, especially in 
organisation of myelinated fibers (Poliak et al, 1999; Traka et al, 2003). It is tempting to 
speculate that Neurexin IV is a Robo co-receptor, since weak interaction between Slit and 
Neurexin IV was observed in Drosophila embryos deficient in Robo. However, the 
possibility that other Robo family members were responsible for this effect cannot be 
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discarded and this notion of Neurexin IV as co-receptor needs further experimental 
scrutiny. Similarly, Hernández-Miranda et al, 2011 showed direct interactions between 
Robo1 and neuropilin1 in mice. The authors noticed that Robo1 deficient mouse neurons 
are significantly less responsive to semaphorins. Semaphorins are soluble or membrane 
bound extracellular proteins with very versatile functions, including axon guidance, 
immune response and bone development (Yazdani & Terman, 2006). Semaphorins are 
ligands that act through their receptor, plexin, which can also recruit neuropilins as co-
receptors (Yazdani & Terman, 2006). Covasphere aggregation assays and co-
immunoprecipitation studies revealed that Robo1 directly associates with neuropilin1, but 
not with plexin or neuropilin2. These interactions were mediated by Robo1 Ig1-Ig2 
domains as deletion of this region abolished neuropilin1 binding (Hernández-Miranda et al, 
2011). Finally, the extracellular Robo4 domain was suggested to act as a membrane-bound 
ligand in trans for the UNC5B receptor (Koch et al, 2011). The authors, using various 
biophysical, biochemical and functional tools made a compelling case for this model, 
however, it is difficult to believe that Robo4 is only a ligand. Robo4 retains the Robo-
specific cytoplasmic tail and was demonstrated to be an active receptor in various different 
cells (Jones et al, 2009; Kaur et al, 2006; Sheldon et al, 2009). It is more likely that Robo4 
has different modes of signalling which in turn vary between different cells. Also, Robo4 is 
the most diverged Robo family member, so it is unlikely that this type of interaction is 
present in other Robo proteins.  
The intracellular part of Robo is of special interest. It is on average a 600-800 amino acids 
long, poorly conserved polypeptide. It has no identifiable domains, catalytic activity or 
even secondary structure and thus most likely is an intrinsically unstructured protein. The 
only defining feature of Robo’s intracellular part is several short conserved stretches of 
amino acids, so-called conserved cytoplasmic motifs (CC). Historically, four of these are 
described in the literature (CC0-CC3), however close inspection of sequence alignments 
reveals several additional highly conserved sequence patches (personal observations). The 
exact composition of the CC motifs varies between different Robo proteins, indicating 
signalling and functional diversity within the Robo family (Figure 1.2B). Since Robo does 
not possess catalytic activity, it must exert its signal transduction by binding various 
adaptors and signalling molecules within the cell (see section 1.4.2). In this situation, a 
lack of rigid structure might be advantageous, as it allows greater flexibility and more 
variable binding partners. Binding flexibility and diversity, in fact, is one of the main 
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functional properties attributed to other intrinsically unstructured proteins (Dunker et al, 
2008).  
1.4 Slit‐Robo	signalling		
1.4.1 Robo	transmembrane	signalling	mechanism	
One of the first questions about Slit-Robo signalling is how the single pass receptor Robo 
transmits signal across the cellular membrane. Receptors built from multiple 
transmembrane helixes, like G protein-coupled receptors (GPCR) transmit signal by 
conformational changes where helices are shifted in relation to each other (Milligan & 
Smith, 2007). Single pass membrane proteins cannot undergo membrane-spanning 
conformational changes as a single helix is not sufficient to transmit structural changes 
between intracellular and extracellular domains. Many single pass receptors, like receptor 
tyrosine kinases (RTK) or Toll-like receptors, thus rely on changes in oligomerisation state 
to transmit signal across the membrane (Kang & Lee, 2011; Li & Hristova, 2010). A 
substantial amount of evidence indicates that Robos utilise oligomerisation for their 
signalling as well. 
IgCAMs, as their name implies, tend to have multiple binding abilities. Homomeric protein 
oligomerisation, heteromeric association with other proteins, cis- as well as trans- 
interaction with receptors from other cell surfaces are all reported for members of this 
family. Robos do not make an exception. Covasphere aggregation assays, where 
fluorescent beads are coated with protein of interest and their aggregation is directly 
observed with microscope, demonstrated that extracellular parts of human Robo1, Robo2 
and Robo3 are homomeric molecules which in addition can form heteromeric complexes 
(Camurri et al, 2005; Hernández-Miranda et al, 2011; Hivert et al, 2002). Robo1 also 
interacts with Robo4, as they can be co-precipitated and Robo4 can retain Robo1 in 
intracellular vesicles of COS-7 cells (Kaur et al, 2008; Sheldon et al, 2009). On the other 
hand, Biocore assays failed to detect any Robo1-Robo4 ectodomain interactions (Koch et 
al, 2011; Suchting et al, 2005). Using gel filtration and native PAGE, Yoshikawa et al, 
2008 showed that the extracellular Robo4 domain is an oligomer and exists as a dimer or 
even trimer in vitro. Attempts to identify determinants responsible for homophilic Robo 
interactions were inconclusive, with data indicating that mammalian Robo-Robo binding 
might be driven by multiple and redundant sites (Liu et al, 2004). In Drosophila, 
multimerisation was observed for Robo2 but not for Robo. Chimeric Robo-Robo2 
constructs with swapped Ig domains revealed that oligomerisation is driven by the Robo2 
Ig3-Ig5 fragment (Evans & Bashaw, 2010). 
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Based on parallels with other IgCAM family members, one might expect that Robos are 
capable of association in trans. Unfortunately, information about this type of interaction is 
scarce. Several different genetic and functional studies imply Robo interactions with Slit 
adsorbed on the other cell surface or even formation of a Robo-Slit-Robo sandwich (Kraut 
& Zinn, 2004; Strickland et al, 2006). Others were able to observe Slit independent Robo 
functions and argued that this observation might be explained by Robo-Robo interactions 
in trans (Parsons et al, 2003).  
Association of Robo cytoplasmic regions was reported as well, although information about 
it is much more limited. GST pulldown experiments showed that Drosophila Robo and 
Robo2 C-terminal domains can form homo- and heteromers with homophilic interactions 
being preferred (Simpson et al, 2000b). Kaur et al, 2006 also mentioned oligomerisation of 
the mammalian Robo4 C-terminal domain which was observed by some third party, 
however, remained unpublished.  
All experimental data strongly indicate that Robo receptors are capable of oligomerisation, 
so one can argue that Robos transmit signalling across the cellular membrane by changing 
their oligomerisation state (Hohenester, 2008). Binding of Slit is proposed to cause 
dissociation or association of Robo molecules, which in turn allows recruitment of 
downstream signalling molecules by Robo’s cytoplasmic tail. A somewhat similar 
mechanism where a ligand, called netrin, induces receptor oligomerisation has been 
suggested for another IgCAM family member, DCC (Mille et al, 2009; Stein et al, 2001). 
Currently it is unclear which oligomerisation state corresponds to activated receptor in the 
case of Robo and experimental data suggests different conclusions. First of all, it seems 
Figure 1.5 Putative Robo transmembrane siganlling mechanisms 
Robo transmembrane signaling is likely achieved by changes in receptor oligomerisation state. Slit binding 
may induce oligomer dissociation (A) or monomer association (B) which in turn enables recruitment of 
siganlling molecules within the cell. Dimers are depicted for clarity, but higher order oligomers are 
possible as well.  
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that in many of the cases described above, Robo homophilic interactions were observed in 
the absence of Slit. These observations directly support a model where inactive Robo exist 
as an oligomer which dissociates upon Slit binding. On the other hand, Robo constructs 
lacking their cytoplasmic domain display dominant-negative behaviour (Bashaw & 
Goodman, 1999; Hammond et al, 2005; Hocking et al, 2010; Jia et al, 2005). Given that 
this effect is achieved at a functional level and not via secondary effects, such as protein 
retention or increased degradation, it would mean that a Robo heterodimer consisting of 
truncated and full-length forms is functionally deficient. This observation is more 
compatible with a model where Slit induces Robo oligomerisation.  
Several independent groups have created and used Robo constructs where either an 
intracellular or extracellular Robo segment was exchanged with that of the other receptor. 
Bashaw & Goodman, 1999 created Frazzled (extracellular part) – Robo (intracellular part) 
and Robo (extracellular part) – Frazzled (intracellular part) hybrids. Frazzled (Fra) is 
another IgCAM molecule, DCC-like netrin receptor in Drosophila which mediates 
attraction in neurons. The authors successfully achieved reversal of function as Fra-Robo 
was acting as a repulsive receptor for netrin, while Robo-Fra was acting as an attractive 
Slit receptor in Drosophila embryos. This total exchangeability of intracellular and 
extracellular parts between Fra and Robo would imply identical transmembrane signalling 
mechanisms. Frazzled closely resembles DCC both in sequence and domain composition, 
so one could expect that it follows the activation via oligomerisation mechanism suggested 
for DCC. This in turn would indicate that Robo’s active form is oligomeric. On the other 
hand, it is worthy noting that Bashaw & Goodman, 1999 used Robo for chimera creation, a 
receptor which according other papers is not capable of dimerisation (Evans & Bashaw, 
2010). 
Similarly, Stein & Tessier-Lavigne, 2001 created mammalian Met-Robo1 and trkA-Robo1 
chimeras, where Robo’s extracellular part was exchanged with extracellular domains of 
hepatocyte growth factor receptor (Met) or nerve growth factor receptor (trkA). Both Met 
and trkA are tyrosine kinase receptors responding to hepatocyte growth factor (HGF) or 
nerve growth factor (NGF) respectively. Neuron growth cones normally do not respond to 
HGF or NGF, however neurons expressing Met-Robo1 and trkA-Robo1 showed clear 
repulsive responses to HGF or NGF (Stein & Tessier-Lavigne, 2001). Analogous 
experiments were also repeated with a trkA-Robo4 chimera in HEK 293 cells. NGF acting 
via trkA-Robo4, like Slit2 acting via native Robo4, was able to abrogate HEK 293 cell 
migration towards serum (Park et al, 2003). It is generally accepted that tyrosine kinase 
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receptors are mediating their signalling by ligand-induced dimerisation or oligomerisation 
(Li & Hristova, 2010). Since RTK-Robo chimeras were acting in a similar way to full 
length Robo, one can argue that Robos, like RTK, are undergoing ligand induced 
oligomerisation.  
In summary, while there is little doubt that Robos oligomerise, current experimental data 
do not clearly favour any of the possible transmembrane signalling models. Ligand-
induced Robo dissociation is more supported by direct evidence, as Robo extracellular 
domains multimerise independently from Slit. On the other hand, many indirect 
experiments point towards Robo activation by ligand-induced oligomerisation. Clearly, 
further biochemical and biophysical studies are necessary to resolve this question.  
1.4.2 Robo	downstream	signalling	
 
As mentioned above, Robo receptors do not possess any catalytic activity. From the very 
beginning it was assumed that Robo signals by recruiting adaptors and other signalling 
proteins (Figure 1.6). Their unusual, intrinsically unstructured C-terminal domain implies 
promiscuous and flexible interactions and experimental data more than confirms this 
picture. Here I will review Robo interacting cytoplasmic proteins and related signalling 
pathways.  
1.4.2.1 Rho	family	GTPases		
Small Rho family GTPases such as RhoA, Rac1 and Cdc42 have emerged as one of the 
main Slit-Robo signalling effectors. These proteins are key regulators of the actin 
cytoskeleton and cell movement. Small Rho family GTPases can switch between an active 
GTP-bound form and an inactive GDP-bound form. The cycling of Rho GTPases between 
these two states is regulated by guanine nucleotide exchange factors (GEFs) and 
GTPase-activating proteins (GAPs). GEFs activate GTPases by stimulating release of 
guanosine diphosphate (GDP) to allow binding of guanosine triphosphate (GTP) while 
GAPs work to accelerate GTP hydrolysis and thus deactivate GTPases. Twenty different 
small Rho family GTPases are identified, however GEF and GAP families contain more 
than 70 members each (Hall, 2005; Heasman & Ridley, 2008). Whilst initially it was 
believed that each member of small Rho family GTPases’ is tailored to a specific function, 
new data reveal a much more complex picture. It seems that GTPases form spatially and 
temporally overlapping subcellular pools, where the functional outcome is decided by 
crosstalk between different Rho GTPases and integration of signals from multiple GEFs 
and GAPs (Pertz, 2010). This aspect of Rho GTPases is well reflected in Slit-Robo 
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signalling, where Slit acting through the Robo is able to both activate and sequester their 
activity.  
Wong et al, 2001 were first to elucidate a signalling cascade between Robo1 and Rho 
GTPases. Using Robo1 cytoplasmic domain as bait in a yeast two-hybrid screen they 
identified a novel family of GAP proteins and called them Slit-Robo GAPs (srGAP). In 
HEK293 cells, treatment with Slit2 increased srGAP1 binding to Robo1 CC3 motif and 
caused Cdc42 inactivation. Slit2 also caused activation of Rac1, but this effect was 
independent from srGAP1 and likely mediated by another pathway (Wong et al, 2001).  
Two independent studies revealed another Robo binding GAP protein called Vilse (also 
known as CrossGAP, CrGAP or ARHGAP39). It binds Robo’s CC2 fragment and takes 
part in regulating Rac1 activity in Drosophila (Hu et al, 2005; Lundström et al, 2004). 
Both studies used genetic tools to elucidate Robo-Vilse signalling details with great 
success but opposite results. Overexpression of Vilse reduced the severity of the Robo 
knockout phenotype in Drosophila trachea cells, which indicates that Robo acting through 
Vilse downregulates Rac1 activity (Lundström et al, 2004). On the other hand, 
overexpression of Vilse in neurons exacerbated the Robo knockout phenotype which 
Figure 1.6 Robo downstream signalling 
Experimental evidence indicates that Robo receptors control various different aspects of cell functions via 
Rho family GTPases (see subsection 1.4.2.1), PI3K (see subsection 1.4.2.2), cadherins and β-catenin (see 
subsection 1.4.2.3), paxillin (see subsection 1.4.2.5) and other molecules described in section 1.4.2 
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implies that in this particular case, Robo sequestrates Vilse to activate Rac1 (Hu et al, 
2005). The mechanism behind differential Vilse effects in different cells remains unknown.  
GEF proteins are also utilised by the Slit-Robo signalling axis. Incubation with Slit caused 
recruitment of a GEF protein called Son of sevenless (Sos) to Robo and subsequent Rac1 
activation in HEK 293 cells (Yang & Bashaw, 2006). Genetic disturbance of Sos interfered 
with Robo’s functions as an axon guiding molecule, confirming the biological relevance of 
this signalling pathway in Drosophila (Yang & Bashaw, 2006). Sos does not bind Robo 
directly, instead an adaptor protein Dock (also known as Dreadlock, the mammalian 
homologue is called Nck) mediates Slit-dependent interactions between them. Deletion of 
Robo’s CC2 or CC3 motif reduced Dock binding, however only the combined removal of 
CC2 and CC3 was able to abolish binding completely. While interacting with Robo, Dock 
also recruits the serine/threonine-protein kinase PAK1, which is the main effector of Rac1 
and Cdc42 (Fan et al, 2003). One can expect that these interactions are preserved in 
mammals as well, since it was demonstrated that the mammalian Dock homolog Nck is 
able to bind Robo1 and Robo2 and is necessary for Slit-Robo functions in rodent neurons 
(Round & Sun, 2011). 
Yeast two-hybrid screening and complementary biochemical experiments showed that 
Robo4 cytoplasmic domain directly interacts with Wiskott–Aldrich Syndrome Protein 
(WASP) and its more widely expressed homolog, neural WASP (NWASP) (Sheldon et al, 
2009). Additionally, WASP was implicated in Robo4 induced HEK 293 migration (Kaur et 
al, 2006). WASP is a well known player in actin cytoskeleton regulation. It mediates 
signalling between Cdc42 and the Arp2/3 complex, which initiates polymerisation and 
branching of actin filaments. WASP/NWASP is well positioned to serve as a Robo4 
effector, but unfortunately, no further structural and functional details are currently 
available. 
Taking all these findings into account, it looks like Robo itself can act as a platform that 
recruits a whole range of Rho GTPase modulators and downstream effectors, often with 
opposing functions (Figure 1.6). We are only beginning to unravel this complex knot of 
interactions and it would be very interesting to see how these promiscuous bindings are 
regulated and integrated.  
1.4.2.2 PI3K	and	Akt	
The phosphoinositide 3-kinase (PI3K) pathway regulates an extraordinarily diverse group 
of cellular functions: cell proliferation, differentiation, motility, survival and intracellular 
Chapter 1  29 
 
trafficking (Vivanco & Sawyers, 2002). This pathway is extremely complex, with many 
branches and feedback loops and a full description of it is beyond the scope of this text. 
The core of the pathway consists of PI3K and a serine/threonine protein kinase called Akt. 
In response to external stimuli, PI3K activates Akt by causing its phosphorylation via 
secondary messengers. In turn, Akt may phosphorylate many different targets around the 
cell.  
More and more evidence is emerging that the PI3K – Akt pathway is modulated by Slit-
Robo signalling. It seems that Robo directly interacts with PI3K as treatment with Slit2 
induced Robo1 and p85 (one of the PI3K subunits) co-immunoprecipitation in eosinophils 
(Ye et al, 2010). Recombinant Slit2 inhibited Akt phosphorylation in breast cancer cells, 
Jurkat cells (T lymphocyte like cells) and myoepithelial cells (Macias et al, 2011; Prasad et 
al, 2004; Prasad et al, 2007). Similarly, overexpresion of Slit2 caused reduction of Akt 
phosphorylation in breast cancer cells (Prasad et al, 2008) while knockdown led to 
increased phosphorylation in lung cancer cells (Tseng et al, 2010). On the other hand, 
incubation with Slit2 activated PI3K in HUVEC cells and PI3K inhibitors were able to 
disrupt Slit2 induced attraction and tubulogenesis in HUVEC cells (Wang et al, 2003). 
Likewise, treatment with Slit2 promoted angiogenesis through mTORC2-dependent 
activation of Akt, while PI3K and Akt inhibitors significantly impaired pro-angiogenic 
Slit2 effects in primary vascular endothelial cells (Dunaway et al, 2011). What factors 
determine these differential interactions between Slit-Robo and PI3K-Akt remain 
unknown.  
1.4.2.3 Abl,	Wnt	and	Cadherins	
Multiple studies show interactions between Slit-Robo and Wnt signalling pathways. The 
Wnt pathway is primarily known for its role in development and cancer, but is also 
involved in normal physiological functions of the adult organism (Logan & Nusse, 2004). 
In the resting state epithelial cell β-catenin is bound by cadherins at the adherens junctions 
where it links cadherins to the actin cytoskeleton. Free β-catenin is bound by a multiprotein 
degradation complex, one component of which is glycogen synthase kinase 3 (GSK3β). 
GSK3β phosphorylates β-catenin and triggers its ubiquitination and degradation thus 
keeping the concentration of free cytoplasmic β-catenin low. Wnt ligand acting via the 
Frizzled receptor inactivates the degradation complex and causes accumulation of 
cytoplasmic β-catenin. β-catenin is eventually translocated to the nucleus where it activates 
the LEF1/TCF transcription factor and stimulates expression of target genes (Logan & 
Nusse, 2004). 
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Slit-Robo signalling appears to modulate the Wnt pathway in several different ways. The 
cytoplasmic tyrosine kinase Abl was the first identified link between Slit-Robo and Wnt 
signalling pathways. Abl binds to the CC3 motif and is able to phosphorylate several 
different tyrosine residues in the human Robo1 cytoplasmic domain (Bashaw et al, 2000). 
These modifications were directly detected only when Robo-expressing cells were co-
transfected with a constitutively active Abl form, however genetic and functional studies 
indicate that Abl mediated Robo phosphorylation antagonises Robo activity in Drosophila 
and thus likely is biologically relevant (Bashaw et al, 2000). Abl appears to associate with 
Robo independently of Slit binding (Rhee et al, 2002). However, upon binding Slit, the 
Robo-Abl complex recruits the scaffold protein Cables, which in turn associates with N-
cadherin-bound β-catenin. This results in Abl-mediated phosphorylation of β-catenin and 
its transportation to the nucleus (Rhee et al, 2007; Rhee et al, 2002). In this way the Slit-
Robo signalling axis achieves a twofold effect. First of all, loss of β-catenin should lead to 
rapid loss of N-cadherin mediated cell adhesion. Indeed, Robo antagonises E-cadherin 
adhesion during Drosophila heart lumen formation (see section 1.5.2) (Santiago-Martínez 
et al, 2008). Second, Slit induced β-catenin translocation to the nucleus causes 
transcriptional activation via the classical Wnt pathway and thus might induce long term 
effects on cellular functions (Rhee et al, 2007).  
Interestingly, many independent studies report an alternative intersection of Slit-Robo and 
Wnt signalling pathways with directly opposing effects to those reported by Rhee et al, 
2007. In breast and lung cancer cells Slit2, acting via the PI3K and Akt pathway described 
above, activated GSK3β by reducing its phosphorylation. In turn this led to increased β-
catenin phosphorylation and destruction, augmented association between β-catenin and E-
cadherin and stronger E-cadherin mediated adhesion (Prasad et al, 2008; Tseng et al, 
2010). Similarly, another study with primary and immortalised basal myoepithelial cells 
showed that Slit2 induces β-catenin redistribution from nuclear to cytosol/membrane 
fractions (Macias et al, 2011). Although not addressing Slit-Robo and Wnt interplay 
directly, in agreement with these observations, many authors also noted that Slit-Robo 
signalling stabilises cadherins in the cellular membrane (London et al, 2010; Shiau & 
Bronner-Fraser, 2009; Stella et al, 2009).  
At this point it would seem that positive Slit-Robo signalling effects on cadherin functions 
are observed more often than negative. Factors determining these different modes of action 
remain unknown. Since in some cases Slit-Robo proteins had no observable effects on N-
cadherin or β-catenin (Yiin et al, 2009), it is tempting to speculate that the presence or 
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correct localisation of signalling intermediates channels Slit-Robo signalling in one or the 
other direction. 
Additionally, it appears that Robo and cadherins have more intricate, possibly Wnt 
pathway unrelated interactions. Bauer et al, 2011 showed that in an oral squamous cell 
carcinoma cell line, overexpression of P-cadherin increased expression and secretion of 
Slit2, but not other Slit proteins. This indicates transcriptional feedback loops between 
cadherin and the Slit-Robo signalling axis and adds yet another layer of complexity.  
1.4.2.4 Mena	
Kidd et al, 1998a noticed that the Robo intracellular sequence contains a potential binding 
site for a Drosophila protein called Enabled (also known as Ena, three homologs are 
identified in mammals: Mena, VASP and Evl). Consequently, the same group showed that 
in Drosophila Ena genetically and biochemically interacts with Robo. They identified CC2 
as the main Ena binding site, however others might exist as well, since a construct lacking 
CC2 was able to retain some Ena binding capability and repulsive activity (Bashaw et al, 
2000). In agreement with these data, Ena co-localisation with Robo was observed during 
heart lumen formation in Drosophila (Santiago-Martínez et al, 2008). Vertebrate Robo4 
also directly interacts with Mena (Jones et al, 2009; Park et al, 2003). Other vertebrate 
Robo family members are thought to bind Mena as well since they all contain the CC2 
motif. Mena family proteins usually are concentrated at focal adhesion points, the edge of 
the lamellipodium and the tips of filopodia of migratory cells. Some unresolved questions 
remain, but at the molecular level Mena proteins are generally attributed actin anti-capping 
functions i.e. they enable actin filament extension even in the presence of high local 
concentration of capping proteins (Bear & Gertler, 2009). At the functional level, Mena 
has important roles in morphogenesis, axon guidance and cell migration. Therefore, this 
protein family is perfectly positioned to serve as Robo effectors. Unfortunately, little is 
known about Mena functions in the context of the Slit-Robo signalling axis. In Drosophila 
and C. elegans, Ena binding to Robo was necessary for the repulsive effects of the 
receptor, however there was no obvious relation between Robo interactions with Slit and 
Ena recruitment (Bashaw et al, 2000; Yu et al, 2002). There is a possibility that Ena is 
constantly associated with Robo and that the receptor functions as a heterocomplex. On the 
other hand, Fan et al, 2003 reported a weak but repeatable correlation between cell 
treatment with Slit and Robo-Ena association. Either way, signalling pathways employed 
downstream of Robo-Ena/Mena remain unknown.  
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1.4.2.5 Arf6		
A yeast two-hybrid screen with the Robo4 cytoplasmic domain as bait identified the 
adaptor protein Hic-5 as a potential Robo4 interacting protein (Jones et al, 2009). Hic-5 is 
a paralogue of the better described paxillin and since both proteins were 
immunoprecipitated by the Robo4 cytoplasmic tail, further studies were focused on 
paxillin. Full length Robo4 was able to immunoprecipitate paxillin only after treatment 
with Slit2 protein. The Robo4 region responsible for paxillin binding was broadly 
identified as a stretch of 35 amino acids between CC0 and CC2 (Jones et al, 2009). This 
region is poorly conserved in other Robo family members, so paxillin binding to other 
Robo proteins remains unknown, even doubtful. Paxillin is able to recruit GIT1 protein 
which acts as a GTPase-activating protein for ADP-ribosylation factor 6 (Arf6). This 
Paxillin-GIT1-Arf6 module is utilised by several different signalling systems and plays a 
crucial role in membrane traffic, adherens junction turnover and epithelial cell migration 
(Nishiya et al, 2005). Slit2 treatment reduced Arf6 activity in endothelial cells and these 
effects were dependent on Robo4-paxillin-GIT1 interactions (Jones et al, 2009). VEGFR 
and integrin signalling promotes activation of Arf6, therefore the authors suggested a 
model where Slit2 stimulates recruitment of a paxillin–GIT1 complex to the cytoplasmic 
tail of the Robo4 receptor, causing local inactivation of Arf6 and intersection of pro-
angiogenic VEGFR and integrin signalling (Jones et al, 2009). In agreement with this 
model, a recent study observed that Slit2 reduced Arf6 activation and had anti-angiogenic 
effects in mice corneas with virus-induced keratitis (Mulik et al, 2011). 
1.4.2.6 USP33	
A yeast two-hybrid screen has also demonstrated that the Robo1 cytoplasmic tail recruits 
ubiquitin specific protease 33 (USP33/VDU1). Further biochemical studies showed that 
USP33 binds to the Robo1 CC3 fragment and Slit2 has no observable effect on this 
interaction (Yuasa-Kawada et al, 2009a; Yuasa-Kawada et al, 2009b). USP33 is a 
deubiquitinating enzyme which protects proteins from proteosomal degradation and 
regulates receptor trafficking. USP33 together with USP20 removes ubiquitination from 
the β2 adrenergic receptor, inhibits its lysosomal trafficking and promotes recycling and 
resensitization of the receptor (Berthouze et al, 2009; Li et al, 2002). Relatively little is 
known about endogenous Robo ubiquitination and its biological relevance, as it was only 
detected after Robo1 and ubiquitin ligase were contransfected into HEK 293 cells (Yuasa-
Kawada et al, 2009b). However, it was demonstrated that USP33 is necessary for Slit-
Robo mediated inhibition of breast cancer cell migration and the collapse of neuron growth 
cones (Yuasa-Kawada et al, 2009a; Yuasa-Kawada et al, 2009b). Microscopy and biotin 
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labelling experiments showed that Slit2 induced USP33 dependent Robo1 receptor 
redistribution from vesicles to plasma membrane in the breast cancer cell line MDA231 
(Yuasa-Kawada et al, 2009a). Similarly, knockdown of USP33 in neurons reduced Robo1 
level in plasma membrane, but only if cells were stimulated with Slit2 (Yuasa-Kawada et 
al, 2009b). The authors argued that USP33 may protect Robo1from degradation or 
facilitate its recycling from endocytic vesicles. Contrary to these observations and 
speculations, proteosomal inhibitors had no effect on Slit2 induced retinal growth cone 
collapse (Piper et al, 2006). Further studies and independent confirmation are necessary to 
establish the role of ubiquitination in Slit-Robo signalling. This topic is of particular 
importance, since currently little is known Robo1 desensitisation.  
1.5 Slit‐Robo	biological	functions	
1.5.1 Development	and	wiring	of	nervous	system	
The Slit-Robo signalling axis most likely first emerged as a mechanism to control neuronal 
migration and guide axon projections in bilateral organisms. Bilateral organisms can be 
divided into two mirror image halves by a longitudal axis of symmetry. The same virtual 
axis in the central nervous system (CNS) is called the midline and it is an important part of 
its organisation. Axons that cross the midline and link two sides of the nervous systems are 
called commissural axons. They are crucial for transferring sensory information and 
organising co-ordinated motor responses. Crossing the midline poses a challenge for 
neuron growth cones, since initially they must be attracted to the midline and then that 
attraction switched to repulsion to prevent re-crossing. A series of elegant studies 
established the mechanism behind midline crossing for Drosophila and mice and in both 
cases Slit-Robo proteins were an essential part of it (Figure 1.7). 
Midline glial cells express Slit and netrin proteins. Netrin acts via the DCC receptor to 
attract commissural growth cones. Meanwhile, premature repulsive effects of Slit are 
evaded by downregulating cell surface Robo. In Drosophila, a protein called comm sorts 
Robo from the Golgi into endosomes not allowing it to reach the growth cone. After 
crossing the midline, an unknown mechanism downregulates the expression level of 
comm, Robo reaches the cell surface and makes axon growth cones sensitive to repellent 
Slit (Keleman et al, 2002; Kidd et al, 1998b). Midline crossing in vertebrates follows 
basically the same mechanism, where Robo activity is downregulated before and 
upregulated after crossing the midline. Vertebrates, however, do not have a known comm 
protein orthologue and employ a different mechanism to control the temporal and spatial 
activity of Robo. Chen et al, 2008 demonstrated that two differently spliced Robo3 forms 
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are expressed in commissural neurons. Robo3.1, which differs from Robo3.2 by a dozen 
amino acids at the very end of the C-terminal domain, is expressed before crossing the 
midline. Robo3.1 blocks Robo1 and Robo2 activity thus negating premature repulsive 
functions of Slit. When the midline is crossed, neurons switch to Robo3.2 expression, 
which appears to cooperate with Robo1 and Robo2 in sensing Slit repulsion (Chen et al, 
2008; Sabatier et al, 2004). Moreover, in the presence of Slit2, Robo1 binds to the DCC 
receptor and abolishes netrin-induced attraction, further facilitating repulsion and 
Figure 1.7 Slit-Robo role in midline crossing and longitudinal tract formation 
Schematic view of midline crossing by axons and longitudinal tract positioning in Drosophila (A and C) 
and vertebrates (B and D). In Drosophila, Slit expressed by midline repels Robo expressing neuron 
growth cones thus preventing axons crossing into the opposite side. Commissural axons express protein 
comm which downregulated Robo at the cell surface and thus enables midline crossing. Midline re-
crossing in these axons is prevented by downregulation of comm and consequent Robo delivery to the 
cell surface (A). In mammals midline crossing is regulated by Robo3.1, an alternative Robo3 splicing 
form. In commissural axons it antagonises Robo1 and thus allows successful crossing of the midline. 
When growth cone reaches the opposite side, Robo3.1 is downregulated removing Robo1 inhibition and 
thus preventing midline re-crossing (B). After crossing the midline both mammals and Drosophila axons 
are sorted into different longitudinal tracts which occupy specific positions in relation to the midline: 
medial, intermediate and lateral (C and D). "Robo code" hypothesis suggests that axons are sorted into 
these tracts according to expressed Robo type. Alternatively, it was suggested that total cumulative 
concentration of Robo, but not the type of Robo, determines axon sorting into longitudinal tracts. Figure 
taken from de Wit et al, 2011. 
Chapter 1  35 
 
preventing midline recrossing by commissural axon growth cones (Stein & Tessier-
Lavigne, 2001). 
After crossing the midline, commissural axons turn longitudinally and extend in parallel to 
the midline forming so called longitudinal axon tracts. Within these tracts axons are 
organised into discrete threads which occupy specific positions in relation to the midline: 
medial, intermediate and lateral. Experimental evidence strongly indicates that axon 
sorting into these specific threads is achieved through Slit-Robo signalling (Figure 1.7B 
and D). In Drosophila, longitudinal axons have a striking Robo expression pattern: medial 
axons express only Robo, intermediate axons express Robo and Robo3 while lateral axons 
express all three Robos (Rajagopalan et al, 2000b; Simpson et al, 2000a). These 
observations led to the so called “Robo code” hypothesis according to which Robo 
homologues have differential Slit binding and/or downstream signalling and thus, by acting 
in combination are able to sort axons into different longitudinal threads. Genetic gain- and 
loss-of function studies strongly support this model. Robo3 knockout in Drosophila caused 
axons to shift from intermediate into the medial zone. Similarly, heterologous expression 
of Robo3 shifted medial axons into more lateral pathways (Rajagopalan et al, 2000b; 
Simpson et al, 2000a). However, two recent papers cast serious doubt over the “Robo 
code”. Spitzweck et al, 2010 directly demonstrated the irrelevance of the “Robo code” by 
generating and analysing a series of “Robo swaps”, where each of the three Robo receptors 
was expressed from three different robo loci. It turned out that Robo is essential and cannot 
be substituted by either Robo2 or Robo3 when it comes to preventing midline re-crossing. 
However, the choice of longitudinal pathway does not depend on Robo subtype, since 
knocking in either Robo or Robo2 into the Robo3 locus completely rescued the 
longitudinal phenotype of Robo3 knockout Drosophila (Spitzweck et al, 2010). Similarly, 
Evans & Bashaw, 2010 showed that overexpression of Robo3 or Robo2, in the background 
of double Robo/Robo2 or Robo/Robo3 knockout respectively, is sufficient to shift axons 
laterally. These observations also argue against a combinatorial “Robo code”. Overall, 
these results are more compatible with a model where the longitudinal pathway is specified 
by the total Robo level, with higher combined receptor expression driving axons further 
away from the midline.  
The majority of our knowledge about the role of Robo in lateral axon positioning comes 
from Drosophila because of their simpler anatomy and the availability of genetic tools. 
Nevertheless, several studies hint that Robos fulfil a similar role in vertebrates. In Robo1 
knockout mouse embryos, the medial axon threads are reduced and the dorsal threads are 
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thicker, suggesting a lateral shift of the Robo2 expressing axons. Conversely, in Robo2 
knockout embryos, the medial threads are thicker, and the dorsal are thinner, indicating a 
medial shift of Robo1 positive axons (Long et al, 2004). Finally, chick commissural axons 
that misexpress Robo2 fail to cross the midline and preferentially adopt a longitudinal 
pathway (Reeber et al, 2008). 
In addition to commissural axon guidance during midline crossing, Slit-Robo control 
general axon targeting within the CNS. They are responsible for proper axon path finding 
in the visual systems of the Drosophila, zebrafish and mice (Fricke et al, 2001; Hutson & 
Chien, 2002; Pappu et al, 2011; Plump et al, 2002; Tayler et al, 2004). Another part of the 
CNS with a well described Slit-Robo role is the olfactory system. In Drosophila, distinct 
subtypes of olfactory axons express unique combinations of Robo proteins and thus are 
targeted to different positions in the olfactory lobes (Jhaveri et al, 2004). In mice, Slit and 
Robo gradients “sort” axons expressing the same odorant receptor and force them to 
converge on the same glomerulus (Cho et al, 2007; Cho et al, 2009; Nguyen-Ba-Charvet et 
al, 2008). At least in Drosophila, Slit-Robo also guide neuron wiring outside the CNS. In 
combination with netrin/Frazelled they target motorneuron dendrites to their respective 
muscle field (Brierley et al, 2009; Mauss et al, 2009).  
All Slit-Robo functions described so far were related to axon growth cone guidance. 
However, ample evidence exists that Slit-Robo signalling is able to control migration of 
neuronal cells. Slit-Robo control cortical interneuron migration as Robo1 knockout mice 
embryos had substantially higher numbers of migratory interneurons in their cortex 
(Andrews et al, 2008; Andrews et al, 2006; Andrews et al, 2007). Likewise, olfactory bulb 
interneuron migration relies on repulsive Slit activity (Hu, 1999). Interestingly, Kaneko et 
al, 2010 suggests that Slit expressed by migratory neurons helps to clear a path from Robo-
expressing glia. This leads to formation of so called “glia tubes” which facilitate migration 
of young neuron chains (Kaneko et al, 2010).  
1.5.2 Muscular	and	cardiac	system	development	
Slit and Robo proteins are not restricted to the nervous system. They are expressed in a 
wide variety of tissues and organs suggesting additional roles to those during nervous 
system development. The first evidence that Slits and Robos have additional functions 
came from studies in Drosophila myoblast migration. The midline source of Slit in fly 
embryos repels Robo-expressing myoblasts from the midline, but after a while, the same 
cells change their behaviour and require Robo to extend toward Slit expressing muscle 
attachment sites (Kidd et al, 1999; Kramer et al, 2001). This switch possibly plays an 
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essential role in the generation of muscular architecture, however the mechanism behind 
the switch remains unknown. Subsequently, Halperin-Barlev & Kalcheim, 2011 
demonstrated that the Slit-Robo signalling axis takes part in organising the avian muscular 
system. Vertebrate muscles develop from somites, transient epithelial structures which 
further develop into dermomyotome and sclerotome. The earliest muscle progenitors, 
called pioneer myoblasts, arise from somites and engage in complex migration which lays 
down the pattern for further waves of myoblast migration and muscle development. 
Pioneer myoblasts express Robo2, whereas the dermomyotome and caudal sclerotome 
express Slit1. Knocking down either Robo2 or Slit1 with RNAi interfered with pioneer 
myoblast migration and subsequent muscle fibre formation (Halperin-Barlev & Kalcheim, 
2011). Given these remarkable functional similarities between Drosophila and birds, one 
can expect that mammalian muscle development involves similar mechanisms.  
The Slit-Robo axis also plays an important role in the development of the heart. In 
Drosophila, the heart is formed by two bilateral groups of heart precursor cells which 
migrate towards the midline of the embryo and then fuse to form a linear heart tube. 
Several independent studies, albeit with some contradictory details, revealed that proper 
migration, alignment, polarisation and fusion of these precursor myoblasts depends on Slit, 
Robo and Robo2 proteins (MacMullin & Jacobs, 2006; Qian et al, 2005; Santiago-
Martínez et al, 2006). At the end of this migratory phase, heart precursor cells acquire a 
concave shape with Slit-Robo proteins accumulated on the concave surface (Figure 1.8). 
Adhesive E-cadherin interactions seal opposing myoblast edges, while repulsive Slit-Robo 
Figure 1.8 Heart lumen formation in Drosophila 
In wild type Drosophila adjacent cardioblasts fuse together via E-cadherin expressing cell surface domains. 
Slit-Robo proteins prevent full fusion and enable lumen formation (A). If Slit-Robo signalling axis is 
deficient, no lumen or small ectopic lumen is formed (B). Figure taken from Helenius and Beitel, 2008. 
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signalling prevents total cell-cell fusion and prevents the newly formed lumen from 
complete closure (Santiago-Martínez et al, 2008; Medioni et al, 2008). 
The early stages of Drosophila heart formation are similar to those of vertebrates and given 
the strongly conserved Slit-Robo role in neuron guidance, one can expect that chordate 
heart formation involves Slit-Robo signalling as well. Indeed, in zebrafish, Slit2, Robo1 
and Robo4 appear to regulate cardiac development (Fish et al, 2011). The authors 
demonstrated that vascular endothelial growth factor (VEGF) acting via its cognate 
receptor VEGFR2 is a main mediator of heart precursor cell migration. Slit and Robos in 
this system act as cardioblast migration inhibitors, however what functions they actually 
confer remain unclear. Most interestingly, miRNA-218 regulates Robo1 expression during 
heart development in zebrafish (also see sections 1.5.6 and 1.5.7 for more miRNA 
functions in angiogenesis and cancer). Knockdown of miRNA-218 or overexpression of 
Robo1, and unexpectedly knockdown of Robo1, caused delayed migration and abnormal 
heart development, showing that precise titration of Robo1 is necessary for correct 
myoblast migration (Fish et al, 2011).  
The role of Slit-Robo in the development of the mammalian cardiac system currently 
remains vague. Medioni et al, 2010 showed that Slit2, Slit3, Robo1 and Robo2 are 
expressed in the developing mouse heart, however, Slit or Robo knockout animals 
generally do not suffer from serious cardiac abnormalities (Andrews et al, 2006; Plump et 
al, 2002; Xian et al, 2001b). Slit3 knockout mice had enlarged right ventricles, however it 
is difficult to assess these changes since the animals suffered from diaphragmatic hernia 
and many organs were dislodged from their natural positions (Liu et al, 2003). The 
alternative explanation that single knockouts failed to reveal cardiac phenotypes because of 
Slit or Robo redundancy between different family members is also possible. 
1.5.3 Kidney	development	
Homozygous Slit2 knockout mice die at birth because of multiple developmental defects 
including abnormal kidneys (Plump et al, 2002). Slit3 knockouts caused kidney and ureter 
agenesis in some animals, however when these organs did form they appeared normal (Liu 
et al, 2003). Homozygous Robo2 knockout animals had similar kidney deformations as 
Slit2 knockouts, indicating that Slit2-Robo2 signalling is necessary for correct 
organogenesis of the kidney (Grieshammer et al, 2004). Murine kidney originates from a 
single nephric duct outgrowth called the ureteric bud (UB), formation of which is 
controlled by glial cell line-derived neurotrophic factor (GDNF). In Slit2 and Robo2 
knockout embryos, multiple ectopic UB are formed leading to the development and fusion 
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of multiple ureters and kidney (Grieshammer et al, 2004). Given the repulsive nature of 
Slit-Robo signalling, one could expect that Slit2 restricts ectopic ureteric buds by repelling 
UB-forming cells, however no evidence was found to support this assumption. The authors 
instead favoured a different model, where Slit2 signals through Robo2 to inhibit GDNF 
expression. This idea is based on the fact that the Slit2 knockout kidney phenotype can be 
rescued by reducing GDNF dosage (Grieshammer et al, 2004). The mechanism by which 
Slit2-Robo2 interact with GDNF remains unknown and additional studies are needed to 
clarify exactly how UB restriction is achieved.  
1.5.4 Lung	development	
Homozygous mouse embryos with defective Robo1 alleles show delayed lung maturation, 
reduced lung volume and increased amounts of mesenchymal tissue. The few animals that 
survived postnatally had abnormal and hyperplastic bronchial epithelium (Xian et al, 
2001b). Independently, a microarray based screen also identified Slit3 as one of the factors 
controlling lung development (Greenberg et al, 2004). Expression profiling revealed that 
Slit2, Slit3, Robo1 and Robo2 are expressed mainly in the mesenchymal tissue of 
developing lungs, although epithelial localisation was also observed for Robo1 and Robo2 
(Anselmo et al, 2003; Greenberg et al, 2004). Lung mesenchyme undergoes dramatic 
tissue remodelling during organogenesis which incorporates cell differentiation, apoptosis 
and migration. Given the already known functions of Slit-Robo in other organs and tissues, 
it is reasonable to suspect that Slit-Robo plays an important role in organising cellular lung 
architecture. Unfortunately, at this stage little is known about the mechanism involved.  
While Drosophila have no real lungs, they employ the so called tracheal system, an 
elaborate whole body spanning network of air filled tubes, which bring oxygen and remove 
carbon dioxide. Most fascinatingly, development of the tracheal system in Drosophila is 
guided by Slit-Robo signalling. Slit, Robo and Robo2 are indispensable for correct tracheal 
branch outgrowth towards their target tissue (Englund et al, 2002). The authors also 
suggest that in this system Slit can cause both attractive and repulsive responses, where the 
effects of Slit are determined by different combinations of Robo and Robo2 receptors 
(Englund et al, 2002).  
1.5.5 Other	developmental	functions	
In situ hybridisation with whole-mount mouse embryos revealed striking Slit-Robo 
expression patterns in developing limbs (Holmes et al, 1998; Vargesson et al, 2001; Yuan 
et al, 1999). For example, at stages E11.5 and E13.5, Slit2 was strongly expressed in all 
interdigital spaces (Holmes et al, 1998; Yuan et al, 1999). At stage E13.5 Robo1 is 
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expressed along the borders of developing digits, however this pattern gradually changes 
and at E15.5 Robo1 expressing regions form “rings” roughly marking the joints of the 
digits (Vargesson et al, 2001). Strangely enough, despite these beautiful expression 
patterns no further work has been done regarding the role of Slit-Robo in limb 
development. The authors speculated about a possible Slit-Robo role in apoptosis, axon 
innervations or myoblast migration, but only speculation about myoblast migration has 
some supporting evidence as Slits and Robos co-localise with the migratory myoblast 
marker Pax7 (Vargesson et al, 2001).  
Expression profiling also hints at a possible Slit-Robo role in the development and 
functions of the ovary. Slit2, Slit3, Robo1, Robo2 and Robo4 were expressed in fetal sheep 
ovary, with Robo2 and Robo4 levels changing significantly across different gestation 
stages (Dickinson et al, 2010). Slit-Robo proteins might also have important functions in 
adult ovaries during luteolysis (Dickinson et al, 2008). The corpus luteum, also known as 
the yellow body, is a temporary endocrine structure in mammalian ovaries formed from the 
follicle after ovulation. It produces progesterone and other hormones which facilitate 
various processes related to fertilisation and pregnancy. If the oocyte is not fertilised, the 
corpus luteum stops secreting progesterone and decays in a process called luteolysis. If egg 
fertilisation and implantation occurs, human chorionic gonadotropin (hCG) is released, 
saving the corpus luteum from degradation and thereby prolonging its functions. Dickinson 
et al, 2008 showed that Slit2, Slit3, Robo1 and Robo2 are expressed in the corpus luteum. 
Moreover, Slit2, Slit3 and Robo3 expression was increased in late stages of luteolysis and 
significantly reduced after corpus luteum “rescue” in vivo with exogenous hCG. Likewise, 
treatment with hCG significantly inhibited Slit2, Slit3 and Robo2 expression in cultured 
luteinized granulosa cells (Dickinson et al, 2008). Luteolysis involves a considerable 
amount of tissue remodelling so the idea that the Slit-Robo signalling axis might play a 
role is not too far-fetched. This study also suggests that Slit-Robo expression might be 
regulated by hormones, although so far this has not been observed in any other system. As 
a side note, although most likely it is evolutionarily unrelated to mammals, proper gonad 
formation in Drosophila also depends on functional Slit-Robo proteins (Weyers et al, 
2011).  
1.5.6 Angiogenesis	
Formation of new blood vessels is achieved by two different processes: vasculogenesis and 
angiogenesis. Vasculogenesis is de novo formation of the vascular system during embryo 
development. Angiogenesis, on the other hand, is the formation of new blood vessels from 
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already existing vessels by endothelial cell sprouting. Angiogenesis is crucial for normal 
functioning of the adult organism, but it also plays a major role in various pathological 
processes like cancer, diabetic retinopathy or psoriasis (Pandya et al, 2006; Risau, 1997). 
VEGF is a major regulator of angiogenesis; it promotes endothelial proliferation, migration 
and formation of capillary tube structure. In addition to VEGF, many other signalling 
molecules promote or suppress angiogenesis and Slit-Robo proteins, especially Robo4, 
play a substantial role in the regulation of angiogenesis. 
Because of its divergent structure, Robo4 was the last family member to be discovered. 
Originally identified as a possible endothelial marker by a computational screen, Robo4 
expression indeed co-localised with the vasculature and especially with sites of intensive 
angiogenesis (Huminiecki et al, 2002; Park et al, 2003). Initially described as a very 
specific endothelial marker (Huminiecki et al, 2002; Okada et al, 2008; Seth et al, 2005), 
Robo4 is now reported to be additionally expressed by hematopoietic stem cells and 
vascular smooth muscle cells (Liu et al, 2006; Shibata et al, 2008; Smith-Berdan et al, 
2011). In agreement, Robo4 was detected in many endothelial cell lines in vitro: human 
umbilical vein endothelial cells (HUVEC), human dermal microvascular endothelial cells 
(HDMEC), and mammary microvascular endothelial cells (HMME2). While Robo4 seems 
to be a ubiquitous marker of endothelial cells, coexpression of Robo1, Robo3, Slit2 and 
Slit3 was also reported, but levels varied between different tissues (Liu et al, 2006; Small 
et al, 2010; Zhang et al, 2009). 
The role of Robo4 in angiogenesis has attracted intense interest from the scientific 
community, but despite substantial advances, fundamental details such as the identity of 
the Robo4 ligand and the actual effects of Robo4 on blood vessel formation remain 
somewhat obscure. Even relatively simple assays, such as transwell cell migration, are 
reported to give outright opposite results. Park et al, 2003 and Seth et al, 2005 
demonstrated that Slit2 prevents HMVEC or HUVEC migration towards VEGF, 
meanwhile Wang et al, 2003 and Howitt et al, 2004 successfully used Slit2 protein as an 
attractant for HUVEC cells. Matters were complicated even more by the fact that HUVEC 
cells express Robo1. As mentioned above (see section 1.3), the ability of Robo4 to bind 
Slit2 is debatable, so it is unclear which protein was responsible for these functional Slit2 
effects. Two independent studies tried to resolve these discrepancies by selectively 
knocking down Robo1 and Robo4 expression in HUVEC cells with siRNA (Kaur et al, 
2008; Sheldon et al, 2009). In both cases Slit2 showed pro-migratory effects on HUVEC 
cells, however while Kaur et al, 2008 reported an increase in Slit2 activity after Robo4 was 
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depleted, under the same conditions Sheldon et al, 2009 observed a reduced HUVEC 
response to Slit2. Both papers demonstrated Robo1 association with Robo4 by 
co-immunoprecipitation. Sheldon et al, 2009 additionally showed that overexpression of 
Robo4 induced excessive filopodia in HUVEC cells, while knockdown of Robo1 abolished 
this effect. Moreover, Slit2 activity on HUVEC cells was blocked by soluble Robo1, but 
not by the Robo4 ectodomain, indicating significant crosstalk between Robo1 and Robo4. 
On the other hand, Kaur et al, 2008 showed that Robo4, but not Robo1, mediates HUVEC 
attraction to serum, which presumably contains an as yet unknown VEGF-independent 
ligand. While these studies failed to clarify existing contradictions, they are pointing to 
possible reasons for them. It appears that even in such a simple system as in vitro HUVEC 
migration, Robo4 effects are highly context dependent and rely heavily on crosstalk with 
other Robo proteins.  
Different in vivo models were used to assess Slit-Robo roles in angiogenesis with 
predictably different outcomes. As many other cancer cells (see section 1.5.7), the human 
malignant melanoma cell line A375 expresses Slit2 protein. A375 cell-derived solid 
tumours in xenografted mice developed microvessels to sustain themselves. This ability 
was diminished by administration of a soluble extracellular Robo1 domain or anti-Robo1 
antibody (R5) and enhanced by the presence of Slit2 (Wang et al, 2003). While these 
results clearly support a positive role of Slit-Robo in angiogenesis, little can be inferred 
about the exact mechanism since authors have not addressed the possible presence of other 
Slit-Robo proteins in their model and acknowledged that the anti-Robo1 antibody might 
cross-react with other Robo proteins. The same group extended their observations, albeit 
with the same shortcomings, and demonstrated that the R5 antibody, which presumably 
blocks Slit2-Robo1 interactions, reduced angiogenesis in the chick embryo chorioallantoic 
membrane. They also showed that the same antibody is able to reduce new vessel 
formation and growth in DMBA (7,12-Dimethylbenz(a)anthracene)-induced hamster 
buccal pouch squamous cell carcinoma (Wang et al, 2003). The most convincing evidence 
that the Slit-Robo signalling axis promotes angiogenesis unexpectedly came from work 
with Slit3. Zhang et al, 2009 showed that endothelial and smooth muscle cells from lung, 
brain and kidney, but not from liver and heart, express Slit3. They proceeded to 
demonstrate that Robo3 stimulated proliferation in HUVEC and lung endothelial cells 
(LuEC) and promoted their motility and migration. They also showed that in their hands 
Slit3 binds both Robo1 and Robo4, however only Slit3-Robo4 binding affects HUVEC and 
LuEC migration. Treatment with Slit3 initiated sprouting of microvesels in an ex vivo rat 
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aortic ring assay and enhanced angiogenesis in chicken chorioallantoic membrane and 
mouse corneal assays. The authors also revealed vascular abnormalities in the developing 
diaphragm of homozygous Slit3 knockout animals (Zhang et al, 2009).  
Robo4 knockdown in zebrafish led to a temporal and spatial disruption of embryonic 
vascular development. This knockdown phenotype indicates a possible role of Robo4 as a 
guidance cue for the developing vasculature, however the underlying mechanism remains 
elusive (Bedell et al, 2005). Jones et al, 2008 tried to ascertain Robo4 functions in 
mammals by generating Robo4 knockout mice with a reporter gene inserted within the 
Robo4 locus. Surprisingly, homozygous Robo4 knockout mice were completely viable and 
fertile, with no obvious defects in vasculature development or function. The reporter gene 
showed that Robo4 is expressed in more mature parts of blood vessels and not in 
pioneering sprouting cells. These observations were incompatible with the “guidance” 
theory, therefore the authors hypothesized that Robo4 is required to maintain vascular 
stability. In agreement with this assumption they showed that treatment with recombinant 
Slit2 inhibits lung endothelial cell migration and tube formation, decreases VEGF induced 
vascular permeability in vitro and in vivo, and also reduces pathological angiogenesis in 
oxygen-induced retinopathy in mice (Jones et al, 2008). All these effects were assumed to 
be mediated by Slit2-Robo4 interactions, since the effects of recombinant Slit2 were 
abrogated in Robo4 knockout animals and cells. The authors also suggested that Robo4 
promoted vascular stability by antagonising VEGF signalling (Jones et al, 2008). It is also 
worth mentioning that in direct contradiction to Zhang et al, 2009, Jones et al, 2008 
showed that Slit3 had identical effects to those of Slit2 and acted in an anti-angiogenic 
manner, even though both studies used similar assays. In a follow-up publication, the same 
group extended their observations and showed that Slit2, acting via Robo4, controlled 
vascular stability during inflammation (London et al, 2010). One of the effects of 
inflammation is leakage of blood vessels, which if uncontrolled can lead to tissue oedema 
and organ damage. The authors demonstrated that treatment with recombinant Slit2 
reduces vascular permeability and increases animal survival in pulmonary inflamation, 
polymicrobial sepsis and influenza infection models (London et al, 2010). These effects 
were Robo4 dependent as they disappeared in Robo4 knockout animals. 
Use of recombinant Slit2 proteins is a potentially problematic approach, as some authors 
speculated that the source of experimental contradictions might be varying methods of Slit 
preparation (Marlow et al, 2010). This makes genetic experiments particularly attractive 
and Marlow et al, 2010 analyzed how various combinations of Slit-Robo knockouts affect 
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vascularisation of mammary glands in mice. The authors showed that in their experimental 
system, Slit2 and Slit3 are expressed by mural cells (smooth muscle cells and pericytes 
surrounding small blood vessels) while Robo4 and Robo1 are present in endothelial cells. 
Additionally, Robo1 is expressed in surrounding epithelial cells of the gland. Only 
combined Slit2+/- Slit3-/- (homozygous Slit2 knockout is lethal, hence heterozygous mice 
were used instead) and Robo1-/- Robo4-/- knockouts affected vascular composition. In 
both cases vessel density was increased about twofold. Robo1-/- Robo4-/- mice also 
showed increased autophosphorylation of VEGFR2. All these observations support 
findings from Jones et al, 2008 and London et al, 2010 and their idea that Robo4 
antagonises VEGF signalling and thus acts as an anti-angiogenic and vasculature 
stabilising factor.  
Slit2 and Slit3 are closely related proteins so their redundancy was not unexpected. On the 
other hand, the necessity to remove both Robo1 and Robo4 before any phenotypic effects 
were observed is more puzzling. If Robo1 and Robo4 were forming functional 
heterodimers as proposed by others (Kaur et al, 2008; Sheldon et al, 2009), knockdown of 
either should have functional consequences. Marlow et al, 2010 proposed a possible 
explanation of this phenomenon. They showed that Robo1 expressed on surrounding 
epithelial cells of the gland, acting via an unknown mechanism, suppresses expression of 
pro-angiogenic signalling molecules VEGF and CXCL12. The authors suggest a model 
where Slits and Robo4 acts as “brakes” to VEGF. Removing them would not cause a 
change in phenotype under normal conditions. It takes a secondary pro-angiogenic 
stimulus, in this case upregulation of VEGF and CXCL12 caused by Robo1 knockout, for 
a phenotype to manifest itself.  
Koch et al, 2011 added another twist to the Robo4 story. Since in their hands Slit2 was not 
binding Robo4, the authors performed a bio-layer interferometry-based protein-protein 
interaction screen to identify possible Robo4 ligands. A vascular-specific netrin receptor 
UNC5B was detected as a Robo4 ectodomain interacting protein and this interaction was 
further confirmed with surface plasmon resonance (Koch et al, 2011). Both soluble or 
membrane bound Robo4 ectodomains were able to activate UNC5B downstream signalling 
pathways, but not the other way around. Activated UNC5B counteracted VEGF signalling 
by inhibiting VEGF-mediated Src kinase activation. Likewise, blocking Robo4-UNC5B 
interactions with specific antibodies substantially increased angiogenesis and vascular 
permeability in vivo (Koch et al, 2011). This study largely confirms observations that 
Robo4 is dispensable for development, but necessary for maintenance of blood vessel 
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integrity under inflammatory stress. On the other hand, these experiments show that 
instead of being a receptor, Robo4 is a membrane bound ligand for UNC5B which 
mediates the vascular effects. Koch et al, 2011 findings raise more questions than answers. 
It is doubtful that Robo4 is only a cell surface bound ligand, as it retains a cytoplasmic tail 
and appears to be an active receptor in other experimental systems (Jones et al, 2009; Kaur 
et al, 2006; Sheldon et al, 2009). Most likely these divergent data illuminate separate parts 
of a complex signalling system, the full picture of which is yet to be revealed.  
As mentioned previously, the introns of Slit2 and Slit3 encode a microRNA molecule 
called miRNA-218. This feature is well preserved evolutionarily and conserved between 
animals as different as zebrafish and humans (Fish et al, 2011; Small et al, 2010; Tie et al, 
2010). Small et al, 2010 showed that miRNA-218 is able to repress Robo1 and Robo2 
expression, as well as some other components of the Slit-Robo signalling axis, like 
srGAP2 and enzymes necessary for heparan sulphate biosynthesis. Blocking miRNA-218 
in the mammalian retina led to increased vascular permeability but decreased density and 
thickness (Small et al, 2010). Blocking of miRNA-218 also caused greater HUVEC 
migration in a scratch healing assay, while overexpression reduced it. It is difficult to 
unambiguously infer a Robo1 role from these experiments. Robo4 does not seem to be 
targeted by miRNA-218 and the authors speculate that a miRNA-218 feedback loop might 
be responsible for regulating the Robo1-Robo4 ratio and hence formation of the Robo1-
Robo4 heterodimer (Small et al, 2010). In turn this might decide overall the outputs of Slit-
Robo signalling in the vasculature. 
Dunaway et al, 2011 tried to consolidate published pro- and anti-angiogenic Slit effects 
and concluded that Slit tends to be angiogenic alone and angiostatic in the presence of 
VEGF. They suggested that some tertiary factor, induced by VEGF, can modulate 
endothelial cell responses to Slit. Accordingly, Slit2 alone promoted angiogenesis through 
activation of Akt in primary vascular endothelial cells and in vivo models. However, the 
presence of a protein called ephrin-A reversed Slit2 activity and converted it into an anti-
angiogenic factor (Dunaway et al, 2011). Ephrin-A is a surface bound ligand for the Eph 
family receptor tyrosine kinases whose expression in endothelial cells is induced by 
VEGF. Ephs and ephrins, like Slit-Robo, are major players in axon and neuron guidance, 
cell migration and vascular development. A remarkable feature of the ephrin/Eph 
signalling axis is its ability to transduce signals in both ways, from ligand to receptor 
expressing cells and vice versa (Pasquale, 2010). The exact mechanism of crosstalk 
between Slit-Robo and Ephrin-Eph pathways, as well as its biological relevance remains 
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unknown. It is tempting to speculate that this interplay between Slit2 and ephrin-A1 is 
required for temporary separation of pro-angiogenic VEGF stimulus and stabilising Slit-
Robo effects. One can suggest, that initial pro-angiogenic VEGF signals bypass Slit-Robo 
blockade and among other effects switches ephrin-A1 synthesis on. In turn Ephrin-A1 
accumulates and switches Slit signalling into angiostatic mode.  
Proper functioning of the vasculature depends on a balance between angiogenic stimuli and 
angiostatic factors, and it seems that Slit-Robo mirrors this duality and metastability when 
it comes to their role in angiogenesis. It is also worth mentioning that Slit-Robo are not the 
only neuronal guidance cues employed in regulation of the vasculature. Three other major 
signalling pathways responsible for nervous system development, semaphorin-neuropilin, 
ephrin-Eph and netrin-UNC5 play even more important roles than Slit-Robo (Lu et al, 
2004; Wilson et al, 2006). As mentioned above, some of them, like neuropilin1, UNC5 and 
ephrin-A1, are already known to interact with the Slit-Robo signalling pathway. Given the 
currently observed high variation of experimental results, it might be a good strategy to 
analyse all these signalling pathways together, since functional relations forged in neuron 
wiring might be preserved in vasculature regulation.  
1.5.7 Cancer	
In addition to physiological functions, Slit-Robo seems to play a role in pathological 
conditions like cancer. Xian et al, 2001b observed that Robo1 gene maps within the third 
chromosome region often subjected to deletions in lung and breast cancer. Accordingly, 
heterozygous Robo1 knockout mice are prone to developing lymphomas and carcinomas 
about 3 times more often than control animals, with invasive lung adenocarcinoma being 
the predominant pathology (Xian et al, 2001a). It was also demonstrated that breast and 
kidney tumour cells tend to have a hypermethylated Robo1 promoter which silences its 
expression (Dallol et al, 2002). Similar epigenetic Slit2 silencing was observed in lung, 
breast, colorectal and glioma tumours and hepatocellular carcinoma (Dallol et al, 2003a; 
Dallol et al, 2003b; Jin et al, 2008). Slit1 promoter hypermethylation was detected in 
glioma cell lines while Slit3 was frequently silenced in breast, lung, colorectal and glioma 
tumour cell lines and in primary breast tumours and gliomas (Dickinson et al, 2004). 
Narayan et al, 2006 also showed that all Slits, Robo1 and Robo3 are epigenetically 
inactivated during the early stages of cervical cancer. In the clinic, downregulation of 
Robo1 and Robo2 strongly correlated with poorer survival of patients with oral cavity 
cancer (Ghosh et al, 2008), while low Slit2 expression was associated with poorer clinical 
outcome in lung and breast cancer (Brantley-Sieders et al, 2011; Tseng et al, 2010). All 
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these observations would suggest that Slit-Robo act as tumour suppressor genes. On the 
other hand, many other tumour cell lines and primary tumours do express Slit-Robo 
proteins (Schmid et al, 2007; Wang et al, 2003). Increased expression of different Slit-
Robo proteins was observed in prostate cancer, colorectal cancer and hepatocellular 
carcinoma (Gröne et al, 2006; Ito et al, 2006; Latil et al, 2003). A clinical study also 
revealed that elevated expression of Slit and Robo1 proteins in endometrial cancer was 
associated with higher risk of reccurrence (Ma et al, 2010). All these data demonstrate that 
Slit-Robo proteins are linked to cancer in an intricate and complex way.  
Some reports show that Slit-Robo proteins can directly control cancer cell proliferation and 
apoptosis. Re-expression of Slit2 in colorectal carcinoma and glioma cancer cell lines, 
which have their innate Slit2 epigenetically silenced, induced growth suppression and 
apoptosis (Dallol et al, 2003a; Dallol et al, 2003b). In vitro cancer cell proliferation was 
suppressed by recombinant Slit2 in hepatocellular carcinomas, esophageal squamous cell 
carcinomas and breast cancer cells (Jin et al, 2008; Kim et al, 2008; Marlow et al, 2008; 
Prasad et al, 2008). Kim et al, 2008 also observed an increased number of apoptotic cells in 
solid tumours derived from Slit2 transfected HT1080 cells. However, these Slit2 apoptotic 
effects are far from ubiquitous. There are equally abundant reports of Slit2 having no 
detectable effect on cancer cell proliferation or apoptosis (Dai et al, 2011; Schmid et al, 
2007; Tseng et al, 2010; Werbowetski-Ogilvie et al, 2006; Yiin et al, 2009). Generally, it 
seems that Slit-Robo play only secondary roles in cancer cell survival. One can argue that 
in some cases malignant transformation distorts cell signalling systems in such a way that 
the Slit-Robo signalling axis gains new functions that are harmful to cancer cells and thus 
is silenced epigenetically.  
Angiogenesis is another cancer pathology area where Slit-Robo proteins could play an 
important role. Tumour survival completely depends on its ability to induce angiogenesis 
to get accesses to oxygen and nutrients. Robo4 and Robo1 functions in angiogenesis are 
well documented (see section 1.5.6), but surprisingly, little is known about it in the context 
of cancer. As mentioned above, one group reported pro-angiogenic Slit2-Robo1 effects in 
A375 cell derived solid tumours and DMBA-induced hamster buccal pouch squamous cell 
carcinoma (Wang et al, 2003; Wang et al, 2008). No other studies have addressed this 
topic. Given the obvious importance of this area it is doubtful that it has been ignored. 
More likely this informational vacuum was created by the bias of negative results, and 
indeed, some authors mention in passing that they have failed to observe any Slit effects on 
the density of tumour blood vessels (Kim et al, 2008). 
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The most widely accepted model suggests that tumours produce growth factors and 
signalling molecules to attract blood vessels. However, more recently it was proposed that 
endothelial cells establish a vascular niche themselves, which actively promotes tumour 
survival with growth factors and other signalling molecules (Butler et al, 2010). Brantley-
Sieders et al, 2011 demonstrated that EphA2 receptor tyrosine kinase knockout increases 
Slit2 expression in endothelial cells, which in turn suppresses tumour growth in vitro and 
in vivo. The authors argue that this is an example of a vascular niche in action, since, 
EphA2 is often overexpressed in tumour vasculature, presumably causing Slit2 suppression 
and tumour growth promotion. 
Slit-Robo proteins primarily are known as cell motility regulators, so a lot of studies have 
concentrated on their possible role in metastasis. It is relatively well established that the 
CXCR4/CXCL12 axis drives breast cancer metastasis to bones, lungs and lymph nodes 
(Muller et al, 2001). Prasad et al, 2004 used the classical Boyden chamber assay to 
evaluate possible Slit2 effects on this migration. The lower part of the Boyden chamber 
was loaded with media containing CXCL12 and Slit2 or respective controls. Cells were 
pre-treated with Slit2 for 30 minutes and then added to the upper part of chamber. In this 
setup, Slit2 significantly inhibited cancer cell migration towards CXCL12. Additionally, 
the same authors showed that treatment with Slit2 reduced cancer cell invasion through 
Matrigel and adhesion to various substrates (Prasad et al, 2004). Using an identical 
experimental setup, Schmid et al, 2007 largely confirmed these observations, however they 
also noticed that Slit2, when placed in the lower chamber only, acted as attractant for the 
same breast cancer cells. To complicate matters even more, glioma cells were repelled by 
Slit2. When Slit2 was added to the lower chamber, glioma cell migration into it decreased, 
while Slit2 addition to the upper chamber facilitated cell movement from it. When the Slit2 
gradient was destroyed by adding equal amounts of protein into each chamber, Slit2 lost its 
effect on glioma cell migration (Mertsch et al, 2008).  
In vitro experiments have generally displayed inhibitory Slit2 effects on metastasis. Slit2-
transfected fibrosarcoma cells (HT1080), when injected into athymic mice, formed less 
metastases in comparison to those transfected with vector only (Kim et al, 2008). 
Expression of Slit2 also inhibits glioma cell infiltration into the brain parenchyma (Yiin et 
al, 2009). On the other hand, Tie et al, 2010 reported that in gastric cancer cells Slit2-
Robo1 signalling actively triggers metastasis. The authors found that decreased expression 
of a known Robo1 suppressor, miRNA-218 (see sections 1.5.2 and 1.5.6), is associated 
with advanced clinical stage, lymph node metastasis and poor prognosis for patients. They 
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also isolated gastric cancer sublines with different metastatic potential and found that 
Robo1 was expressed at high levels in invasive cells and at low levels in non-invasive 
cells, whereas miR-218 had the opposite expression pattern. Re-expression of miRNA-218 
or direct knockdown of Robo1 led to reduced invasiveness both in vitro and in vivo (Tie et 
al, 2010). It appears that in cancerous cells, like in endothelial cells, Slit-Robo signalling 
and its effects strongly depend on cellular context, tissue of origin and crosstalk with other 
signalling pathways.  
1.5.8 Leukocytes	and	immune	response	
One of the more unexpected Slit-Robo functions was uncovered when Wu et al, 2001 
showed that Slit2 is able to inhibit chemotactic leukocyte movement. Directional leukocyte 
migration is a crucial process in the inflammatory response and it is primarily regulated by 
positive guidance cues like chemokines. Endogenous negative regulators of chemotaxis are 
relatively unknown and could potentially serve as broad spectrum anti-inflammatory 
agents. Nevertheless, Slit-Robo role within the immune system has attracted considerably 
less interest than other fields. Systematic and consistent analysis of Slit-Robo expression in 
leukocytes is not published yet. Different studies have reported Robo1 expression on the 
majority of MHC II type cells (B cells, macrophages, dendritic cells (DC)), as well as 
monocytes, eosinophils and neutrophils (Geutskens et al, 2010; Guan et al, 2003; Kanellis 
et al, 2004; Tole et al, 2009; Ye et al, 2010). However, information about the other 
members of the Slit-Robo family is scarce, possibly reflecting an absence of expression as 
negative results usually remain unreported. Of those reported, Slit3 expression was 
induced by treatment with lipopolysaccharide (LPS) in primary macrophages (Tanno et al, 
2007), while Robo4 is expressed in hematopoietic stem cells (HSC) but its expression is 
lost after differentiation (Shibata et al, 2008; Smith-Berdan et al, 2011). So it seems that 
Robo1 is the main player in the hematopoietic system.  
Wu et al, 2001 was the first to demonstrate leukocyte chemotaxis inhibition by Slit2 in 
transwell migration asays. Since then many other studies were able to replicate similar 
results using identical assays but different cells and chemokines: peripheral blood 
mononuclear cell (PBMC) and CXCL12, HL-60 and fMLP (N-formyl Met-Leu-Phe) (Wu 
et al, 2001); ex-vivo leukocytes and CCL2, CCL5, CX3CL1, fMLP (Kanellis et al, 2004); 
Jurkat cells, primary monocytes and CXCL12 (Chen et al, 2004; Prasad et al, 2007); 
primary neutrophils and fMLP, C5a, CXCL-8 (Tole et al, 2009). Interestingly, time-lapse 
microscopy revealed that Slit2 affects directional cell movement but not random 
movement or speed (Tole et al, 2009; Yuasa-Kawada et al, 2009a). This indicates that Slit2 
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effects in leukocytes are solely anti-chemotactic, as it abolishes the sense of direction but 
not the ability to move.  
The ability of Slit2 to stop leukocyte migration was confirmed in multiple in vivo models. 
Recombinant Slit2 reduced hapten-induced Langerhans cell migration in skin explants 
(Guan et al, 2003). These effects were efficiently blocked by soluble Robo1 extracellular 
domain confirming that Slit2-Robo1 signalling is mediating inhibition. Treatment with 
Slit2 also reduced inflammatory responses in a contact hypersensitivity model (Guan et al, 
2003). In this experiment, Slit2 was injected into the dorsal side of one ear, which was then 
painted with the hapten. Five days later, the second ear was painted with the same hapten 
and inflammation intensity evaluated. Treatment with Slit2 arrested Langerhans cells 
within the first ear, as was demonstrated by immunohistochemistry, and consequently 
significantly reduced swelling in the second ear, since less Langerhans cells were able to 
reach draining lymph nodes and activate T cells (Guan et al, 2003). The authors speculated 
that Slit2, which is constitutively expressed in the skin, might be necessary for steady state 
retention of Langerhans cells within the skin. Similar results were observed in a kidney 
inflammation model, where recombinant Slit2 treatment reduced leukocyte infiltration into 
the kidneys and considerably improved renal histology and function (Kanellis et al, 2004). 
The authors also observed that the inflammation induced a downregulation of endogenous 
Slit2 in the kidneys and was further able to exacerbate inflammation by blocking 
endogenous Slit2 with antibodies (Kanellis et al, 2004). Likewise, Tole et al, 2009 
observed leukocyte recruitment inhibition by recombinant Slit2 administration in 
peritoneal inflammation.  
While the majority of published papers demonstrate negative Slit effects on leukocyte 
migration, two recent studies unexpectedly revealed Slit as a potentiating agent for 
chemotaxis. Ye et al, 2010 showed that in vitro Slit2 inhibits neutrophil migration but 
activates chemotactic responses in eosinophils. They also observed an identical effect in 
lung inflammation models. Within the lungs, Slit2 is expressed by Clara cells, forming a 
Slit2 gradient along the bronchus-alveoli axis (high to low expression levels). Challenging 
the lungs with LPS or ovalbumin induced neutrophil and eosinophil infiltration, 
respectively. In turn, mice overexpressing Slit2 had lower neutrophil, but higher eosinophil 
infiltration (Ye et al, 2010). The authors show that the response is geared towards one or 
the other outcome by differential expression of the downstream signalling molecule 
srGAP1 (see section 1.4.2). Neutrophils express high levels of srGAP1 and thus the Slit-
Robo axis is steered towards the inhibitory srGAP1-mediated signalling. Eosinophils have 
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considerably lower srGAP1 expression, hence the “pro-migratory” PI3K-Akt pathway 
becomes the primary Slit-Robo effector (Ye et al, 2010).  
Even more unexpectedly, Geutskens et al, 2010 showed that Slit1 and Slit3 promote 
monocyte migration in transwell assays and a peritonitis model. Earlier studies using 
similar assays showed strong inhibitory Slit2 effects on monocyte migration (Chen et al, 
2004; Prasad et al, 2007). One can argue that different Slit proteins might have different 
functions, and Geutskens et al, 2010 experiments seem to suggest exactly that. However, 
there are several issues with this model. First of all, the authors have not tested Slit2 
themselves, even though Slit2 is commercially available from the same supplier they 
obtained the other Slit proteins from. Given how variable Slit effects are in other systems, 
it is crucial to perform these experiments in parallel. Second, the Slit3 concentration used 
by the authors was 10-100 times higher than those usually used for Slit2 in other 
publications (Geutskens et al, 2010). Third, Slit proteins have 70% sequence identity, and 
Robo binding residues are even more highly conserved. Moreover, all three mammalian 
Slit proteins bind Robo1 with almost identical affinity (Suchting et al, 2005). This does not 
completely discard the possibility that different Slit proteins might have diverse functions, 
but makes it unlikely; indeed, this was never directly observed before. Slit-Robo signalling 
flexibility and its strong dependency on cellular context is widely known (see sections 
1.5.6 and 1.5.7) and it is more likely that once again Slits may enhance or reduce the 
chemotactic movement of leukocytes depending on cell differentiation, relative expression 
of the Robo1 receptor or other unknown factors.  
As mentioned above, Robo4 is specifically expressed in HSCs while bone marrow (BM) 
stromal cells express Slit2 (Shibata et al, 2008). Additionally, Smith-Berdan et al, 2011 
showed that the level of Robo4 was very low in fetal HSCs residing in liver but was 
upregulated once HSC moved to the bone marrow. HSCs residing within bone marrow 
retain high Robo4 expression, but lose it upon leaving the BM. Consistent with these 
findings, Robo4 knockout mice showed disturbed HSC localisation. Robo4-deficient HSCs 
more readily left the BM and entered the peripheral blood. Poorer BM engraftment and 
compensatory CXCR4 and CXCL12 upregulation were also observed (Smith-Berdan et al, 
2011). Based on these experiments and previous knowledge about HSC homing, the 
authors suggested a model where CXCR4 and CXCL12 guide cells over a long range 
towards the BM. Once within the niche, Robo4 helps HSCs to establish and maintain 
stable engraftment. The exact mechanism by which this is achieved remains unknown. 
Slit2 is expressed by BM stromal cells, but in vitro assays failed to reveal any Slit2 effects 
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in HSC migration or proliferation (Smith-Berdan et al, 2011). On the other hand, if Slit2 is 
required for Robo4 mediated cell-cell adhesion, solution based assays would fail to detect 
it.  
1.6 Final	thoughts	about	Slit‐Robo	proteins	
One constantly reccurring aspect of Slit-Robo signalling and function is the strong 
dependency on cellular context. Contradictory findings are often reported even when 
researchers are using very similar experimental setups. Slit-Robo proteins are a new, 
quickly expanding research area so in some cases those discrepancies might appear simply 
because of the novelty of the field. Nevertheless it does not explain such a high prevalence 
of inconsistencies and thus the importance of context most likely represents actual 
properties of the Slit-Robo signalling axis.  
Robos are somewhat unique receptors in terms of their structurial organisation. No other 
membrane protein was reported to contain a 700 amino acid long unstructured polypeptide 
as its cytoplasmic domain so far. Our knowledge about intrinsically unstructured proteins 
implies an exceptional variety of Robo binding partners and this view is largely confirmed 
by experimental data. Signalling molecules with directly opposite functions, like GAP’s 
and GEF’s (see section 1.4.2), are known to be recruited by Robo. So one can argue that 
Robo context dependency is hardwired in its structure.  
An alternative model is that context dependency arises from “deeper” downstream 
signalling networks. Perfect examples here are small Rho family GTPases, which appear to 
be the main Robo signalling targets. As mentioned above (see section 1.4.2), Cdc42, Rac1 
and RhoA exist as a complex interconnected signalling network, where the functional 
outcome results from integration of many different modulators. In this case context 
dependency is not so much a property of the Robos themselves, but of the signalling 
network lying downstream.  
With two recent publications we begin to uncover possible mechanisms behind Robo’s 
dependency on cellular context. As already mentioned above, the presence of Ephrin-A 
was enough to switch Slit2 effects from pro-angiogenic to anti-angiogenic in endothelial 
cells (Dunaway et al, 2011). Unfortunately, the precise mechanism of crosstalk remains 
unknown. The Ephrin/Eph kinase signalling axis can transmit signal in both directions, so 
it is not even clear which part of it is responsible for crosstalk. Similarly, Slit2 inhibits 
neutrophil but activates eosinophil chemotaxis (Ye et al, 2010). These differential Slit2 
effects were determined by srGAP1 expression level. Neutrophils express high levels of 
Chapter 1  53 
 
srGAP1 protein which directly interacts with Robo1 and transmits inhibitory signalling. 
Eosinophils have considerably lower amounts of srGAP1, hence P3IK binds Robo1 instead 
of srGAP1 and mediates promigratory effects (Ye et al, 2010). This latter example shows 
how competition between Robo1 binding partners determines the overall signalling 
outcome and supports the idea that context dependency is an innate feature of Robo 
receptors. 
1.7 Receptor	oligomerisation‐methods	and	techniques	
 
Receptor oligomerisation is driven by protein-protein interactions and thus relies on similar 
techniques. In some cases it is even possible to reconstruct a oligomeric state of the 
receptor by expressing and analysing separate receptor domains as soluble proteins. 
Obviously, the major difference between cytoplasmic proteins and receptors is that the 
latter are functioning within the phospholipid bilayer, and substantial evidence shows that 
transmembrane domains and membrane lipids are important elements of receptor-receptor 
interactions (Hubert et al, 2010). This aspect puts considerable constraints on the design of 
experiments and most of them are done with solubilised receptors 
(co-immunoprecipitation) or in vivo with intact cells (resonance energy transfer methods, 
bimolecular fluorescence complementation etc).  
1.7.1 Co‐immunoprecipitation	
Co-immunoprecipitation is probably the simplest and most straightforward approach to 
detect receptor oligomerisation. In its simplest form, two receptor constructs differentially 
tagged with epitope tags are co-expressed in a heterologous system. Cells are lyzed and 
one of the proteins is immunoprecipitated with a corresponding antibody. If the second 
protein interacts with the immunoprecipitated receptor, it will be co-precipitated and SDS-
PAGE followed by Western blotting with the second antibody will reveal its presence. 
Method variation with untagged endogenous proteins from native tissues is also possible. 
This approach however is often limited by the availability of suitable antibodies and low 
endogenous expression of native proteins. Use of native proteins also is not suitable for 
detection of homooligomerisation, as without an additional tag it is impossible to 
discriminate between directly precipitated and co-precipitated molecules. Although co-
immunoprecipitation is a standard technique, it has its own share of problems and 
shortcomings. A lot of problems arise from the necessity to optimise properties of the lysis 
buffer. Cell lysis buffer for co-immunoprecipitation must be able to solubilise the proteins 
in question, yet preserve protein-protein interactions. Sometimes this requires a great deal 
of empirical optimisation and troubleshooting (variations in detergent composition and 
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ionic strength are most common), before these opposing buffer properties are combined for 
a particular protein (Harlow & Lane, 1999). This issue is especially relevant for receptors, 
since their solubilisation requires the use of more aggressive detergents at relatively higher 
concentrations, which might destroy weaker protein-protein interactions giving false-
negative results. On the other hand, some receptors, especially those with multiple 
membrane spanning helices, have large hydrophobic surfaces which can lead to 
nonspecific aggregation, giving false-positive results. To counter these shortcomings 
various strategies and control experiments must be employed. Weak and transient receptor 
associations can be "fixed" using chemical crosslinking before cell lysis. A vast selection 
of crosslinking reagents is available from commercial suppliers with varying chemistry and 
linker length. Crosslinking reagents with different cell permeability properties also can be 
selected, allowing specific crosslinking of extracellular parts of the receptor only (Melcher, 
2004). Nonspecific aggregation at least in some cases can be ruled out by a control 
experiment, where differentially tagged receptors are expressed in different cells and those 
cells are mixed before lysis and co-immunoprecipitation. However, as always, care must 
be taken when interpreting results, as receptors capable of interaction in trans might create 
the impression of aggregation.  
1.7.2 Resonance	energy	transfer	
Biophysical methods based on resonance energy transfer (RET) between two different 
molecules have already become standard tools for the measurement of receptor 
oligomerisation. Many different approaches and methodologies have been derived, 
however the same fundamental principle lays at the heart of each of these techniques. If the 
emission spectrum of one fluorophore (donor) overlaps with the absorption spectrum of 
another (acceptor), energy can be transferred from donor to acceptor. This transfer does not 
depend on the exchange of photons; it primarily occurs via resonation of donor and 
acceptor dipoles. The German physicist Theodor Förster developed theory describing RET 
more than fifty years ago, which can be expressed by the following formulae: 
ሾ1.1ሿ			ܧ ൌ ܴ଴
଺
ܴ଴଺ െ ݎ଺ 																																			 ሾ1.2ሿ			ݎ ൌ ܴ଴ሺ
1
ܧ െ 1ሻ
ଵ/଺ 
ሾ1.3ሿ					ܧ ൌ 1 െ ߬஽஺߬஽ 																												ሾ1.4ሿ								ܧ ൌ 1 െ
ܨ஽஺
ܨ஽  
E here represents energy transfer efficiency, r – distance between fluorophores and R0 
marks the so called Förster distance, which incorporates all other factors affecting RET and 
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is a constant for a given fluorophore pair. It is noteworthy that the Förster distance includes 
an orientation factor, since RET depends on the alignment of donor and acceptor dipoles. 
Energy transfer is most efficient when dipoles are parallel and totally disappears if donor 
and acceptors dipoles are aligned perpendicularly. Formula [1.1] can be rearranged into 
[1.2] demonstrating that, by knowing the energy transfer efficiency E it is possible to 
calculate the distance between fluorophores. Experimentally, E values can be established 
by measuring either the fluorescence lifetime [1.3] or fluorescence intensity [1.4] of the 
donor under two different conditions, with the acceptor present (DA) or not (D).  
Förster distance can also be defined as the distance between fluorophores which gives 50% 
RET efficiency. Typical values of R0 are 20-100 Ǻ. These values are very similar to the 
diameter of biological macromolecules and hence RET is a convenient tool for measuring 
distances between two proteins. Additionally, the power of six dependency between RET 
efficiency and the distance between fluorophores makes distance measurements extremely 
sensitive. Changes as small as 1-2 Ǻ can be detected under the right conditions. All of 
these useful properties make RET an extremely popular "molecular ruler" to assess 
conformational changes and interactions between biomolecules.  
1.7.2.1 Fluorescence	resonance	energy	transfer	
The classical RET method, called fluorescence resonance energy transfer (FRET), 
measures RET between two fluorophores. In this situation, RET manifests itself as donor 
quenching and excitation of acceptor, since energy is transferred from donor to acceptor. 
Historically, FRET was first used to evaluate protein or DNA interactions and 
conformational changes in solution (Clegg, 1995; Selvin, 1995; Wu & Brand, 1994). 
Biological macromolecules were usually labelled with chemical fluorophores and 
fluorescence intensity or fluorescence lifetime measurements were conducted in a cuvette 
with a fluorometer. Under this setup it was relatively easy to control the experimental 
conditions and concentrations of fluorophores, which allowed relatively straightforward 
quantification of energy transfer efficiency. Unfortunately, this method could not be used 
to study receptor oligomerisation and the development of new technical approaches was 
needed where FRET could be measured in intact cells. Although attempts to measure 
FRET in vivo by injecting prelabeled proteins into a cell were made early on, in vivo 
techniques really gained prominence only with development of FRET fluorophore pairs 
based on green fluorescent protein (GFP) (Carlson & Campbell, 2009).  
GFP based FRET pairs facilitate FRET measurements between proteins residing in cells, 
including membrane receptors, by removing tedious and problematic protein labelling and 
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injection procedures. Nevertheless, this method has its own shortcomings. Cells are not 
homogenous and have substantial background fluorescence, thus the actual measurements 
are usually performed offline from images taken with a fluorescence microscope. Most 
standard and popular widefield microscopy systems are only able to measure fluorescence 
intensities but not fluorescence lifetimes. Fluorescence intensity, as opposed to lifetime, 
directly depends on fluorophore concentration and needs to be accounted for before an 
actual energy transfer efficiency is calculated. In a standard experiment two samples, one 
containing donor and acceptor, the other containing only donor at the same concentration 
as in the first sample, would be measured and energy efficiency calculated according to 
formula [1.4]. Ironically, it is impossible to know or strictly control natively expressed 
fluorophore concentrations. Protein expression is subject to biological variation and 
concentrations will vary from cell to cell and even within cell regions, making it 
impossible to have two samples with an identical donor concentration. The exception is 
FRET sensors, where donor and acceptor are connected by the same polypeptide and thus 
their concentration is always equal.  
Several different approaches can help to circumvent this limitation. First of all, in some 
situations the calculation of energy transfer efficiency is dispensable. If one needs to know 
only relative changes in FRET, without calculating actual distances, one can use an index 
devised from fluorescence intensity measures which roughly represent FRET intensity. 
This approach is also called sensitized emission FRET imaging. Many different indices are 
suggested by different researchers, each of them having slight advantages under certain 
experimental circumstances (Gordon et al, 1998; Xia & Liu, 2001; Berney & Danuser, 
2003). Generally they are adequate to assess receptor oligomeristion states. A drawback of 
this approach is that absolute values of a particular index depend on the optical pathway 
and thus will not be comparable between different microscopes or even different filter sets. 
To address this problem, the so called constant G was suggested, which can be measured 
for each device and used to normalise FRET indices (Chen et al, 2006; Gordon et al, 
1998).  
The second FRET measurement technique is to remove acceptor from the sample by 
photobleaching. If FRET is present, donor fluorescence is quenched because some of the 
donor energy is transferred to the acceptor. Photobleaching the acceptor fluorophore 
releases this quenching and increases the donor fluorescence. In this situation, energy 
transfer efficiency can be calculated directly by formula [1.4] since we know donor 
fluorescence intensity with and without acceptor in the same sample. The main 
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disadvantage of this method is its destructive nature, as the sample can only be used once 
and thus time-lapse and dynamic measurements are impossible. Additionally, it is not 
always easy to obtain complete acceptor destruction without affecting the donor and even a 
small remaining fraction of active acceptor can lead to gross errors in distance calculations 
(Berney & Danuser, 2003).  
The most precise and least ambiguous, but technically most complex and demanding 
FRET measurement method is fluorescence-lifetime imaging microscopy (FLIM). Energy 
transfer efficiency can be directly calculated from donor and acceptor lifetimes according 
to formula [1.3] without the need for concentration corrections. FLIM, however, has its 
own share of problems. Sophisticated equipment, rarely available within most life science 
laboratories, is needed to perform these measurements. Data analysis is not trivial, as the 
fluorescence lifetimes of GFP derivatives are often multiexponential and overlap with 
many endogenous cell fluorophore lifetimes. Rigorous mathematical analysis and careful 
interpretation are needed when analysing FLIM data (Chang et al, 2007). 
Advances in the chemistry of lanthanide complexes have created another biologically 
relevant label for FRET measurements. Lanthanide cryptates are chemically stable, 
biologically inert compounds with uniquely long fluorescence lifetimes. The average 
fluorescence lifetime of common fluorophores is in the range of nanoseconds, while the 
fluorescence lifetime of lanthanide cryptates reach micro and even milliseconds. A method 
called time-resolved FRET (TR-FRET) utilises this difference to separate FRET signal 
from background fluorescence (Bazin et al, 2002). After the excitation impulse, 
fluorescence measurements are delayed for 10-60 microseconds, thus excluding 
background noise and collecting only lanthanide cryptate fluorescence. TR-FRET is a 
sensitive and precise method which allows employment of relatively simple, high-through 
equipment like plate readers, thus becoming the method of choice in industrial settings. In 
TR-FRET, terbium or europium cryptates serve as a FRET donor, while the FRET 
acceptor is usually phycobilliprotein and its derivatives, although other molecules can also 
be used. Obviously, it is impossible to encode these labels genetically, so fluorophore-
conjugated antibodies are usually employed to label cell surface receptors (Maurel et al, 
2004). Donor and acceptor labelled antibodies against common epitope tags are 
commercially available from several different suppliers. New, irreversible protein labelling 
techniques like Snap-tag or Clip-tag are commercially adapted to time-resolved FRET as 
well.  
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1.7.2.2 Bioluminescence	resonance	energy	transfer	
Bioluminescence resonance energy transfer (BRET) is a natural phenomenon observed in 
bioluminescent jellyfish and sea polyps. A bioluminescent protein, aequorin in the case of 
Aequora victoria, oxidises its substrate coelenterazine and emits blue light. GFP absorbs 
part of the aequorin energy via resonance energy transfer and emits its own green 
fluorescence giving jellyfish an overall greenish luminescence. It is interesting to notice 
that even though GFP has become a standard tool in cellular biology, actual BRET 
biological functions remain vague (Alieva et al, 2008). 
BRET is based on resonance energy transfer so its efficiency is distance-dependent and can 
be used to monitor protein-protein interactions, including oligomerisation of receptors. 
Originally, BRET systems used luciferase from the sea pansy Renilla reniformis (RLUC) 
as donor, coelenterazine as substrate for RLUC and enhanced yellow fluorescent protein 
(eYFP) as acceptor (Xu et al, 1999). Both RLUC and eYFP are relatively small proteins so 
they can be fused to a protein of interest and BRET measurements performed in intact 
cells. Since then, several different modified BRET systems were created modifying and 
improving donor, acceptor or luciferase substrate characteristics (De et al, 2007; De et al, 
2009; Pfleger et al, 2006). The main advantage of BRET over FRET is that there is no 
need for excitation illumination. This removes various issues related to background 
fluorescence, photobleaching, phototoxicity and acceptor excitation. BRET’s shortcomings 
are lower light output in comparison to that of FRET and the requirement for external 
addition of the luciferase substrate. 
1.7.3 Fluorescence	recovery	after	photobleaching	
Fluorescence recovery after photobleaching (FRAP) is a relatively new technique to study 
receptor oligomerisation in living cells (Dorsch et al, 2009). In this technique, yellow 
fluorescent protein (YFP) is fused to an extracellular part of one receptor, while the other 
receptor caries cyan fluorescent protein (CFP) at its intracellular part. The constructs are 
coexpressed in cells, a small area of the cell membrane is bleached and the time-course of 
fluorescence recovery is monitored. The speed and extent of fluorescence recovery 
depends on lateral mobility of tagged proteins. It is possible to reduce this mobility by 
burdening receptor with bound antibodies. Anti YFP antibody will bind YFP-tagged 
receptors reducing their mobility and impairing fluorescence recovery of this construct as 
observed by YFP fluorescence. Anti YFP antibody does not affect recovery of CFP signal, 
unless there are direct associations between YFP and CFP tagged receptors. If the receptors 
in question oligomerise, the anti YFP antibody will affect recovery of both YFP and CFP 
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fluorescence. Quantitative FRAP studies can provide information about complex stability 
and the level of oligomerisation (Dorsch et al, 2009). 
1.7.4 Bimolecular	fluorescence	complementation		
Bimolecular fluorescence complementation (BiFC) is a method based on structural 
reconstitution of the fluorescent protein. A fluorescent protein is split into two inactive 
parts and those parts are fused to the proteins of interest. Separately these constructs are 
not fluorescent, but if they interact, complementary FP fragments are brought into 
proximity which leads to spontaneous reconstitution of active fluorescent protein. The 
intensity of the observed fluorescence is therefore directly proportional to extent of 
protein-protein association and can be evaluated using standard laboratory equipment like 
a fluorescence microscope or plate reader. A more complicated BiFC setup, using several 
fluorescent proteins with different spectral characteristics, can be used to detect multiple 
protein-protein interactions (Vidi et al, 2011). The main shortcoming of BiFC is the 
irreversible nature of complementation. Once functional FP is formed, interacting proteins 
usually would not be separated again. This makes dynamic time-lapse experiments almost 
impossible. BiFC also is prone to false positive results, since weak and transient 
interactions can be stabilised by complementation itself. 
1.8 Aims	of	the	project	
The first aim of this project is to investigate Robo1 transmembrane signalling mechanisms. 
Published data indicates that Robo, like many other single pass membrane receptors, most 
likely transmits its signal across the membrane by changing its oligomerisation state 
(Hohenester, 2008). I will use a range of biochemical and biophysical techniques to 
determine Robo oligomeric status in resting and signalling competent states. Establishing 
this hopefully will help to elucidate mechanism of Robo1 transmembrane signalling.  
The second aim of my study is to elucidate the role of Slit-Robo within the immune 
system. Robo1 protein is expressed by various leukocytes, Slit-Robo signalling affects 
inflammation and inflammation affects Slit-Robo expression levels. Experimental evidence 
indicates a functional connection between the immune system and the Slit-Robo signalling 
axis, however, the precise role or underlying mechanisms remain unknown. Using multiple 
approaches I will establish an initial working hypothesis and then I will test it using 
appropriate methods.
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2 Materials	and	methods		
2.1 Materials		
2.1.1 Reagents,	enzymes,	medium	components	and	kits	
 
The majority of chemicals were from Sigma-Aldrich (Poole, Dorset, UK) or Fisher 
Scientific (Leicester, UK). DNA restriction endonucleases, GoTaq polymerase, calf 
intestinal alkaline phosphatase (CIAP), Wizard Plus SV Miniprep kit and T4 ligase were 
from Promega (Southampton, UK). TRIzol, protein markers, NuPage Novex pre-cast 4-12 
% Bis-Tris gels, NuPage MOPS SDS running buffer, antibody-Alexa Fluor® 594 
conjugates and SuperScript III were purchased from Invitrogen (Paisley, UK). RNeasy kit, 
QIAfilter Plasmid Maxi Kit, PCR purification kit, DNeasy blood and tissues and QIAquick 
gel extraction kit were from (Qiagen Crawley, UK). High fidelity Phusion polymerase was 
from New England Biolabs (MA, USA). Polynucleotide kinase, complete EDTA-free 
protease inhibitor tablets, collagenase D, DNAse I and DNA markers were from Roche 
(Lewes, UK). Agarose was from Flowgen Biosciences (Nottingham, UK). Secondary 
horseradish conjugated antibodies were from GE Healthcare Life Sciences (Little Chalfont, 
UK). Red PCR Master Mix was from Rovalab (Teltow, Germany). X-ray film was from 
Konica (Hohenbrunn, Germany). ECL reagent and BCA assay was purchased from Pierce 
(Tattenhall, UK). Rac1/CDC42 activation assay kit was from Millipore. SNAP-Lumi4-Tb 
cryptate and SNAP-Red were purchased from Cisbio Bioassays (Codolet, France). SYBR 
Green PCR Master Mix was from Applied Biosystems.  
2.1.2 Buffers	and	microbiological	culture		
Phosphate Buffered Saline (PBS) (10 x)  
137 mM NaCl, 2.7 mM KCl, 1.5 mM KH2PO4 , 8 mM Na2 HPO 4 , pH 7.4  
Diluted 1 in 10 prior to use and stored at 4°C  
Tris Buffered Saline (TBS) (10 x)  
20 mM Tris-base, 150 mM NaCl, pH 7.4  
Diluted 1 in 10 prior to use and stored at room temperature  
Tris-EDTA (TE) Buffer  
10 mM Tris, 0.1 mM EDTA, pH 7.4  
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Radioimmune precipitation assay (RIPA) Buffer (2x)  
100 mM HEPES (pH7.4), 300 mM NaCl, 2 % (v/v) Triton X-100, 1 % (w/v) Na 
deoxycholate, 0.2 % (w/v) SDS . Stored at 4°C. Diluted 1:2 prior to use with:  
0.5 M NaF, 0.5 M EDTA, 0.2 M NaH2PO4, 10% (v/v) ethylene glycol, complete 
EDTA free protease inhibitor tablet  
Physiological Saline Solution  
130 mM NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 20 mM HEPES, 10 mM D-
glucose, pH 7.4 
Laemlli Buffer (6x)  
200 mM Tris-HCl, 8 % (w/v) SDS, 0.4 % (w/v) bromophenol blue, 40 % (v/v) glycerol,  
500 mM DTT. Stored in aliquots at -20°C  
TAE Buffer (50 x) pH 8.0  
40 mM Tris base, 5 mM EDTA, 5.71 % (v/v) glacial acetic acid  
Diluted 1 in 50 prior to use and stored at room temperature  
DNA Gel Loading Buffer (5 x)  
0.25 % (w/v) bromophenol blue, 40 % sucrose (w/v) in distilled H2O  
LB medium (Luria-Bertani Medium)  
1 % (w/v) bactotryptone, 0.5 % (w/v) yeast extract, 1 % NaCl (w/v), pH 7.4. Sterilised by 
autoclaving at 126°C  
SOC medium 
2% (w/v) bactotryptone, 0.5% (w/v) yeast extract, 10mM NaCl, 2.5mM KCl, 10 mM 
MgCl2, 20mM glucose. Sterilised by autoclaving at 120°C  
2.1.3 Oligonucleotides	
All oligonucleotides were purchased from Eurofins MWG and are listed in Table 2.1 
2.1.4 Bacteria	strains		
XL1-Blue E. coli - endA1 gyrA96(nalR) thi-1 recA1 relA1 lac glnV44 F'[ ::Tn10 proAB+ 
lacIq Δ(lacZ)M15 Amy CmR] hsdR17(rK- mK+) 
ER2925 E. coli - ara-14 leuB6 fhuA31 lacY1 tsx78 glnV44 galK2 galT22 mcrA dcm-6 
hisG4 rfbD1 R(zgb210::Tn10)TetS endA1 rpsL136 dam13::Tn9 xylA-5 mtl-1 thi-1 mcrB1 
hsdR2  
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Table 2.1 Oligonucleotides used in this study 
  ID Sequence Notes 
Sl
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LZ40 CCGAAAGCTCAAGAGAAGTCC mSlit2 cloning, flanking left 
LZ41 AGCATGAATTAGTCCAACATGG mSlit2 cloning, flanking right 
LZ44 TGTAGGGTGTATGGTGTGTGG mRobo1 cloning, flanking left 
LZ45 TAGCATCGTAAGCCTCTCTGG mRobo1 cloning, flanking right 
LZ103 TAGGATCCTGCCCGGCCCAGTGCTCCTGT BamHI-Slit2 
LZ104 TATGCGGCCGCTTAGGAGGCACATCTCGCGCAGCCGCACTTC Slit2-STOP-NotI 
LZ105 CACCATGATCGCGGAGCCTGCTCGCTTTTACCTCTTTG KpnI-SS-EcoRI-myc-EcoRV linker 
LZ106 GATTAATATGTCTCTGTTCAGGCTCCCGTCTTCGTCAGGAAG KpnI-SS-EcoRI-myc-EcoRV linker 
LZ107 AATTCGAACAAAAACTTATTTCTGAAGAAGATCTGGAT KpnI-SS-EcoRI-myc-EcoRV linker 
LZ108 ATCCAGATCTTCTTCAGAAATAAGTT KpnI-SS-EcoRI-myc-EcoRV linker 
LZ109 TTTGTTCGAATTCTTCCTGACGAAG KpnI-SS-EcoRI-myc-EcoRV linker 
LZ110 ACGGGAGCCTGAACAGAGACATATTAATCCAAAGAGGT KpnI-SS-EcoRI-myc-EcoRV linker 
LZ111 AAAAGCGAGCAGGCTCCGCGATCATGGTGGTAC KpnI-SS-EcoRI-myc-EcoRV linker 
LZ112 TCGATATCGGCTCCCGTCTTCGTCAGGAAGATT EcoRV-mRobo1-XbaI 
LZ113 TATCTAGATCAGCTTTCAGTTTCCTCTAATTC EcoRV-mRobo1-XbaI 
LZ114 ATGCGGCCGCTAGTTACTGTTGGCGTGAAGGTAAAG EcoRV-mRobo1-NotI 
LZ115 ATCTCGAGTATCAAAGAGGAGGCGAAGCCGTC XhoI-mRobo1-XbaI 
LZ116 ATTCTAGATCAGCTTTCAGTTTCCTCTAATTC XhoI-mRobo1-XbaI 
LZ125 TAGCGGCCGCATGGTGAGCAAGGGCGAGGAG NotI-FP forward 
LZ126 TTACTCGAGCTTGTACAGCTCGTCCATGCCG FP-XhoI rev 
LZ127 TTACTCGAGTTACTTGTACAGCTCGTCCATGCCG FP-STOP-XhoI rev 
LZ128 TAGAATTCGACTACAAGGATGACGATGACAAGGATATCAT EcoRI-FLAG-EcoRV 
LZ129 ATGATATCCTTGTCATCGTCATCCTTGTAGTCGAATTCTA EcoRI-FLAG-EcoRV 
LZ150 CTGATATCGAATTTGGGGTTCCAGTTCAAC 5 Ig deletion 
LZ151 CTGATATCTTAGATTCTCACGGAAACCCCGTGT Ig ir FNIII deletion 
LZ152 TAGAATTCATGGACAAAGACTGCGAAATG Snap-clip -EcoRI fw 
LZ154 TAGATATCATGGACAAAGACTGCGAAATG Snap-clip -EcoRV rv 
Se
qu
en
ci
ng
 
LZ8 GAAGCCAGTCTGAGAGCCAGG mSlit2 sequencing 
LZ9 AAACTTAGGACATTTCGACTCC mSlit2 sequencing 
LZ10 CTGCACAACTTGAACCTTCTC mSlit2 sequencing 
LZ11 AAATTCTTCTCACCAGTAACC mSlit2 sequencing 
LZ12 AAGTAACAACCGAATAAGCAC mSlit2 sequencing 
LZ13 GGAGGAACTTGTCACTTAAAG mSlit2 sequencing 
LZ14 AGAGAAGTGTGAGAAATTGG mSlit2 sequencing 
LZ15 ACCTGTGAATGTGAGGAAGG mSlit2 sequencing 
LZ16 ACGATGGTCTCTCTAAAACGG mRobo1 sequencing 
LZ17 ACTATACGAGGAGGAAAACTC mRobo1 sequencing 
LZ18 GAAGTTACTGATGTGATTGC mRobo1 sequencing 
LZ19 GCAAATGCCTATGGAATTAGT mRobo1 sequencing 
LZ20 CGAAGTATCACATAAACAAGA mRobo1 sequencing 
LZ21 AGCCAATTATAACAACCAACT mRobo1 sequencing 
LZ22 CATGTCCGTAGATGAAAGCT mRobo1 sequencing 
LZ23 AGTGTCAGTTCATCCGATGG mRobo1 sequencing 
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 LZ55 GGCAAACATTACACGCTCAA hSlit1 expression detection forward 
LZ56 CTTCATCTGCGTCTTGGTGA hSlit1 expression detection reverse 
LZ57 TGGCTATCAGGGAGAAAAGTG hSlit2 expression detection forward 
LZ58 CCGCTGTCTTCATCTGTGG hSlit2 expression detection reverse 
LZ59 TGACAAGGACAACGGCATC hSlit3 expression detection forward 
LZ60 ACTGCTGGCTGCTTCTGG hSlit3 expression detection reverse 
LZ61 AAAGTAGCACGACGGCAAAT hRobo1 expression detection forward 
LZ62 CCTGGCTGGTGTTTCAGTTT hRobo1 expression detection reverse 
LZ63 TCCTGCTATCTCCTTTGGACA hRobo2 expression detection forward 
LZ64 AACCTAACGGTGGAACTGGA hRobo2 expression detection reverse 
LZ65 AAGCCTCTCTGTGACCAGGA hRobo3 expression detection forward 
LZ66 TGATGACCCCATTTTGCTG hRobo3 expression detection reverse 
LZ67 CGCAGGGGACTCTCTTCTC hRobo4 expression detection forward 
LZ68 TTTGGGAAAGGTTCTTGGAA hRobo4 expression detection reverse 
LZ71 ACACCCACTCCTCCACCTTT hGAPDH 
LZ72 TTCCTCTTGTGCTCTTGCTG hGAPDH 
Ex
pr
es
si
on
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 LZ81 ATGGAGCCAACTGCGTAGAC mSlit1 expression detection forward 
LZ82 AATCCCATTGTCCTCTGCTG mSlit1 expression detection reverse 
LZ83 TCACACTTCAGATTGCCACAG mSlit2 expression detection forward 
LZ84 CCATCCACAGAGAGGGAAAG mSlit2 expression detection reverse 
LZ85 ACAATGACCCCTTGGCACT mSlit3 expression detection forward 
LZ86 CCACTGCTGGTTGCTTCTG mSlit3 expression detection reverse 
LZ87 TCCTACAGCCACCAATCCAC mRobo1 expression detection forward 
LZ88 CTGAGACAAGGGGTCCTGAA mRobo1 expression detection reverse 
LZ89 GAGCCGTCCAGGTCTTCTAA mRobo2 expression detection forward 
LZ90 GTCGCTGTTTTATCCCCTTG mRobo2 expression detection reverse 
LZ91 AGTGGGGAGAGGAGAGTGGT mRobo3 expression detection forward 
LZ92 GAGCTGTTGGAACCCCTAGA mRobo3 expression detection reverse 
LZ93 GCTCCTTCCTCGCTGATAC mRobo4 expression detection forward 
LZ94 GCCTCCACTCCCACAAAG mRobo4 expression detection reverse 
LZ77 AAAATGGTGAAGGTCGGTGT mGAPDH,  
LZ78 GTTAGTGGGGTCTCGCTCCT mGAPDH 
  
 
  
LZ203 AAGACCTGTGCTTCTGTCAG Slit2 mouse genotyping 
LZ204 AAGTCTAGTAGAGTCGAGCG Slit2 mouse genotyping 
LZ205 AAACAGGTTTCTACCGCACG Slit2 mouse genotyping 
 
2.2 Methods	
2.2.1 RNA	extraction	
Tissue samples were flash-frozen in liquid nitrogen and stored at -80°C until required. On 
the day of the experiment the samples were submerged into the liquid nitrogen and ground 
into a fine powder using pestle and mortar. Initial crude RNA purification was performed 
using a TRIzol reagent (Invitrogen) according to the manufacturer’s instructions. The 
pulverized tissue sample was dissolved in the appropriate volume of TRIzol, mixed with 
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1/5 volume of chloroform and centrifuged at 12000g for 10 min at -4°C. An aqueous upper 
phase was transferred to a new tube and RNA was precipitated from the solution by adding 
equal volume of isopropanol and centrifuging the mixture at 10000g for 15 min at -4°C. 
The supernatant was discarded and RNA pellet dissolved in RNase free water. The second 
step of RNA purification was performed using RNeasy kit from Qiagen according to the 
manufacturer’s instructions. RNA from cultured cells was extracted omitting the TRIzol 
step and using the RNeasy kit directly. Quality and concentration of purified RNA was 
assessed by agarose gel electrophoresis and spectroscopy. To avoid possible RNA 
degradation, cDNA was synthesized immediately after RNA purification, when it was 
necessary, the RNA samples were stored at -80°C until required. 
2.2.2 cDNA	synthesis		
cDNA synthesis was performed using SuperScript III (Invitrogen) or AffinityScript 
(Stratagen) cDNA synthesis kits according to the manufacturers’ instructions. Initially, 
primers were annealed to mRNA 
 1 μg total RNA 
 500 ng oligo(dT) primers 
 RNase free water up to 14.2 μl 
The mixture was incubated at 65°C for 5 minutes and then cooled slowly to room 
temperature.  
cDNA for Slit-Robo expression analysis was synthesised as follows: 
 14.2 μl total RNA with primers 
 2 μl 10x RT buffer 
 1 μl AffinityScript reverse transcriptase 
 0.5 μl RNase Block 
 2 μl 100 mM DTT 
 0.8 μl 100 mM dNTP 
The mixture was incubated at 42°C for 70 minutes to synthesize cDNA, then at 70°C for 
15 minutes to inactivate reverse transcriptase.  
cDNA for Slit2 and Robo1 cloning was synthesised according to following protocol: 
 14.2 μl total RNA with primer 
 2 μl 10x RT buffer 
 1 μl SuperScript III reverse transcriptase (another 0.5 μl of enzyme was added after 
30 minutes) 
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 0.5 μl RNase Block 
 2 μl 100 mM DTT 
 0.8 μl 100 mM dNTP 
The mixture was incubated at 55°C for 70 minutes to synthesize cDNA, then at 70°C for 
15 minutes to inactivate reverse transcriptase. Reactions without reverse transcriptase were 
routinely used as negative controls to account for possible genomic DNA contamination. 
2.2.3 Genomic	DNA	extraction		
Genomic DNA from mouse tissues was extracted using Qiagen "DNeasy blood and 
tissues" kits according to the manufacturer’s instructions. 
2.2.4 Construction	of	custom	polylinker	
In order to facilitate Robo1 cloning and tagging a new polylinker containing Robo1 
signalling sequence and epitope tags was introduced into pcDNA3. Oligonucleotides 
LZ105-LZ111 were phosphorylated using polynucleotide kinase (Roche): 
 2 μl 10x phosphorylation buffer 
 4 μl 100 μM oligonucleotide 
 1 μl 100 mM dATP 
 1 μl polynucleotide kinase 
The reaction mixture was incubated for 30 minutes at 37°C, phosphorylated 
oligonucleotides were then pooled, incubated at 100°C for 5 minutes and left to cool to 
room temperature. The formed double stranded DNA sequence was then ligated into the 
pre-cut pcDNA3 vector. 
2.2.5 PCR		
Slit2 and Robo1 genes and various constructs were synthesised using Phusion polymerase 
(NEB) as follows: 
 5 μl cDNA    95°C -- 3 min 
 10 μl 5x HF buffer   95°C -- 1 min 
 500 nM of each primer  62°C -- 1 min 
 0.5 μl Phusion polymerase  72°C -- 1.5 min 
 5 μl 1 mM dNTP   25 cycles from step 2 
 1.5 μl DMSO    72°C -- 10min 
 water up to 50 μl 
RT-PCR was performed using Red PCR Master Mix (Rovalab) as follows: 
 5 μl 5x Red PCR Master Mix    95°C -- 3 min   
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 0.5-2 μl cDNA     95°C -- 1 min 
 500 nM of each primer   55°C -- 1 min 
 water up to to 50 μl of total volume  72°C -- 1min 
30 cycles from step 2 
72°C -- 5min 
Genotyping was performed using GoTaq (Promega): 
 50 ng genomic DNA    95°C -- 5 min 
 10 μl 5x GoTaq buffer  94°C -- 1 min 
 500 nM of each primer  65°C -- 1 min 
 200 nM of each dNTP   72°C -- 1.5 min 
 1.25 U GoTaq polymerase  30 cycles from step 2 
 Water up to 20 μl   72°C -- 10min 
2.2.6 Plasmid	DNA	extraction	and	purification	
Mini preparations of plasmid DNA from bacterial cultures were performed using Wizard 
Plus SV Miniprep kit (Promega). QIAfilter Plasmid Maxi Kit (Qiagen) was used to purify 
larger amounts of plasmid DNA. All kits were used according to the manufacturer's 
instructions. 
2.2.7 Digestion	of	DNA	with	restriction	enzymes	
To carry out cloning, select minipreps or analyse constructs, DNA samples were digested 
with restriction enzymes as follows: 
 1 μl of appropriate enzyme (Promega) 
 1 μl 10x corresponding buffer (Promega) 
  0.2 - 1 μg DNA 
 water up to 10 μl 
 The mixture was incubated 1 - 3h at temperature indicated by the enzyme supplier. 
2.2.8 DNA	dephosphorylation	
When it was relevant, vector DNA was treated with calf intestinal alkaline phosphatase 
(CIAP) to remove 5`-phosphate groups.  
 0.05 U CIAP (Promega) 
 30 μl DNA  
 5 μl 10x CIAP buffer  
 water up to 50 μl 
The mixture was incubated at 37°C for 30 min. Dephosphorylated DNA was purified using 
"PCR purification kit" from Qiagen according to the manufacturer’s instructions. 
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2.2.9 DNA	ligation	
To generate required constructs DNA fragments were ligated using T4 DNA ligase. Vector 
and insert ratio was varied from 1:3 to 1:6. Typical reaction mixture contained: 
 1 U T4 DNA ligase (Promega) 
 1 μl 10x T4 DNA ligase buffer  
 50-100 ng vector DNA and corresponding amount of insert DNA 
 water up to 10 μl  
The reaction mixture was incubated for 16 h at 4°C and then directly used for bacteria 
transformation. 
2.2.10 DNA	gel	electrophoresis	
Agarose gel DNA electrophoresis was used to analyse digested DNA, verify created 
constructs or purify required DNA fragments from digestion mixture. 0.8%-1.6% (w/v) 
agarose gels were prepared in 1x TAE buffer with SYBR Safe DNA stain (SYBR Safe 
DNA stain was supplied as 10000x concentrate). Samples containing 0.2 - 0.5 μg of DNA 
were mixed with 6x loading buffer and loaded onto the gel. A DNA marker was also 
loaded in order to determine the size of visualized bands. The electrophoresis was run at 
125 V voltage until bromophenol dye from loading buffer travelled 2/3 of gel length. The 
DNA fragments were visualized with UV light using a BioRad Gel Doc 2000 
transilluminator. 
2.2.11 DNA	purification	from	gel	
DNA fragments of interest were cut from gel and purified using QIAquick gel extraction 
kit (Qiagen) as per manufacturer's instructions 
2.2.12 Preparation	of	competent	bacterial	cells	
XL1-Blue E. coli strain was streaked onto a LB plate with 50 μg/ml kanamycin and grown 
overnight at 37°C. The selected single colony was inoculated into 4 ml LB medium, grown 
overnight at 37°C and then subcultured into 100 ml of LB medium. Once culture reached 
OD600 of 0.5, 50 ml of cells were chilled on ice for 5 min, centrifuged to remove medium 
and resuspended in 20 ml of ice-cold solution 1 (30 mM KCl, 10 mM RbCl2, 10 mM 
CaCl2, 50 mM MnCl2, 15% (w/v) glycerol, pH 5.8). Cells were kept on ice for 5 min, 
centrifuged again to remove solution 1 and resuspended in 2 ml of ice-cold solution 2 (10 
mM RbCl2, 75 mM CaCl2, 15% (w/v) glycerol, 10 mM MOPS, pH 6.5). After keeping on 
ice for an additional 15 minutes cells were aliquoted into Eppendorf tubes 200 μl each and 
stored at -80°C. 
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2.2.13 Bacterial	transformation	
Competent E. coli cells were incubated with 1-50 ng of DNA on ice for 30 minutes and 
heat shocked for 2 min at 42°C. After heatshock cells were chilled on ice for 2 min, 
inoculated into 500 μl of SOC medium and incubated with shaking at 37°C for 1 hour. 
Finally cells were plated on LB-agar plates with appropriate antibiotic and grown 
overnight at 37°C. 
2.2.14 Cell	maintenance	
All cells were maintained in a humidified incubator with 95% air and 5% CO2 at 37°C. 
HEK 293T 
Human embryonic kidney cells were grown as a monolayer in Dulbecco's Modified Eagle 
Medium (DMEM) supplemented with 10% (v/v) newborn calf serum, 2nM L-glutamine, 
100 U/ml penicillin and 0.1 mg/ml streptomycin.  
Flp-In T-Rex HEK 293 
Parental Flp-In T-Rex HEK 293 cells were maintained in DMEM (high glucose) 
supplemented with 10% (v/v) newborn calf serum, 2nM L-glutamine, 100 U/ml penicillin, 
0.1 mg/ml streptomycin and 100 μg/ml zeocin.  
Flp-In HEK 293 based cell lines 
Cell lines based on Flp-In HEK 293 cells were maintained in DMEM (high glucose) 
supplemented with 10% (v/v) newborn calf serum, 2 mM L-glutamine, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, 10 μg/ml blasticidin and 200 μg/ml hygromycin. 
Double stable cell lines stably expressing two different proteins were maintained in 
medium additionally supplemented with 1 mg/ml geneticin. 
Other cell lines 
THP-1, Raji, CA46, ACVA-1, HUT78, JURKAT, K562, MEG-01 and HMC-1 cells were 
grown in suspension in RPMI 1640 medium supplemented with 10% (v/v) newborn calf 
serum, 2 mM L-glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin. 
3T3 and B16 cells were maintained in DMEM supplemented with 10% (v/v) newborn calf 
serum, 2nM L-glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin.  
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2.2.15 Transient	cell	transfection		
For Western blot analysis, HEK 293T cells were transfected using polyethylenimine (PEI). 
Day before the transfection 2x106 cells were plated in 10 cm tissue culture dishes. Next 
day, 5 μg of DNA was combined with 30 μg of PEI in 500 μl of 150 mM NaCl solution, 
thoroughly mixed and incubated for 10 minutes at room temperature. Cell medium was 
changed to fresh and the DNA-PEI mixture was added to the cells in a drop-wise manner 
gently mixing the medium.  
HEK 293T cells intended for visualisation by microscopy were transfected using Effectene 
reagent (Qiagen) according to the manufacturer’s instructions.  
2.2.16 Stable	cell	line	generation	
Flp-In T-Rex HEK 293 cells were transfected with a mixture of pcDNA5/FRT/TO vector 
(harbouring myc-Robo1-CIT, FLAG-Robo1-CER, myc-Robo1-CIT-Robo1 or FLAG-
Robo1-CER-Robo1 construct) and the pOG44 vector in a 1:9 ratio with Effectene reagent 
(Qiagen). After 48 hours, the medium was changed to medium supplemented with 200 
µg/ml hygromycin to initiate selection of stably transfected cells. Resistant clones were 
induced with 1 mg/ml doxycycline and screened by immunoblotting and 
immunocytochemistry. 
Double stable cell lines were created by transfecting Flp-In T-Rex HEK 293 cells stably 
expressing myc-Robo1-CIT or myc-Robo1-CIT-Robo1 construct with a pcDNA3 vector 
harbouring FLAG-Robo1-CER or FLAG-Robo1-CER-Robo1 construct. After 48 hours, 
the medium was changed to medium supplemented with 1 mg/ml geneticin to initiate 
selection of stably transfected cells. Resistant clones were induced with 1 mg/ml 
doxycycline and screened by immunoblotting and immunocytochemistry. 
2.2.17 Immunocytochemistry	
Cells were grown on poly-D-lysine coated coverslips in 6-well plates and transfected with 
appropriate Robo1 constructs using Effectene reagent (Qiagen). Next day, cells were 
washed once for 5 minutes with room-temperature PBS and incubated with Hoechst dye 
for 15 minutes (in some cases staining with Hoechst was omitted). Cells then were washed 
again with PBS 2x 5 minutes and fixed by the addition of 2 ml 3.7 % (w/v) formaldehyde 
for 10 minutes. Fixed cells were washed three times for 5 minutes with PBS and incubated 
with 3% (w/v) low fat milk in PBS for 10 minutes. Primary anti-FLAG antibody (F7425, 
Sigma) was added at dilution 1:400 to the cells and incubated for 1 hour. Cells were 
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washed 3x 5 minutes with PBS and incubated with secondary anti-rabbit antibody 
conjugated to Alexa Fluor 594 dye (Invitrogen) in 3% (w/v) low fat milk PBS for another 
hour. Alternatively, SNAP staining was performed by adding SNAP-Surface 549 (Cisbio 
Bioassays) dye. After the final incubation cells were washed 3x 5 minutes with PBS and 
coverslips were mounted onto microscope slides using Immu-mount (Thermo Scientific) 
mounting medium. Mounted coverslips were stored in the dark at 4ºC before being imaged 
using epifluorescence microscopy. 
2.2.18 Recombinant	Slit2	purification	
HEK 293T cells were transferred into medium containing 1% of FBS and transfected with 
the pcDNA3 vector harbouring Slit2-(His)6 construct. Supernatant was collected 48 hours 
later, its pH was adjusted to 7.5 and NaCl was added to final concentration of 500 mM. 
Slit2-(His)6 protein from this solution was purified using AKTAprime plus 
chromatography system with 1 ml HisTrap HP column using a default pre-programmed 
procedure for His-tagged proteins. Binding buffer composition was 20 mM Na3PO4, 500 
mM NaCl, 20 mM imidazole, pH 7.4. Elution buffer composition: 20 mM Na3PO4, 500 
mM NaCl, 500 mM imidazole, pH 7.4 
2.2.19 Protein	crosslinking	
HEK 293T cells transiently co-expressing differently tagged truncated and full-length 
Robo1 constructs were treated with 100 ng/ml of Slit2 (R&D Systems) or PBS as a 
negative control for 15 minutes. Cell medium was removed and cells were washed with 
PBS. DTSP crosslinking reagent (Sigma, D3669), which was stored as 200 mM solution in 
DMSO, was added into tissue culture dishes with cells in PBS in a dropwise manner to a 
final concentration of 2 mM. Cells were incubated at room temperature under gentle 
agitation for 30 min and the crosslinking was stopped and remaining DTSP reagent was 
neutralised by adding 1 M Tris·HCl (pH 7.4) solution to a final concentration of 50 mM. 
Cells were incubated for an additional 5 minutes and lysed as described below.  
2.2.20 Preparation	of	cell	lysates	
Adherent cells were lysed as follows. Medium was removed and cells were washed 3 times 
with PBS. An appropriate volume of 1x RIPA buffer was added to the cells still attached to 
the surface of a tissue culture dish, cells were scraped from the flask using a disposable cell 
scraper and transferred to a centrifuge tube. Cells growing in suspension were centrifuged 
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at 300g for 5 minutes, medium was removed and the pellet was washed 3 times with PBS. 
Finally, the pellet was suspended in appropriate volume of 1x RIPA buffer.  
The lysates were passed 4x through a 21-gauge needle, rotated for 30 min at 4°C on a 
rotating wheel and then centrifuged at 14000 g for 10 minutes to remove cell debris. The 
supernatant was carefully transferred into fresh tubes and the protein concentrations of the 
samples were determined using BCA assay (Pierce). Samples were used immediately for 
co-immunoprecipitation or SDS-PAGE or stored at -20°C until required. 
2.2.21 Co‐immunoprecipitation	
The protein concentration of the cell lysates was equalised to 1 µg/µl using 1x RIPA. 30 µl 
of anti-FLAG antibody conjugated agarose beads (Sigma, A2220) was added to 700 µl of 
equalised cell lysate and incubated overnight at 4°C on a rotating wheel. In parallel, 100 µl 
of equalised cell lysate was reserved as a control sample. Next day, the samples were 
centrifuged at 8000 g for 3 minute at 4°C, the supernatant removed and the beads washed 
three times in 1x RIPA buffer. Finally, the beads and the control samples were resuspended 
in 50µl Laemmli buffer and analysed using SDS-PAGE and Western blotting. 
2.2.22 Sodium	dodecyl	sulphate	polyacrylamide	gel	electrophoresis	
Protein samples were resolved using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE). Samples and molecular weight markers were loaded onto 
pre-cast NuPage Novex bis-tris gels with 4-12 % acrylamide concentration (Invitrogen). 
NuPage MOPS SDS buffer was used for electrophoresis at 200 V using the XCell Surelock 
mini-cell gel tank until the dye front reached the foot of the gel. 
2.2.23 Western	blotting		
Following separation of samples by SDS-PAGE proteins were electrophoretically 
transferred onto nitrocellulose using the XCell II blot module. Proteins were transferred at 
30V for 2 hours in transfer buffer (0.2M glycine, 25mM Tris and 20% (v/v) methanol). To 
block non-specific binding sites, the nitrocellulose was incubated in 5% (w/v) low fat milk, 
0.1% (v/v) Tween 20 TBS at room temperature on a shaker for two hours. The membrane 
was incubated with primary antibody overnight at 4°C in 5% (w/v) low fat milk, 0.1% 
(v/v) Tween 20 TBS containing the required antibody. After overnight incubation, the 
membrane was washed 4 times in 0.1% (v/v) Tween 20 TBS over a 20 minute period. 
Membrane was then incubated with the horseradish peroxidase linked secondary antibody 
in 5% (w/v) low fat milk, 0.1% (v/v) Tween 20 TBS at room temperature for 20 minutes. 
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Again, the membrane was washed 4 times in 0.1% (v/v) Tween 20 TBS over a 20 minute 
period. Finally, the nitrocellulose was incubated for 5 minutes with ECL solution, exposed 
to blue Kodak film and film developed.  
Table 2.2 List of antibodies used for Western blotting 
Antigen Supplier Dilution Secondary 
antibody 
Dilution
c-myc (#2272)  Cell Signaling 1:2000 anti- rabbit 1:5000 
FLAG (F7425) Sigma 1:5000 anti-rabbit 1:5000 
HIS6 (sc-803) Santa Cruz 1:500 anti-rabbit 1:5000 
Robo1 (AF1749) R&D Systems 1:1000 anti-goat 1:10000 
Robo1  DSHB 1:500 or neat hyb. 
supernatant 
anti-mouse 1:5000 
ERK1/2 (#4695) Cell Signaling 1:1000 anti-rabbit 1:5000 
phospho ERK1/2 
(#9216) 
Cell Signaling 1:1000 anti-mouse 1:5000 
Slit2 (G19) Santa Cruz 1:1000 anti-goat 1:10000 
srGAP (ab57504) Abcam 1:500 anti-mouse 1:5000 
 
2.2.24 Transwell	migration	assays	
Transwell migration assays were performed using Corning 12 mm polycarbonate 
membrane inserts with 3.0 µm pores. Lower chambers were filled with 600 μl of migration 
medium (RPMI, 20mM HEPES, 1% BSA) containing relevant reagents or equal volume of 
PBS as a negative control. THP-1 cells or human PBMC were suspended in migration 
medium at a density of 2x106 cells per ml, treated with relevant reagents if necessary and 
100 μl of this suspension was the placed into upper chamber. The transwell kit was 
incubated for 3 hours at 37°C in humidified incubator. At the end of incubation the inserts 
were removed and cells present in lower chamber were counted using MacsQuant flow 
cytometer.  
2.2.25 FRET	imaging	
Cells were grown on poly-D -lysine-treated glass coverslips and induced with doxycycline 
or transiently transfected using Effectene (Qiagen) to express the appropriate Cerulean and 
Citrine-tagged Robo1 constructs. Robo1 construct expressing cells were placed into a 
microscope chamber containing physiological HEPES-buffered saline solution (130 mM 
NaCl, 5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 20 mM HEPES, and 10 mM D-glucose, pH 
7.4) and imaged using an inverted Nikon TE2000-E microscope (Nikon Instruments). 
Excitation light was generated from a mercury lamp with monochromator set to 430 and 
500 nm for the sequential excitation of Cerulean and Citrine-tagged constructs 
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respectively. Excitation light was reflected through the objective lens using a cyan/yellow 
fluorescent protein dual band dichroic filter (Semrock; Rochester, NY, catalog no. 
FF440/520-Di01). Donor, acceptor and FRET channel images were acquired using the 
same exposure time (150 or 300 ms) and were detected using either a high speed emission 
filter wheel (Prior Scientific Instruments, Cambridge, UK) coupled to a 12-bit mode Cool 
Snap-HQ digital camera or a Quadview 2 (QV2) image splitting device attached to a Cool 
Snap-HQ2 camera operated in 14-bit mode. Using the emission filter wheel configuration 
donor, acceptor and FRET signals were sequentially detected using 542/27 and 472/30 nm 
emitters supplied by Semrock. Detection of equivalent signals using the QV2 image 
splitter was achieved using the following Chroma (Chroma, Brattleboro, VT), ET series 
dichroic and emitters: ET t505LPXR dichroic, ET535/30m, ET 470/30m. Hardware was 
controlled and data collected using Metamorph software (version 7.6.3 Molecular Devices, 
Sunnydale, CA). Saved donor, acceptor and FRET channel images were background-
subtracted, and RFRET index was calculated as follows: 
ܴܨܴܧܶ ൌ ܫிሺܫ஺ െ ܫ஽ܤ஽஺ሻܤ஺ி ൅ ሺܫ஽ െ ܫ஺ܤ஺஽ሻܤ஽ி 
BDA and BAD represent the proportion of donor or acceptor bleed through into the acceptor 
and donor channel, respectively. BAF and BDF represent the amount of acceptor and donor 
contamination in the raw FRET signal channel. All bleed through coefficients were 
calculated from control cells expressing Cerulean or Citrine alone. ID, IB and IF represent 
the average fluorescence intensity of region of interest (ROI) for donor, acceptor and 
FRET channels respectively. Dozens of ROIs were measured in three randomly selected 
view fields for each sample. Final results are presented as a mean of 6 individual 
transfection or inductions. 
2.2.26 Time	resolved	FRET	
HEK 293T cells were transiently transfected with the myc-SNAP-Robo1-CIT or myc-
SNAP-Robo1-CIT-Robo1 constructs, incubated for 24 hours and then transferred into a 96 
well plate at a density of 50 000 cells per well. Next day the growth medium was replaced 
with 100 μl labelling medium (Cisbio Bioassays) containing appropriate concentrations of 
SNAP-Lumi4-Tb and SNAP-Red labels (Cisbio Bioassays). Plates were incubated for 1 h 
at 37 °C, 5% CO2 in a humidified atmosphere and washed four times with labelling 
medium. Finally, plates were either read directly after this or Slit2 (R&D Systems) was 
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added to a final concentration of 100 ng/ml and the plate monitored over time course of 45 
minutes. Emission signals from the SNAP-Lumi4-Tb cryptate (620 nm), the FRET signal 
resulting from the acceptor SNAP-Red (665 nm) and fluorescence intensity of Citrine 
fluorescent protein (530 nm) were recorded using a PheraStar FS (BMG Labtech) plate 
reader.  
2.2.27 Protein	arrays	
Peptide libraries based on rat Robo1 sequence (NCBI Reference Sequence: NP_071524.1) 
were synthesized on cellulose membranes using Fmoc (9-fuorenylmethyloxycarbonyl) 
chemistry with the AutoSpot Robot ASS 222 (Intavis Bioanalytical Instruments). The 
interactions of spotted peptides with Robo1-Fc chimera (Robo1 extracellular domain fused 
to human Fc fragment, R&D Systems) were determined by overlaying the cellulose 
membranes with 50 μg/ml of Robo1-Fc protein in 1% (w/v) milk powder solution in 0.1% 
(v/v) Tween 20 TBS buffer. Bound Robo1-Fc protein was detected with anti-human Ig 
antibody coupled with horseradish peroxidise as in Western blotting.  
2.2.28 QPCR	
QPCR analysis was performed using SYBR Green chemistry and Applied Biosystems 
7900HT QPCR machine. Copy number of gene of interest was determined from standard 
curves generated by amplifying serial dilutions of standard templates (PCR fragments of 
gene of interest with known concentration). In parallel with samples and standards, non-
template reactions were used to control for non-specific amplification. Primers for 
detection and standard synthesis were designed using Primer3Plus software 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) and are listed in Table 
1. The detection primers when possible were designed to span intron-exon boundaries to 
prevent amplification of genomic DNA. Each sample or standard was undertaken in 
triplicate (three PCR replicates for each biological replicate). A typical QPCR reaction 
mixture contained: 
 10 μl 2x Power SYBR Green mix (Applied Biosystems) 
 50 pmol of each primer 
 2 μl of cDNA 
 water up to 20 μl of total volume 
Thermal cycle conditions were as follows: 1 cycle at 95°C for 10 min, 40 cycles 95°C for 
15s, 60°C for 1 min. 
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2.2.29 RAC1	assay	
Rac1 activity was measured using Rac1/CDC42 activation assay kit according to the 
manufacturer’s instructions (Millipore). Briefly, cells were lysed and active GTP bound 
Rac1 was precipitated from the lysate with agarose beads coated with GST fusion-protein 
corresponding to the p21-binding domain of human PAK1. Samples were run on SDS–
PAGE and Western blot analysis was used to evaluate amount of activated Rac1. 
2.2.30 Robo1	antibody	purification		
Hybridomas producing Robo1 antibody were acquired from The Developmental Studies 
Hybridoma Bank (University of Yaowa) and grown in Iscove's DMEM medium 
supplemented with 10% (v/v) heat inactivated FBS and 0.5 mg/ml gentamicin. Spent 
hybridoma medium was collected and its composition adjusted to match that of binding 
buffer by adding (NH4)2SO4 to a final concentration of 0.8 M and adjusting pH to 7.5. The 
mixture then was subjected to purification using AKTAprime plus chromatography system 
and 1 ml HiTrap IgM HP column. A default pre-programmed procedure for IgM 
purification was employed with following buffer compositions: binding buffer - 20 mM 
Na3PO4, 0.8 M (NH4)2SO4, pH 7.5; elution buffer #1 - 20 mM Na3PO4, pH 7.5; elution 
buffer #2 - 20 mM Na3PO4, 30% (v/v) isopropanol, pH 7.5 
2.2.31 Animals	
Slit2 knockout animals of CD-1/129Sv outbred genetic background were generated by 
Plump and colleagues (Plump et al, 2002). Cryo-preserved spermatozoa of these animals 
were obtained from Mutant Mouse Regional Resource Centers (MMRRC, University of 
California, Davis) and animals were rederived by MRC Harwell (Harwell Science and 
Innovation Campus, Oxfordshire, UK) using CD-1 mice as oocyte donor. Rederived 
animals were transferred to the Central Research Facility, University of Glasgow and bred 
and maintained there during course of the experiments. All mice were genotyped using tail 
tip biopsies and PCR. C57BL/6 mice were bred and maintained in the same facility under 
similar conditions. All procedures were carried out in accordance with United Kingdom 
Home Office regulations under the auspices of appropriate Project and Personal Licences. 
2.2.32 Primary	cell	isolation		
Embryonic thymi cell suspensions were prepared as follows. C57BL/6 or Slit2 +/- timed 
pregnant mice were sacrificed by CO2 inhalation. Embryos were immediately dissected, 
decapitated and kept in RPMI medium supplemented with 10% (v/v) FBS, 2mM L-
glutamine, 100 U/ml penicillin and 0.1 mg/ml streptomycin (further referred as complete 
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RPMI) until embryonic thymi were dissected. Individual Slit2 knockout embryonic thymi, 
or pooled C57BL/6 embryonic thymi, were incubated at 37°C for 60 minutes in 700 μl or 2 
mL respectively of 0.125% (w/v) Collagenase D and 0.1% (w/v) of DNAse I (both from 
Roche) in RPMI-1640, with regular agitation. Finally, samples were mashed through 50µm 
cell strainer, centrifuged at 350g for 5 minutes and resuspended in cold FACS buffer (PBS 
with 5 mM EDTA and 2% FCS).  
Human PBMCs were kind gift of Dr H. Baldwin and were prepared from heparinised 
human blood using Ficoll. 
2.2.33 FACS	and	cell	sorting	
Cells were suspended in 100 µl of FACS buffer and Fc block (Miltenyi Biotec, UK) was 
added to the cells at a dilution of 1:20 and incubated for 10 minutes on ice to block non-
specific antibody binding. Then fluorescently-labelled antibodies or isotype controls were 
added to the same buffer and cells incubated on ice for additional 15 minutes. Samples 
were washed twice with 1 ml chilled FACS buffer, cells pelleted by centrifugation at 350g 
at 4°C and resuspended in 100 µl of FACS buffer. When appropriate, cells were stained 
with secondary avidin-APC conjugate (BD Biosciences). After final wash step cells were 
resuspended in 100 µl of FACS buffer with 4 µl of viability dye Via-Probe (BD 
Biosciences) added. Samples were analysed using the MACSQuant (Miltenyi Biotec, UK) 
flow cytometer. Acquisition parameters were established using unstained and single-
stained cells. Results were analysed and visualised using FlowJo software (Treestar Inc. 
USA). All antibodies were used at final concentrations between 1-5 µg/ml.  
TEC sorting was performed by Dr A. White at School of Immunity and Infection MRC 
Centre for Immune Regulation, University of Birmingham. Embryonic thymi were 
disintegrated into single cell suspensions as described in section 2.2.32 Cells were stained 
with CD45 and EpCAM antibodies and CD45- EpCAM+ cells were collected using MoFlo 
XDP (Beckman Coulter) cell sorter. 
Table 2.3 List of antibodies used for flow cytometry 
Antigen Clone Supplier 
Ly51-PE BP-1 BD Bioscience 
CD8-PE 53-6.7 Miltenyi Biotec 
CD45-Vioblue 30F11.1 Miltenyi Biotec 
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CD4-APC GK1.5 Miltenyi Biotec 
EpCAM-APC G8.8 Abcam 
MHCII-APC/Cy7 M5/114.15.2 BioLegend 
Robo1-biotin BAF1749 R&D Systems 
 
2.2.34 In	silico	promoter	analysis		
Sequences for mammalian Slit and Robo promoter analysis were retrieved from NCBI 
Entrez Genome database (http://www.ncbi.nlm.nih.gov/sites/genome). Five thousand base 
pairs (5000 bp) of upstream sequence from the start codon ATG were retrieved for each 
gene of interest for the following mammalian species: Homo sapiens, Bos Taurus, Canis 
lupus familiaris, Mus musculus, Macaca mulatta, Rattus norvegicus, Equus caballus. 
Retrieved sequences were analysed for inter-species conserved TATA boxes and other 
core promoter elements using MatInspector (Cartharius et al, 2005; 
http://www.genomatix.de/). CpG islands were identified using CpG Island Searcher (Takai 
& Jones, 2003; http://www.uscnorris.com/cpgislands2/cpg.aspx). Transcription factor 
binding sites (TFBS) were identified using DiaAlign software (Cartharius et al, 2005; 
http://www.genomatix.de). Information about transcription start sites was obtained from 
Cap-Analysis of Gene Expression (CAGE) database 
(http://fantom31p.gsc.riken.jp/cage/mm5/).  
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3 Study	of	Robo1	transmembrane	signalling	mechanism	
3.1 	Introduction	
Robo proteins, like all single pass transmembrane receptors, have a limitation – a single 
receptor molecule is not sufficient to transmit signal across the cellular membrane. 
Receptors containing a single transmembrane helix therefore react to ligand binding by 
conformational changes within stable multimeric complex (e.g. integrins), changes in 
oligomeric state (e.g. receptor kinases) or intricate clustering (e.g. T cell receptor). Based 
on existing experimental evidence and parallels with other IgCAM molecules Hohenester 
hypothesised that Robo receptors transmit signal across the membrane by changing their 
oligomeric state (Hohenester, 2008). This suggestion, however, is founded on 
circumstantial evidence and direct proof is still lacking. Moreover, the precise 
transmembrane signalling mechanism also remains to be established, as both ligand 
induced oligomerisation and dissociation are possible. 
The main goal of the studies described in this chapter was to test the hypothesis that 
transmembrane Robo signalling involves changes in protein oligomerisation and to 
establish the directionality of those changes. In order to achieve this, FRET based methods 
and co-immunoprecipitation were used to gauge mouse Robo1 oligomeric state in live cells 
before and after treatment with its cognate ligand Slit2. Slit2 and Robo1 were selected as 
experimental models for this project because these particular proteins are the most widely 
expressed and the best characterised members of the Slit and Robo families (see sections 
1.2 and 1.3). Additionally, Robo1 seems to be a prototypic family member as other Robos 
most likely originated from it by duplications followed by divergent evolution.  
3.2 Gene	cloning	and	construct	validation	
3.2.1 Slit2	and	Robo1	cloning	and	construct	design	
FRET measurements and co-immunoprecipitation require heterologous expression of 
proteins tagged with the corresponding fluorophores and epitope tags. Moreover, purified 
Slit2 protein was necessary for the planned experiments as a ligand, thus the first task was 
cloning of Slit2 and Robo1 proteins.  
Both Slit2 and Robo1 are relatively large transcripts (~4.5 kb each) so special steps were 
taken to ensure successful cloning. First of all, mouse brains were used as a source of 
RNA, since brain expresses Slit and Robo proteins at higher levels than other tissues. 
Second, a RT-PCR reaction was modified to enhance synthesis of long cDNA molecules 
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(see section 2.2.2). Last, a cloning PCR reaction was also tailored to facilitate synthesis of 
long fragments (see section 2.2.5). Synthesized PCR fragments encoding full length Slit2 
and Robo1 cDNA were cloned into a pCR4-TOPO vector using a commercial TOPO TA 
cloning kit (Invitrogen) and fully sequenced to validate them. Sequence comparison 
against a RefSeq database (National Center for Biotechnology Information (NCBI)) 
revealed that the cloned cDNA is identical to mouse Slit2 (RefSeq NM178804) and Robo1 
(RefSeq NM019413) respectively. 
Design of a Slit2 construct was relatively straightforward. The original pCR4-TOPO-Slit2 
plasmid was used as a template for PCR with modified primers synthesising a 
KpnI-SS-Slit2-(His)6-NotI DNA fragment. The Slit2 construct was left with its native 
signal sequence (SS) to ensure protein secretion. The PCR fragment was digested with 
appropriate restriction enzymes and ligated into a pcDNA3 vector, putting the construct 
under control of a CMV promoter and enabling its expression in eukaryotic cells (Figure 
3.1A). 
Design of Robo1 constructs was more complicated. First of all, the Robo1 constructs had 
to be tagged with fluorescent proteins meeting FRET pair requirements. GFP spectral 
variants Cerulean (CER, donor) and Citrine (CIT, acceptor) were selected for this purpose 
because of their superior characteristics (Rizzo et al, 2004). A standard practise for this 
type of experiments is to fuse the fluorescent proteins in-frame to the C-terminal end of the 
protein of interest. However, this was not an option for the Robo1 constructs, since a large, 
presumably unstructured cytoplasmic domain might obscure FRET measurements simply 
because of its size and unpredictable structure. In order to circumvent this problem two 
different proteins were engineered: a truncated Robo1 construct, where the cytoplasmic 
Robo1 domain was exchanged for the fluorescent protein, and a full-length Robo1 
construct, where the fluorescent protein was inserted in the middle of Robo1, thirty amino 
acids below the transmembrane domain (Figure 3.1B and C). Robo1 was also N-terminally 
tagged with myc and FLAG epitope tags to facilitate protein detection and enable co-
immunoprecipitation experiments. Since Robo1 has a cleavable N-terminal signal 
sequence, the epitope tags must be inserted after it. To accommodate all these 
requirements, a special subcloning strategy was devised for Robo1. First of all, an artificial 
DNA sequence was assembled from separate oligonucleotides and cloned into pcDNA3 
plasmid creating a custom polylinker containing a Kozak sequence, a Robo1 signal 
sequence, an epitope tag and sites for restriction enzymes (Figure 3.1D). Then, different 
Robo1 fragments and fluorescent proteins were inserted step by step via restriction sites 
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creating truncated and full-length constructs with appropriate modifications. In total four 
Robo1 constructs were created: SS-myc-Robo1-CIT, SS-FLAG-Robo1-CER, 
SS-myc-Robo1-CIT-Robo1, SS-FLAG-Robo1-CER-Robo1 (Figure 3.1B and C). All 
constructs were validated by sequencing.  
3.2.2 Purification	and	characterisation	of	Slit2		
Expression of Slit2-(His)6 protein first of all was verified using Western blot. HEK 293T 
cells were transiently transfected with pcDNA3-Slit2-(His)6 plasmid or mock DNA and 
lysed 48 hours later. Additionally, a sample of spent cell growth medium was collected to 
assess Slit2-(His)6 secretion. All samples were analysed by Western blotting with anti-His 
antibodies. A specific band, approximately 180-190 kDa in size, was detected both in the 
lysate and growth medium of transfected cells, but not in the lysate of cells transfected 
with an unrelated construct or naive HEK 293T cells (Figure 3.2). Theoretically, Slit2-
(His)6 should migrate as a protein with molar mass of 175 kDa, however Slit2 is usually 
heavily glycosylated so an increase in apparent molecular mass is not surprising and in fact 
was reported by others (see section 1.2). Slit2 is also known to be cleaved into two 
fragments migrating with apparent molar mass of 140 kDa and 40-60 kDa respectively, 
however no obvious cleavage products were observed in this experiment (Figure 3.2). 
In order to use Slit2 as a ligand one needs to purify it. Slit2 is a secreted protein, so an 
obvious strategy was to purify Slit2-(His)6 from cultivated cell medium. The standard HEK 
293T medium contains 10% of fetal bovine serum (FBS) which unnecessarily burdens 
protein purification. To facilitate Slit2-(His)6 purification, HEK 293T cells were grown as 
usual but were transferred into medium with a low concentration of serum (1%) before 
transfection with the Slit2-(His)6 construct. The cultivated cell medium was collected 48 
hours after transfection and Slit2-(His)6 was purified from it using Ni2+ chelating 
chromatography (Figure 3.3A). Collected fractions were tested using SDS-PAGE and 
immunoblotting with anti-His and anti-Slit2 antibodies, demonstrating the correct identity 
and molar mass of the purified protein (Figure 3.3B and C). Interestingly, staining with the 
anti-His antibody revealed an aproximatly 60 kDa band which could correspond to the C-
terminal cleavage product, since it would contain the His tag and would be purified 
together with the full-length construct. It is likely that the cleavage products were not 
observed in the previous experiments because of low concentration as they became 
detectable only after Ni2+ chelating chromatography enriched them. Relevant Slit2-(His)6 
fractions, as determined by SDS-PAGE and immunoblotting, were pooled together and 
further concentrated using Amicon spin concentrators. This step was also used to exchange 
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a high salt buffer, carried over from chromatography, into phosphate buffered saline 
(PBS). Concentrated Slit2-(His)6 protein was stored at -4°C. 
Published data show that Slit2 is able to inhibit leukocyte movement towards chemokines 
and since it is the simplest Slit2 activity readout available, a leukocyte transwell migration 
assay (also known as Boyden chamber assay) was chosen to monitor Slit2-(His)6 activity. 
In order to test in house prepared Slit2-(His)6, monocyte-like THP-1 cells were incubated 
with 90 ng/ml of Slit2-(His)6 for 15 minutes and then placed into the upper part of a 
Boyden chamber. Meanwhile, the lower part of the chamber was filled with migration 
medium containing 100 ng/ml of the chemokine CCL2 and the whole chamber was 
incubated for 3 hours allowing cells to migrate. At the end of the experiment migrated cells 
in the lower well were counted using flow cytometry. Negative and positive controls 
lacking Slit2-(His)6 or without chemokine treatment were performed in parallel. As 
expected, treatment with Slit2-(His)6 significantly reduced THP-1 migration towards CCL2 
demonstrating biological activity of the purified protein (Figure 3.4A). 
In-house Slit2 preparation was labour intensive and expensive. Therefore once commercial 
analogues became available they were used instead of locally prepared Slit2-(His)6. As 
with in house prepared ligand, biological activity of commercial mouse Slit2 (R&D 
Systems) was tested using the leukocyte migration assay. Human peripheral blood 
mononuclear cells (PBMC) were incubated with 100 ng/ml of Slit2 (R&D Systems) for 15 
minutes and then placed into the upper part of the Boyden chamber. The lower part was 
filled with medium containing 10 ng/ml of the chemokine CXCL12, cells were allowed to 
migrate for three hours and then counted using flow cytometry. In parallel, control 
experiments were conducted by omitting Slit2 or CXCL12. As expected, CXCL12 induced 
substantial cell migration which was inhibited by Slit2 treatment (Figure 3.4B). Slit2 pre-
incubation with a soluble Robo1-Fc chimera (R&D Systems) abolished the inhibitory Slit2 
properties, further demonstrating that inhibition of chemotaxis is dependent on Slit2 
(Figure 3.4B).  
3.2.3 Expression	and	characterisation	of	Robo1	constructs	
The HEK 293T cell line is a standard expression vehicle for various proteins because of its 
high transfection efficiency, rapid growth and relatively easy maintenance. Although 
originally thought to be human kidney epithelial cells, HEK 293T cells have a transcription 
profile more similar to that of neuronal cells (Shaw et al, 2002) and thus should contain all 
signalling machinery necessary for Robo1 function. Moreover, this cell line was already 
successfully used to express Robo proteins in other studies (Hu et al, 2001; Yang et al, 
Chapter 3  82 
 
2006). All this made HEK 293T cells an ideal cell model both for general expression and 
for more detailed FRET measurements. 
First of all, expression and identity of each Robo1 construct was checked using Western 
blot. HEK 293T cells were transiently transfected with corresponding constructs, incubated 
for 24 hours and then lysed. Samples of cell lysates were resolved by SDS-PAGE and 
immunoblotted with anti-myc or anti-FLAG antibodies. Both antibodies were able to 
specifically detect their corresponding constructs (Figure 3.5). The molar mass of all 
constructs, as inferred from migration within the gel, was significantly higher than 
theoretical. Truncated and full-length Robo1 proteins migrated with an apparent mass of 
180 kDa and 220 kDa respectively, although theoretically their mass is 130 kDa and 206 
kDa. Similar alternations in mobility were reported previously and attributed to N-
glycosylation (Howitt et al, 2004), therefore this experiment confirmed efficient expression 
and correct identity of tested Robo1 constructs.  
Cellular distribution and co-localisation of Robo1 constructs within live HEK 293T cells 
was characterised using fluorescence microscopy. HEK 293T cells were transiently 
transfected with each Robo1 construct and 24 hours later inspected with an inverted 
epifluorescence microscope, directly visualising the incorporated Citrine or Cerulean 
fluorescent proteins. An expression pattern consistent with cell surface localisation was 
observed for each tested construct (Figure 3.6). Additionally, cells were co-transfected 
with two differently tagged Robo1 constructs and co-localisation of Citrine and Cerulean 
fluorescence was examined using Metamorph software. Fluorescence intensity values of 
corresponding pixels from the Citrine and Cerulean images were used as the X and Y 
coordinates in a scatter plot. This plot shows correlation between Citrine and Cerulean 
fluorescence intensity which can be quantified by calculating Pearson’s correlation 
coefficient. Both truncated and full-length Robo1 constructs showed a strong co-
localisation between differently tagged Robo1 proteins with Pearson's correlation 
coefficient values of 0.98 and 0.96 respectively, which indicates highly similar cellular 
distribution of the constructs (Figure 3.6). 
Transient transfection of eukaryotic cells is prone to gross protein overexpression and high 
variability and as a result is not an ideal protein expression method for FRET experiments. 
While initial pilot studies can be performed with transiently transfected cells, a cell line 
stably expressing proteins of interest is a preferable experimental system. Consequently, 
HEK 293 cell lines stably expressing Robo1 constructs were generated to complement 
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experiments based on transient expression. Initially using the commercial Flp-In T-REX 
system (Invitrogen), four separate “single” HEK 293 stable cell lines were created 
expressing myc-Robo1-CIT, FLAG-Robo1-CER, myc-Robo1-CIT-Robo1 or 
FLAG-Robo1-CER-Robo1 constructs from a locus controlled by a tetracycline promoter. 
Then, a second construct, FLAG-Robo1-CER or FLAG-Robo1-CER-Robo1 was 
incorporated randomly into the genome of cells able to express myc-Robo1-CIT or 
myc-Robo1-CIT-Robo1. The outcome of these procedures was two double stable cell 
lines, co-expressing either truncated or full-length proteins. In each case, one construct was 
expressed constantly (FLAG-Robo1-CER or FLAG-Robo1-CER-Robo1), while the other 
was tetracycline inducible (myc-Robo1-CIT or myc-Robo1-CIT-Robo1) (Figure 3.7A and 
B).  
The double stable cell lines initially were tested for Robo1 expression using Western 
blotting. Cells were incubated with increasing amounts of doxycycline (DOX, a 
tetracycline analogue) for 24 hours, lysed, samples of lysate resolved using SDS-PAGE 
and then immunoblotted with anti-myc and anti-FLAG antibodies. As expected, the FLAG 
tagged constructs were constantly expressed, while expression of the myc tag construct 
was induced by 2 ng/ml and 8 ng/ml of doxycycline for truncated and full length constructs 
respectively (Figure 3.7C and D). It is noteworthy that a non-specific band (~170 kDa) 
observed in all Western blots where HEK 293 lysates are analysed using anti-FLAG 
antibody is missing in Figure 3.7C. This is not a gel cropping artefact and image faithfully 
represents the original data. The non-specific band generally has lower intensity and in this 
particular case most likely completely disappeared because of some chemiluminescence 
artefact. These conclusions are supported by the fact that the non-specific band can be 
observed in an identical experiment with the same cell line but different doxycycline 
concentrations (Figure 3.7 E). 
In order to verify Robo1 protein cellular distribution, the double stable HEK 293 Flp-In T-
REX cell lines were incubated with 10 ng/ml of doxycycline for 24 hours and inspected 
with an inverted epifluorescence microscope. Direct visualisation of Citrine and Cerulean 
fluorescent proteins revealed constant expression of the Cerulean tagged constructs, 
doxycycline dependent induction of the Citrine labelled Robo1 and cell surface delivery of 
all proteins of interest (Figure 3.8). Co-localisation of differentially tagged constructs was 
high, although lower then that observed in transiently transfected cells. Closer inspection 
of merged images revealed that constitutively expressed Robo1 constructs (red 
pseudocolour) tended to have higher presence within intracellular vesicles then inducible 
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(green pseudocolour) Robo1 genes (Figure 3.8). This result is not surprising, since a 
constitutively expressed protein has higher concentration and may have higher presence in 
various transport/recycling/degradation pathways then recently induced protein. 
Close inspection of images also revealed differential distribution of truncated and full-
length Robo1 constructs within the membrane. Truncated Robo1 constructs were 
distributed across the membrane more or less evenly, while full-length Robo1 was 
concentrated into patch-like structures, usually within cell-cell contacts (Figure 3.8A and 
B). This phenomenon was further inspected at higher resolution using confocal 
microscopy. “Single” stable HEK 293 Flp-In T-REX cells were incubated with 10 ng/ml of 
doxycycline for 24 hours to induce expression of myc-Robo1-CIT or 
myc-Robo1-CIT-Robo1 constructs. Cells then were fixed and Citrine fluorescence 
imagined with the confocal microscope (Figure 3.9). Results clearly showed differential 
truncated and full-length Robo1 construct distribution within the membrane and thus 
confirmed previous observations with live cells. All three stable cell lines expressing full-
length Robo1 constructs (myc-Robo1-CIT-Robo1, FLAG-Robo1-CER-Robo1 and both of 
them together) showed this particular distribution. Although less obvious because of higher 
variability, this phenomenon was also noticeable in transiently transfected HEK 293T 
cells. The presence of the patch-like structures was not related to protein expression level, 
since their formation had no detectable correlation with doxycycline concentration or 
incubation times. Talking all this into account, the most likely explanation for these 
observations is that full-length Robo1 uses its C-terminal part to anchor to unknown 
subcellular structures and therefore accumulates at certain points within the cellular 
membrane.  
3.2.4 Signalling	activity	of	Robo1	constructs	
Western blotting and microscopy demonstrates that all Robo1 constructs are of the 
expected molecular mass and have clear membrane localisation. These facts already 
strongly indicate that proteins are natively folded and have no gross deficiencies. 
Nevertheless, the Robo1 constructs were further tested for their ability to bind Slit2. HEK 
293T cells were transiently transfected with a FLAG-Robo1-CER-Robo1 construct and 24 
hours latter cells were incubated with 100 ng/ml of Slit2 (R&D Systems) for 15 minutes in 
their growth medium. Cells were then lysed and the FLAG-Robo1-CER-Robo1 protein 
was immunoprecipitated from the lysate using anti-FLAG antibody-coated agarose beads. 
Commercial Slit2 (R&D Systems) contains a His10 tag and hence an anti-His antibody was 
used to detect co-precipitated Slit2. Western blotting revealed that immunoprecipitation of 
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FLAG-Robo1-CER-Robo1 specifically co-precipitated Slit2 as no pull-down was observed 
with mock transfected cells (Figure 3.10). This experiment shows that the Robo1 construct 
interacts with Slit2 present in the cell medium.  
Robo1 produces its signalling activities via a C-terminal domain so truncated Robo1 
constructs that lack the cytoplasmic tail are excepted to be signalling deficient. On the 
other hand, full-length Robo1 should be able to signal as native Robo1 does. Robo1 does 
not possess enzymatic activity and it signals by recruiting various adaptor molecules. 
Previous studies have indicated that the main downstream signalling pathways for Robo1 
involve the small Rho family GTPases Cdc42 and Rac1, whose activity is often used as a 
proxy for Robo1 activation (Wong et al, 2001; Yang & Bashaw, 2006). Consequently, 
signalling capabilities of the myc-Robo1-CIT-Robo1 construct were also assessed via its 
ability to modulate activity of endogenous Rac1. 
HEK 293 Flp-In T-REX cells were incubated with 10 ng/ml of doxycycline for 24 hours to 
induce expression of the myc-Robo1-CIT-Robo1 construct. Then cells were treated for 5 
minutes with 100 ng/ml of Slit2 (R&D Systems) or 100 nM of TPA (12-O-
tetradecanoylphorbol-13-acetate) as a positive control for Rac1 activation. According to 
some reports Slit2 is able to inhibit Rac1 activation (Lundström et al, 2004), therefore Slit2 
ability to reduce Rac1 activation by TPA was also tested by treating cells with both of 
them. Initially cells were incubated with Slit2 for 5 minutes, then with TPA for an 
additional 5 minute period. Cells were then lysed and Rac1 activity was assessed using a 
Cdc42/Rac1 activity measurement kit (Millipore) as per manufacturer’s instructions. 
General assay quality was poor as high background obscured the already low specific 
signal (Figure 3.11A). Although any effect was not statistically significant, TPA treatment 
consistently increased band intensity in all relevant samples. Treatment with Slit2, 
however, had no clear effects on basal or TPA-induced Rac1 activity (Figure 3.11B). 
Efforts to optimise this assay were not successful and these studies remain inconclusive. 
The Slit2-Robo1 signalling axis in this particular experimental system either does not 
activate Rac1 or the assay used is not sensitive enough to detect the effect.  
Several groups have reported that upon activation Robo1 directly binds srGAP1 protein 
(see section 1.4.2). This recruitment could also potentially serve as a proxy for Robo1 
activation. To test this possibility expression of the FLAG-Robo1-CER-Robo1 construct 
was induced in HEK 293 Flp-In T-REX cells by treatment with 10 ng/ml of doxycycline 
for 24 hours. Cells then were treated with 100 ng/ml of Slit2 (R&D Systems) for 15 
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minutes, lysed and the Robo1 construct precipitated from the lysate using anti-FLAG 
antibody-coated agarose beads. Co-precipitation of endogenous srGAP1 was probed using 
an anti-srGAP1 antibody, however no specific Slit2-induced srGAP1 co-precipitation was 
detected (Figure 3.12). 
Pipper and colleagues identified ERK1/2 phosphorylation and activation as one of the 
events downstream of Robo1 signalling, thus ERK1/2 phosphorylation could potentially 
serve as an assay for Robo1 activation (Pipper et al, 2006). In order to test this possibility, 
expression of myc-Robo1-CIT-Robo1 construct was induced by incubating serum-starved 
HEK 293 Flp-In T-REX cells with 50 ng/ml of doxycycline for 24 hours. Cells then were 
treated with 100 ng/ml Slit2 (R&D Systems) for 5 and 15 minutes respectively or with 
10% FBS for 1 minute as a positive control. Cells were lysed and a fraction of 
phosphorylated, active ERK1/2 was determined using Western blotting with antibodies 
specific for phosphorylated or total ERK1/2. As expected, treatment with 10% FBS caused 
an increase in phosphorylation of ERK1/2, however treatment with Slit2 had no detectable 
effects on ERK1/2 activation (Figure 3.13A). 
Alternatively, Prasad and colleagues showed that Slit2 is able to inhibit ERK1/2 activation, 
therefore a Robo1 signalling assay based on ERK1/2 inhibition was also tested (Prasad et 
al, 2004). Expression of myc-Robo1-CIT-Robo1 was induced in serum-starved HEK 293 
Flp-In T-REX cells by incubating them with 50 ng/ml of doxycycline for 24 hours. Cells 
were pre-incubated with 100 ng/ml of Slit2 (R&D Systems) for 15 minutes and then 
ERK1/2 was activated by adding 10% FBS for 1 or 5 minutes. As expected, treatment with 
FBS increased ERK1/2 phosphorylation, however Slit2 had no observable inhibitory 
effects on the extent of ERK1/2 activation (Figure 3.13B).  
Two different reasons might provide a basis for a failure to unambiguously observe full-
length Robo1 signalling activity. First of all, it is possible that the assays used were not 
adequate to detect Robo1 activity. Assessment of Robo1 signalling has always been 
problematic. Assays based on downstream signalling molecules and physiological effects 
are ambiguous and often have produced contradicting results even for highly similar 
experimental protocols (see section 1.4.2 and 1.6). Therefore, it is possible that an absence 
of detectable Robo1 signalling activity was caused by a failure to employ a correct assay or 
correct assay conditions. On the other hand, one cannot discard the possibility that the full-
length Robo1 constructs, produced for these studies are in some manner deficient. Insertion 
of a fluorescent protein might have affected the ability of Robo1 to bind adaptor molecules 
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within the cell. Fusion of a fluorescent protein usually can be relatively safely guided by 
knowledge of the secondary or domain structure of the "host" protein. In the case of 
Robo1, its cytoplasmic part is most likely an intrinsically disordered protein, so naturally 
all attempts to predict its secondary structure or domain organisation in silico were 
fruitless. In this situation an insertion site for the fluorescent proteins was selected 
randomly, close to the cell membrane to minimise possible variations in FRET distance. 
Known functional fragments (CC0-CC3) remained undisturbed, however, since our 
knowledge about intrinsically unstructured proteins and their binding mechanisms is vague 
at best, it is possible that an insertion of a rigid structured domain affects functions of the 
Robo1 cytoplasmic tail. On the other hand, full-length Robo1 is anchored to 
supramolecular structures within the cell, which indicates that the cytoplasm tail of Robo1 
retains at least some functionality. Moreover, the Robo1 cnstructs show other signs of a 
"healthy" protein: they were transported to the cell surface and capable of binding Slit2. 
Therefore, it is reasonable to assume that at least the extracellular part of the protein is 
natively folded and functional.  
3.3 Robo1	oligomeric	state	assessment	with	FRET	imaging		
One of the ways to assess Robo1 oligomeric state and its dependency upon the ligand in 
live cells is FRET imaging, based on sensitised emission of the acceptor. The basis of such 
studies is quite straightforward. Let us assume that Robo1 in the resting state exists as a 
dimer. This association would bring fluorescent proteins into close proximity allowing 
energy transfer between the fluorophores (Figure 3.14A). If Slit2 causes the Robo1 dimer 
to dissociate, incubation of live cells with the ligand would increase average distances 
between the receptors and their incorporated fluorescent protein thus reducing FRET signal 
(Figure 3.14B). The same principles are valid for an opposite mechanism, i.e. ligand 
induced association. Here initially one would observe a low FRET signal which would be 
increased by the addition of the ligand. 
Although transient transfection has considerable shortcomings, when it comes to FRET 
imaging, the relatively straightforward nature of these experiments makes transiently 
transfected cells a good starting model for FRET analysis. HEK 293T cells growing on 
glass coverslips were transiently transfected with Robo1 constructs. The following day a 
coverslip fragment with cells was transferred into a microscope chamber and donor and 
acceptor fluorescence was imaged as described in section 2.2.25 (Figure 3.15). In order to 
assess Slit2 effects on FRET, cells were incubated with 90 ng/ml of Slit2 (in house 
produced) for 30 minutes before collecting the images. FRET signal was quantified from 
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the acquired images and expressed as a RFRET index as described in section 2.2.25. The 
RFRET index for untreated cells expressing truncated Robo1 constructs was 1.81±0.02 
while treated cells showed a RFRET signal of 1.82±0.04 (Figure 3.15, B). Identical 
experiment with full-length Robo1 constructs yielded the RFRET signal of 1.44±0.03 and 
1.46±0.02 respectively (Figure 3.15C). These values indicate that both truncated and full-
length Robo1 receptors form oligomers in live cells, since RFRET index values above 1 
reflect energy transfer. However, in both cases Slit2 failed to induce observable differences 
in the RFRET index, which shows absence of changes in distances between Robo1 
constructs, effectively implying that the oligomeric state of Robo1 is not affected by Slit2.  
Diffusion of membrane proteins is restricted to two-dimensional space and hence random 
molecular collisions along with non-specific protein-protein interactions are much more 
prevalent and therefore need to be accounted for (Vogel et al, 2006). Experiments with 
other proteins and general experience within the group shows that RFRET index values of 
1.81 and 1.44 measured for Robo1 constructs are relatively high and most likely well 
above random “collisional” FRET level. Nevertheless, this assumption was tested 
experimentally by generating a set of potentially non-oligomerising Robo1 constructs.  
As mentioned before, exact determinants responsible for Robo1 oligomerisation remain 
unknown, however, it appears that the extracellular part of the protein is sufficient to drive 
these interactions. Therefore, a Robo1 construct lacking the cytoplasmic tail was further 
truncated, deleting either all five Ig domains (SS-FLAG-Robo1(ΔIg)-CER) or Ig and FnIII 
domains all together (SS-FLAG-Robo1(ΔIgΔFnIII)-CER) (Figure 3.16A). These newly 
generated constructs were checked for expression and correct cell surface delivery using 
immunocytochemistry (Figure 3.16B and C). Verified constructs were co-transfected with 
the SS-myc-Robo1-CIT construct and FRET was measured as described above. 
Additionally, potential FRET was measured between SS-myc-Robo1-CIT and the Robo1-
unrelated human muscarinic acetylcholine receptor M3 tagged with Cerulean. N-terminal 
deletions reduced FRET signal to levels similar to that of the presumed nonspecific 
interactions between Robo1 and the acetylcholine receptor (Figure 3.17). This experiment 
demonstrates that in this particular system “collisional” non-specific FRET signal 
corresponds to 1.2-1.3 and is well below FRET values observed for oligomerisation 
competent Robo1 constructs. 
As mentioned above, transient transfection is not the best experimental system for 
assessing protein-protein interactions and therefore stable cell lines were created in parallel 
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with transient expression experiments (see section 3.2.3). HEK 293 Flp-In T-REX cells 
were grown on glass coverslips and expression of Robo1 constructs was induced by 
incubating cells with 50 ng/ml of doxycycline for 24 hours. A fragment of the coverslip 
was transferred into the microscope chamber and donor and acceptor fluorescence was 
imaged as described in section 2.2.25 (Figure 3.18A). In order to assess Slit2 effects on 
FRET, cells were incubated with 100 ng/ml of Slit2 (R&D Systems) for 30 minutes before 
collecting further images. Once again, a strong FRET signal was observed between the 
differentially tagged Robo1 constructs, however Slit2 had no detectable effects on the 
values of a RFRET index (Figure 3.18B and C). 
Taken together the FRET imaging experiments strongly suggest that Robo1 exists as an 
oligomer in vivo, but contrary to the original hypothesis Slit2 had no observable effects on 
the oligomeric state of the receptor. Interestingly, full-length Robo1 constructs generally 
showed lower RFRET index values than C-terminally truncated proteins. Since full-length 
Robo1 seems to be anchored to other proteins within the cell, it is possible that these 
interactions affect distance between fluorophores or their orientation. Alternatively, one 
can never dismiss the possibility of unknown experimental artefacts related to FRET 
imaging itself, therefore results from FRET imaging were complemented with alternative 
methods.  
3.4 Robo1	oligomeric	state	assessment	with	time‐resolved	FRET	
Time resolved FRET (TR-FRET) is another method suitable for assessing protein-protein 
interactions in live cells. Although based on the same fundamental principles, TR-FRET 
differs from the FRET imaging methodologically: TR-FRET measurements are performed 
with cell populations and different fluorophores and equipment is employed. Therefore the 
TR-FRET experiment is a good alternative approach to verify original observations based 
on the FRET imaging. 
In order to perform a TR-FRET experiment a protein of interest needs to be labelled with 
specific fluorophores which cannot be encoded genetically. Hence, a SNAP tag was added 
to already existing Robo1 constructs. This tag, based on a modified O6-alkylguanine-DNA 
alkyltransferase reacts with benzylguanine derivatives, leading to irreversible covalent 
labelling of the protein with a synthetic probe (Figure 3.19A). A EcoRV-SNAP-EcoRV 
fragment was synthesised using PCR and appropriate synthetic oligonucleotides, digested 
with EcoRV and ligated in to a pcDNA5 vector harbouring truncated or full-length Robo1 
constructs. This way the SNAP tag was added to the extracellular domain of Robo1 
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between a myc epitope tag and the Robo1 sequence creating myc-SNAP-Robo1-CIT and 
myc-SNAP-Robo1-CIT-Robo1 constructs respectively (Figure 3.19B). 
One of the advantages of the SNAP labelling system is that a single construct is sufficient 
for TR-FRET experiments as it can be labelled with both donor and acceptor by applying a 
mixture of them during a cell labelling step. Two different SNAP substrates, 
benzylguanine conjugated either with Lumi4-Tb (donor, Tb cryptate) or RED (acceptor, a 
proprietary fluorophore from Cisbio Bioassays), were used for these experiments. The 
rationale of TR-FRET experiments is very similar to that of FRET imaging. If Robo1 
oligomerises, this association would bring fluorophores into close proximity allowing 
energy transfer between them and high TR-FRET signal (Figure 3.19C). Similarly, an 
oligomer dissociation caused by Slit2 would increase the average distance between 
fluorophores causing a reduction in TR-FRET signal (Figure 3.19D). An opposite 
mechanism, ligand-induced association, is also possible. 
Newly created SNAP-tagged Robo1 constructs first of all were verified for correct 
expression and cell surface delivery. HEK 293T cells were transfected with myc-SNAP-
Robo1-CIT, myc-SNAP-Robo1-CIT-Robo1 or appropriate vehicle controls, incubated for 
24 hours and then lysed. Samples of cell lysates were resolved by SDS-PAGE and 
immunobloted with anti-SNAP and anti-myc antibodies. Both antibodies were able to 
specifically detect their corresponding constructs (Figure 3.20). Additionally, for 
immunecytochemistry experiment HEK 293T cells were transiently transfected with myc-
SNAP-Robo1-CIT, myc-SNAP-Robo1-CIT-Robo1 or a truncated Robo1 construct without 
a SNAP tag. Next day cells were fixed and stained with Hoechst and SNAP-Surface 549, a 
cell impermeant, fluorescent SNAP substrate. Observed staining patterns of the SNAP 
specific dye and its co-localisation with the fluorescence from the Citrine fluorescent 
protein indicated successful expression and cell surface delivery of the constructs (Figure 
3.21). 
SNAP substrates conjugated with donor or acceptor have different SNAP binding rates, 
therefore one needs to establish an optimal donor/acceptor concentration ratio used for cell 
labelling. In order to achieve this, HEK 293T cells were transfected with myc-SNAP-
Robo1-CIT, myc-SNAP-Robo1-CIT-Robo1 or corresponding negative control plasmids, 
maintained for 24 hours and then transferred into a 96 well plate. Next day cells were 
labelled with a mixture of both substrates where donor concentration was kept constant at 
50 nM and acceptor concentration varied between 15 nM and 2 μM. Samples were excited 
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at 340 nm and a raw TR-FRET signal measured at 665 nm using a PHERAstar FS plate 
reader (BMG Labtech). As expected, the strength of the TR-FRET signal was dependent 
upon the acceptor (RED) concentration and followed a bell-shaped distribution, as an 
excess of either donor or acceptor is expected to result in formation of non productive 
donor-donor or acceptor-acceptor labelled pairs (Figure 3.22A). The optimal 
donor/acceptor ratio, yielding the maximal raw TR-FRET signal, was determined to be 2.3 
(Lumi4-Tb/ RED) both for the truncated and full length Robo1 construct. The bell-shaped 
curve observed during acceptor titration is consistent with basal oligomerisation of both 
Robo1 constructs as this kind of dependency should not exist without Robo1-Robo1 
association. Absolute raw TR-FRET values also show Robo1 oligomerisation as they are 
comparable to those observed for other oligomeric proteins within the group. Differences 
in the TR-FRET signal strength observed between the truncated and full-length constructs 
are most likely caused by differential protein expression levels. A raw TR-FRET signal 
measured at 665 nm is not normalised for protein expression levels and thus a smaller 
truncated Robo1 construct, expressed at higher levels, yields a higher TR-FRET signal.  
In order to assess effects of Slit2 on TR-FRET, HEK 293T cells were transfected with 
myc-SNAP-Robo1-CIT or myc-SNAP-Robo1-CIT-Robo1 constructs, incubated for 24 
hours and then transferred into a 96 well plate. Next day cells were labelled with an 
optimal mixture of donor and acceptor SNAP substrates (50 nM Lumi4-Tb, 115 nM RED). 
Cells then were washed to remove unconjugated fluorophores and Slit2 (R&D Systems) 
was added into the wells to a final concentration of 100 ng/ml. Alternatively, an equal 
volume of vehicle was added as a negative control. The resulting TR-FRET signal was 
monitored over the subsequent 45 minute period.  
The addition of the ligand might affect the general optical properties of the sample in the 
plate well, so in these situations TR-FRET is usually expressed as a ratio between acceptor 
fluorescence and donor fluorescence (I665/I620) to normalise all externally induced changes 
(Figure 3.22C). The observed TR-FRET signal in this time course experiment decreased 
over the time because of acceptor quenching. This phenomenon was observed with other 
proteins and does not interfere with monitoring of ligand-induced changes (Xu et al, 2011). 
Nevertheless, in the case of Robo1 constructs, samples treated with Slit2 behaved almost 
identically to those treated with PBS (Figure 3.22C).  
Relatively high differences in a TR-FRET signal were observed for the truncated and full-
length Robo1 constructs. In the case of raw TR-FRET, the observed tenfold difference at 
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least partially can be explained by discrepancy in protein levels. Citrine fluorescence data 
collected from the same samples as TR-FRET shows that the truncated protein was three 
times more abundant than the full-length Robo1 construct (Figure 3.22B). 
Correspondingly, when the TR-FRET signal is expressed as a I665/I620 ratio it becomes 
normalised for protein concentration and the differences in TR-FRET intensity is reduced 
approximately three fold. The remaining mismatch is more difficult to explain. 
Interestingly enough, this trend, that the truncated construct yields higher energy transfer 
efficiency than the full-length receptor was observed during FRET imaging experiments as 
well. One can only speculate that it might be caused by additional protein-protein 
interactions that full-length Robo1 is capable of.  
Overall, TR-FRET measurements yielded similar results and conclusions as FRET 
imaging. In agreement with the original hypothesis, experimental evidence indicates in 
vivo oligomerisation of both truncated and full-length Robo1 constructs. On the other hand, 
Slit2 had no detectable effect on the TR-FRET signal, which indicates that the oligomeric 
state of Robo1 is most likely not affected by binding of the ligand.  
3.5 Robo1	oligomeric	state	assessment	with	co‐immunoprecipitation	
In parallel with biophysical studies Robo1 oligomerisation and Slit2 effects on it were 
assessed using co-immunoprecipitation. All Robo1 construct were originally designed with 
different epitope tags (FLAG and myc respectively) and therefore no additional 
modifications were necessary. HEK293T cells were transiently co-transfected with 
differently tagged truncated or full-length constructs (myc-Robo1-CIT and FLAG-Robo1-
CER; myc-Robo1-CIT-Robo1 and FLAG-Robo1-CER-Robo1), incubated for 24 hours and 
treated with 100 ng/ml of Slit2 (R&D Systems) or vehicle in cell medium for 15 minutes. 
After treatment the cells were washed with ice cold PBS and lysed using RIPA 
(Radioimmunoprecipitation assay buffer). The FLAG-tagged Robo1 constructs were 
immunoprecipitated from the lysate using anti-FLAG antibody conjugated agarose beads 
and co-precipitation of the myc-tagged Robo1 constructs was examined using an anti-myc 
antibody and Western blotting. Limited co-immunoprecipitation was observed for the 
truncated Robo1 construct and none for the full-length (Figure 3.23). 
Given the FRET imaging and TR-FRET results a substantial level of Robo1-Robo1 co-
precipitation might have been expected and failure to observe it seemingly contradicts the 
previous data. However, all energy transfer experiments were performed with intact cells, 
while the immunoprecipitation experiments were performed under relatively harsh 
conditions. A RIPA buffer used for cell lysis and receptor solubilisation might be too 
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denaturing to preserve Robo1 oligomerisation. However, efforts to optimise the cell lysis 
buffer were fruitless as using a milder detergent and buffer compositions caused non-
specific interactions and decreased the fraction of solubilised Robo1 protein. 
One possible strategy to circumvent a problem with complex stability is chemical 
crosslinking. Bifunctional chemical reagents can covalently bridge two interacting proteins 
linking them together and preserving the complex during cell lysis. In other words, 
crosslinking can be used to “freeze” an oligomeric state of the receptor, including any 
changes in it induced by a ligand (Figure 3.24A). A modern crosslinking reagent, like 
DTSP (3,3'-dithiodipropionic acid di(N-succinimidyl ester)), contains an inner disulphide 
bridge which is reduced during denaturing SDS-PAGE, therefore crosslinking does not 
affect protein migration within the gel. An extent of oligomerisation is inferred from 
Western blot band intensity of co-precipitated proteins.  
HEK 293T cells transiently co-expressing differently tagged truncated and full-length 
Robo1 constructs (myc-Robo1-CIT and FLAG-Robo1-CER; myc-Robo1-CIT-Robo1 and 
FLAG-Robo1-CER-Robo1) were treated with 100 ng/ml of Slit2 (R&D Systems) or PBS 
as negative control for 15 minutes. Cell medium was then changed to PBS and cells were 
crosslinked by incubating them with 2 mM DTSP for 30 minutes. Finally, the cells were 
lysed using RIPA buffer, FLAG-tagged Robo1 proteins were pulled down from the lysates 
using anti-FLAG antibody-conjugated beads and co-precipitation of myc tagged Robo1 
constructs was analysed using Western blot (Figure 3.24B). Chemical crosslinking slightly 
increased the co-precipitation efficiency of truncated Robo1 constructs, although, as in the 
biophysical studies, Slit2 had no obvious effects on Robo1 oligomeric state.  
Much more unexpected results of crosslinking were observed when using full-length 
Robo1 constructs. These were effectively removed from the soluble fraction of cell lysates 
(Figure 3.24B). A mouse Robo1 cytoplasmic tail contains 31 lysine, residues DTSP reacts 
with, and being presumably an intrinsically unstructured protein constitutes a good target 
for the crosslinker. As mentioned before, the full-length Robo1 constructs showed a 
distinct distribution within the cell membrane, which potentially indicates their association 
with intracellular structures. It is possible that these structures together with Robo1 were 
crosslinked by DTSP into insoluble aggregates which were removed from the soluble 
fraction during centrifugation of cell lysates. The remaining levels of the full-length Robo1 
protein were so low that it would have been difficult to detect co-precipitation even if it 
was present. In order to test this possibility, a FLAG tagged construct representing soluble 
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Robo1 cytoplasmic domain (FLAG-cRobo1) was transiently expressed in HEK 293T cells. 
Twenty-four hours after transfection, cell medium was changed to PBS and cells were 
crosslinked by incubating them with 0, 0.5, 1, or 2 mM of DTSP for 30 minutes. Finally 
cells were lysed, samples of lysate resolved using SDS-PAGE and then immunoblotted 
with anti-FLAG antibody (Figure 3.24C). Even incubation with 0.5 mM of DTSP 
effectively removed the FLAG-cRobo1 construct out of soluble lysate fraction supporting 
the suggestion that the crosslinking precipitates the full-length Robo1 construct out of 
lysate.  
In summary, efforts to assess Robo1 oligomeric state with co-immunoprecipitation were 
not really successful. Weak co-precipitation of truncated Robo1 constructs, even though 
increased by crosslinking, remained barely above detection limits. Under these conditions 
Slit2 effects on Robo1 oligomerisation would be difficult to detect even if they were 
present. Co-precipitation of full-length Robo1 was not observed at all. Attempts to stabilise 
the full-length Robo1 oligomer by chemical crosslinking completely removed it from 
solution, which in agreement with previous observations suggests that its cytoplasmic tail 
most likely is bound to as yet unidentified subcellular structures. It is also worthy of note 
that co-immunoprecipitation, similarly to FRET imaging and TR-FRET experiments, 
shows that the truncated Robo1 constructs potentially form oligomers more readily than 
the full-length receptors.  
3.6 Robo1	oligomerisation	determinants	
 
Earlier attempts to locate determinants responsible for Robo1 oligomerisation using serial 
domain deletions were inconclusive, indicating that receptor association might be driven 
by multiple and redundant sites (Liu et al, 2004). However, this approach is relatively blunt 
and error prone as results can be obscured by collaterally introduced protein folding 
problems. A protein-protein interaction analysis based on peptide arrays is less biased and 
has higher resolving power because putative contacts can be mapped within relatively short 
stretches of amino acids. Therefore the issue of Robo1 oligomerisation determinants was 
examined using peptide spot arrays. A library of overlapping, 25 amino acid long peptides 
was designed based on the sequence of the rat Robo1 extracellular domain and spotted on 
to cellulose membrane, thus creating a protein array where each spot represents a short 
stretch of the primary rat Robo1 sequence. The rat orthologue was chosen for this 
particular experiment because commercially available rat Robo1 and a human Fc fragment 
chimera (Robo1-Fc, R&D Systems) was an ideal reagent to visualise Robo1-Robo1 
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interactions. First of all, to demonstrate detection specificity, a control overlay was 
performed by incubating the membrane with a 5% milk powder solution in TBS buffer 
over night and blotting it with an anti-Fc antibody. As no non-specific signal was detected 
(Figure 3.25A and B), the same membrane was washed and then incubated with 50 μg/ml 
of rat Robo1-Fc chimera (R&D Systems) in 5% milk powder solution over night. Next day 
the membrane was washed to remove non-specifically bound Robo1-Fc and blotted with 
the anti-Fc antibody to visualise polypeptides on the array that had interacted with Robo1 
(Figure 3.25 A and B). Three independent experiments were performed and Robo1 binding 
polypeptides identified in at least two of them are listed in Figure 3.25C. Mapping of these 
sequences on to the extracellular Robo1 domain revealed that putative oligomerisation 
sites are distributed across many different domains. Potential Robo1-Robo1 binding sites 
were identified in Ig2, Ig3, Ig5, FnIII1, FnIII2 domains as well as within Ig4-Ig5, Ig5-
FnIII1 and FnIII1-FnIII2 interdomain linkers, supporting the notion of multiple and 
possibly redundant Robo1 oligomerisation determinants (Figure 3.25D). Inspection of such 
identified sequences revealed an interesting pattern. It appears that sites located in Ig2, Ig3 
and Ig5 domains cover similar sequences and correspond to roughly the same structural 
element – a flexible, surface-exposed loop between two beta-sheets (Figure 3.26A and B). 
It is also worth noting that this particular loop is considerably longer in Ig1 and Ig4, 
domains that lack any identified Robo1 binding sites. Although these observed patterns are 
really intriguing they must be interpreted with some caution. Ig and FNIII domains are 
roughly 80-100 amino acids in length while the peptides are 25 amino acids in length. It 
means that single peptides cover multiple elements of secondary structure and the overlap 
can be observed even when the actual interaction determinants are different. Further 
protein array experiments with different polypeptide libraries or modified polyptides, 
including alanine scanning arrays, may help to refine and at least partially verify putative 
sites of Robo1 oligomerisation. 
3.7 Discussion	
The main aim of the experiments described in this chapter was to establish a 
transmembrane signalling mechanism of Robo proteins. Being a type I transmembrane 
protein the Robo receptor has a single transmembrane α-helix which effectively blocks 
transfer of conformational changes between extracellular and intracellular parts of the 
protein, making signal transduction within one molecule impossible. For that reason the 
type I receptors usually act as homo- or heterooligomers, where multiple molecules react to 
ligand binding in a coordinated fashion. Not surprisingly, therefore, existing experimental 
data clearly show that the Robo extracellular domain is capable of oligomerisation in vitro 
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(see section 1.4.1). Such ability is quite common among IgCAM receptors, the protein 
superfamily that the Robos belong to. These proteins usually employ changes in 
oligomerisation state as a mechanism to transmit signal across the membrane (see section 
1.4.1), thus Slit–Robo signalling may well involve a change in oligomeric status of Robo, 
both ligand-induced association and dissociation being possible.  
Mouse Robo1 was selected as an experimental model for this task. The protein was cloned 
and two different types of Robo1 constructs were created - full-length and lacking the C-
terminal cytoplasmic tail. The constructs were successfully expressed in HEK 293T cells 
where they, as expected, were transported to the cell surface. Co-immunoprecipitation 
experiments confirmed that heterologously expressed Robo1 interacts with Slit2 present in 
cell medium suggesting that the extracellular part of the construct is natively folded and 
biologically active. The truncated Robo1 construct is signalling deficient by definition, 
however, the full-length Robo1 construct should harbour signalling activity identical to the 
wild type protein. Nevertheless, signalling activity of the full-length construct was not 
detected by any of three different assays employed. As discussed above, Robo signalling is 
strongly context dependent and an apparent lack of it might be simply caused by the failure 
to define correct assay conditions. On the other hand, currently it is impossible to discard 
the possibility that the intracellular part of the full-length construct become deficient after 
insertion of a fluorescent protein. Although a peculiar distribution of the full-length Robo1 
protein may indicate that the cytoplasmic tail interacts with intracellular proteins and thus 
retains at least partial functionality. Moreover, one can argue that even if the cytoplasmic 
tail is deficient it would not affect overall transmembrane signalling mechanism of the 
Robo receptor. Published data and experiments described in this chapter clearly 
demonstrate that the extracellular Robo domain is capable of oligomerisation both in 
solution and as a membrane tethered form. It seems that interactions between the 
extracellular domains are sufficient for Robo1 oligomerisation, and since Slit has access 
only to the extracellular part, one can argue that the extracellular domain is the main 
element in the transmembrane signalling mechanism. The C-terminal Robo1 domain 
would have a more prominent role in the transmembrane signalling mechanism if it had 
had a “repulsive” activity and was acting as a lever to the homophilic extracellular domain. 
However, limited available data shows that the cytoplasmic Robo domain most likely 
oligomerises as well (Simpson et al, 2000b). It is reasonable, therefore, to suggest that the 
Robo1 constructs having the absent or potentially deficient cytoplasmic tail most likely 
would follow the transmembrane signalling mechanism of the wild type Robo1 anyway.  
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In order to test the hypothesis that the Robo receptors transmit signal across the membrane 
by changing their oligomeric state and establish directionality of ligand induced changes, 
three different techniques were used to determine the Robo1 oligomeric state in live cells 
before or after treatment with Slit2: FRET imaging, TR-FRET and co-
immunoprecipitation. The co-immunoprecipitation experiments failed to reveal strong 
Robo1-Robo1 interactions, most likely because of relatively harsh conditions necessary for 
cell lysis and receptor solubilisation. The fact that under milder conditions (TBS buffer 
instead of RIPA) the soluble Robo1 ectodomain was able to bind peptides in a protein 
array experiment largely confirms this assumption. Energy transfer techniques employing 
live cells, meanwhile, showed strong Robo1 oligomerisation thus supporting the original 
hypothesis and pointed towards ligand induced dissociation as the Robo1 transmembrane 
signalling mechanism. Cell treatment with Slit2, however, failed to produce any observable 
changes in FRET signal both in FRET imaging and TR-FRET experiments.  
Experiments described in section 4.2.2 show that HEK 293T cells express natively mRNA 
for Slit1, Slit2, Slit3, Robo1 and Robo2 genes, so one could argue that constitutive 
oligomerisation of Robo1 constructs is induced by endogenous Slit2. A cell line without 
endogenous Slit-Robo expression would be a preferable experimental vehicle, however, as 
the same experiments demonstrate, virtually all transformed cell lines do express some of 
the Slit or Robo family members (see Figure 4.2). Since cell lines free of endogenous Slit-
Robo proteins were not available, the best experimental strategy was to choose one which 
is widely used and easy to work with i.e. HEK 293T cells. Moreover, even though HEK 
293T have high levels of Robo1 mRNA, Western blot experiments show that in 
comparison to the expression of the recombinant construct, protein levels of endogenous 
Robo1 are negligible (Figure 4.5B). Correspondingly, many studies successfully used 
experimental models based on HEK 293T cells heterogeneously expressing Robo1 
constructs and treated with Slit2 treatment (Park et al, 2003; Wong et al, 2001; Yang & 
Bashaw, 2006) indicating that endogenous levels of Slit-Robo are low and do not affect 
behaviour of an experimental system based on heterologous expression.  
One could suggest two additional possible explanations for constitutive Robo1 
oligomerisation and the lack of Slit2 effects upon it, either Slit2 or Robo1 proteins are 
deficient and unable to signal properly or Robo1 transmembrane signalling is not 
dependant on changes in oligomeric state. Experiments clearly demonstrate that Slit2 is 
biologically active and able to bind the Robo1 constructs. Also, as discussed above, even 
though the Robo1 downstream signalling was not detected and the Robo1 intracellular part 
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potentially could be partially deficient, the employed constructs should follow the 
transmembrane signalling mechanism of wild type protein. Hence one can argue that 
changes in oligomeric state were not observed not because of deficiency of the used 
constructs used, but because the Robo1 proteins do not rely on them to transmit signal 
across the membrane. 
What alternative transmembrane signalling mechanism could Robo1 employ? Coleman 
and colleagues suggested that proteolytical shedding of the extracellular Robo domain is 
necessary for receptor activation in Drosophila (Coleman et al, 2010). The authors failed 
to demonstrate a direct connection between Slit binding and Robo cleavage, however, they 
collected a substantial amount of circumstantial evidence. Based on it, it is possible to 
envision a mechanism in which Robo oligomerisation restricts the C-terminal tail and in 
this way prevents downstream signalling. Slit binding may induce conformational changes 
within the extracellular domain which lead to its cleavage by proteases. The released C-
terminal domain would then dissociate into monomers and recruit downstream signalling 
molecules. In this situation the TR-FRET experiments described in this chapter would 
most likely fail to register any changes in distance between fluorophores, as the SNAP-
tagged extracellular domains presumably would be released into cell media without major 
conformational changes. On the other hand, FRET imaging experiments should be able to 
detect dissociation of the C-terminal domain as it employs fluorophores fused to it. 
However, an additional technical issue exists. In order to measure FRET, the Robo1 
constructs were overexpressed above their physiological levels, potentially saturating the 
proteolytical capacity of Robo1 proteases. In this situation only a small fraction of cellular 
Robo1 might actually be cleaved. If cleavage is important in the transmembrane signalling 
mechanism, as proposed by Coleman, it would severely limit the number of actual 
signalling events making them virtually undetectable in the general background of 
abundant resting state receptor. Such a mechanism would explain the lack of Slit2 effects 
both in TR-FRET and FRET imaging experiments. On the other hand, Seki and colleagues 
demonstrated that in mammalian cells, both extracellular and intracellular Robo1 domains 
are cleaved in a consecutive and mutually-dependent manner without an apparent 
involvement of Slit (although the presence of the endogenous Slit cannot be fully 
dismissed). Upon release the C-terminal Robo1 domain was quickly destroyed by the 
proteosomes as it became detectable in cell lysates only when proteosmal inhibitors were 
added (Seki et al, 2010). These observations are more compatible with the idea that the 
proteolysis is more related to receptor desensitisation or recycling then transmembrane 
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signalling. In this situation proteolysis most likely would not interfere with FRET 
measurements. Either way at this point proteolytical cleavage remains a viable mechanism 
and merits further investigation. 
The potential anchoring of full-length Robo1 to intracellular structures also indicates that 
the Robo1 transmembrane signalling might be more complex then was initially assumed. 
Conceptually it is possible to imagine a transmembrane signalling mechanism where the 
Robo1 oligomer detaches from the intracellular complex upon ligand binding, dissociates 
into monomers and recruits downstream signalling molecules. However, experimental data 
presented in this chapter does not support it. On the other hand, an alternative mechanism, 
where constitutively anchored Robo1 receptors act as part of a bigger protein complex, is 
equally likely. One could imagine a mechanism where Robo1 oligomer directly transmits 
ligand-induced conformational changes to permanently associated protein complexes 
within the cell. The observed, apparently constant, association between Robo and Mena 
proteins supports this idea (Bashaw et al, 2000), nevertheless, it remains highly speculative 
and further work is necessary to test it.  
A considerable amount of effort was spent trying to identify intracellular structures that 
Robo1 associates with. Co-immunoprecipitation of full-length Robo1 followed by mass 
spectrometry analysis of precipitate failed to reveal any specific interacting proteins. 
Technical issues might be suspected, since even known Robo1 binding proteins were not 
detected. As discussed in section 1.4.2, many studies suggest positive interactions and 
indirect association between Robo and cadherin - β-catenin complexes. Therefore, one can 
speculate that the observed membrane patches represent adherens junctions or other 
cadherin related cell-cell adhesion substructures. On the other hand, the ability of Robo to 
take part in cell polarity and form membrane domains during heart lumen formation in 
Drosophila was attributed to antagonistic and mutually exclusive interactions between 
Robo and E-cadherin (Medioni et al, 2008, Santiago-Martinez et al, 2000). Thus the 
propensity of Robo to form membrane domains might reflect more than simple association 
with cadherins.  
Experiments described in this chapter also illustrate the organisation of the extracellular 
domain. Published data indicates that the Robo1 extracellular domain most likely exists as 
oligomer in solution (see section 1.4.1). In agreement with this, some of the peptides based 
on the primary Robo1 sequence were able to bind the soluble Robo1 ectodomain, revealing 
potential Robo1-Robo1 interaction sites. These peptide array results indicate multiple and 
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redundant interaction sites spread over multiple domains (Figure 3.25D). However, it must 
be mentioned that the peptide array theoretically could detect the intramolecular protein-
protein contacts responsible for overall folding of the extracellular Robo1 domain. Thus 
not all hits necessarily represent genuine oligomerisation sites. 
Interestingly, some of the identified sequences mapped to the same structural element of 
Ig2, Ig3 and Ig5 domains. This conserved motif consists of a flexible, surface exposed loop 
surrounded by two β-sheets (Figure 3.26). Following the agreed notation for the I-set Ig 
domains (a subtype of Ig domains all Robo Ig domains belong to) it corresponds to C and 
D β-sheets and loop between them (Harpaz and Chothia, 1994). Currently it is impossible 
to infer potential roles of this C-D motif directly. Available structures of separate Robo 
domains carry very little information about an overall folding mechanism for the 
extracellular part of Robo1. In an attempt to circumvent this limitation, known structures 
of oligomeric proteins consisting of I-set Ig domains were examined with the hope that 
they might reveal a common pattern of oligomerisation interfaces or recurring functions of 
the C-D motif. The first three Ig domains from the NCAM molecule form an extended 
structure which dimerises by contacts from the first two Ig domains (Figure 3.27A). In this 
structure, several amino acids from the C β-sheet take part in the dimerisation interface, 
however, contacts from other structural elements are more substantial. While the CD-loop 
and D β-sheet do not contribute to the dimerisation interface in this particular structure, 
close proximity of these elements to their counterparts on an opposite subunit is intriguing 
(Figure 3.27A). Crystal packing imposes its own constrains on a protein complex and in 
some cases the protein in solution might have a slightly different conformation than the 
observed crystal structure, bringing the CD-loop and D β-sheet from Ig1 and Ig2 into a 
contact. PTPRσ (protein tyrosine phosphatase receptor) shows a different arrangement of 
the extracellular domain (Figure 3.27B). In this structure Ig1 and Ig2 are tightly packed 
against each other with some amino acids from the Ig2 C β-sheet taking part in 
interdomain contacts, although interactions from other structural elements were more 
substantial. Additionally, some amino acids from the CD-loop in Ig3 were taking part in 
the dimerisation interface between Ig2 and Ig3 (Figure 3.27B). Although no strict 
conclusions can be drawn from these observations, they are encouraging as the C-D motif 
seems to take part in the oligomerisation and overall folding of the extracellular domains of 
the I-set Ig proteins. 
Robo1 presents a fascinating case where oligomerisation, anchoring with subcellular 
structures and proteolysis intertwine creating a challenging conundrum for anyone wishing 
Chapter 3  101 
 
to elucidate its transmembrane signalling mechanism. It is possible that each of those 
processes represent a different Robo signalling mode. Robo signalling might have separate 
targets and mechanisms depending on its membrane localisation or proteolytical cleavage. 
Data supporting this idea have emerged recently. It appears that the cleaved C-terminal 
Robo1 domain in mammals is transported to the nucleus (Seki et al, 2010). Although the 
actual significance of this process is yet to be discovered it echoes the mechanism of Notch 
signalling where binding of ligand induces proteolytic cleavage and release of the 
intracellular domain, which enters the cell nucleus to modify gene expression (Oswald et 
al, 2001). 
Multiple biochemical, genetic and biophysical studies will be necessary in order to unravel 
this biological complexity of Robo1 signalling. On a molecular level it would be extremely 
useful to reconstitute the stoichiometry and shape of the Robo1 oligomer. An X-ray 
structure of the whole extracellular Robo1 domain is unlikely, therefore biophysical tools 
like ultracentrifugation or small-angle X-ray scattering spectroscopy could be used to 
determine the overall shape of the complex. This model then could be “filled” with known 
or modelled structures of individual Ig and FnIII domains. Information about potential 
Robo1-Robo1 contacts gained from the protein array experiments may facilitate such 
modelling as well. All this would help us to gain a glimpse of the first steps of the 
transmembrane signalling mechanism, i.e. how and what changes Slit2 binding initiates 
within the extracellular Robo1 domain. In parallel, biochemical studies must address the 
oligomeric state of the C-terminal Robo1 domain, its interacting partners and the precise 
role of proteolytic cleavage. This stepwise accumulation of information about Robo 
structure and function will eventually lead to elucidation of its transmembrane signalling 
mechanism. 
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Figure 3.1 Slit2 and Robo1 constructs 
Schematic illustrations of Slit2 (A), truncated (B) and full-length Robo1 constructs (C).  Transmembrane 
(TM), extracellular and intracellular parts of the Robo1 constructs are marked respectively. Robo1 
constructs were created using a custom designed polylinker region (D).  
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Figure 3.2 Slit2-(His)6 expression and secretion 
HEK 293T cells were transiently transfected with a pcDNA3-Slit2-(His)6 plasmid or an unrelated DNA 
construct as a negative control. Samples of cell lysates and medium were resolved by SDS-PAGE and 
immunobloted to detect the His tag. The blot is representative of two independent experiments.  
Chapter 3  104 
 
 
  
Figure 3.3 Slit2-(His)6 purification 
Slit2-(His)6 was purified using Ni2+ chelating chromatography (A), fractions selected based on UV 
absorption  were additionally analysed using SDS-PAGE (B) and immunoblotting with anti-Slit2 and 
anti-His antibodies (C).  
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Figure 3.4 Biological activity of Slit2 
The biological activity of in house (A) and commercially purchased Slit2 (B) was assessed using 
transwell leukocyte migration assays.  (A) Naive or Slit2-(His)6 treated (90 ng/ml, 15 min) THP-1 cells 
were placed into the upper part of a Boyden chamber and allowed to migrate towards 100 ng/ml CCL2 
for 3 hours. Migrated cells in the lower chamber were counted using flow cytometry. (B) Naive or 
Slit2 (R&D Systems) (100 ng/ml, 15 min) treated human PBMCs were placed into the upper part of a 
Boyden chamber and allowed to migrate towards 10 ng/ml CXCL12 for 3 hours. Alternatively cells 
were treated with Slit2 pre-incubated with Robo1-Fc chimera (1:4). Results are represented as a 
mean±SEM, n=3. * p<0.05 as determined by one way ANOVA with Tukey’s post test.  
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Figure 3.5 Expression of Robo1 constructs 
HEK 293T cells were transiently transfected with each of the Robo1 constructs (myc-Robo1-CIT, 
FLAG-Robo1-CER, myc-Robo1-CIT-Robo1, FLAG-Robo1-CER-Robo1) separately or co-transfected 
with both truncated or both full-length constructs. Cells were lysed, samples of lysates were resolved 
by SDS-PAGE and then immunoblotted with anti-myc and anti-FLAG antibodies. Blots are 
representative of three independent experiments.  
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Figure 3.6 Cellular distribution of Robo1 constructs in transiently transfected HEK 293T cells 
HEK 293T cells were transiently transfected with the indicated Robo1 constructs and then visualised 
for Citrine and Cerulean fluorescence with an inverted epifluorescence microscope. Scatter plots show 
co-localisation between differently tagged Robo1 constructs, r is Pearson's correlation coefficient.  
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Figure 3.7 Characterisation of double stable cell lines expressing Robo1 constructs 
Double stable HEK 293 Flp-In T-REX cell lines (A and B) constitutively expressing truncated 
FLAG-Robo1-CER (C and E) or full-length FLAG-Robo1-CER-Robo1 (D) proteins were incubated 
with increasing concentrations of doxycycline for 24 hours to induce myc-Robo1-CIT (C and E) or 
myc-Robo1-CIT-Robo1 co-expression respectively (D). Cells were lysed and expression of the 
constructs was assessed using Western blotting. Images C and D are representative of two 
independent experiments, image E represents a single independent experiment.  
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Figure 3.8 Cellular distribution of Robo1 constructs in HEK 293 Flp-In T-REX cells 
HEK 293 Flp-In T-REX cell lines constitutively expressing truncated FLAG-Robo1-CER (A) or full-
length FLAG-Robo1-CER-Robo1 (B) constructs were incubated with 10 ng/ml of doxycycline to 
induce co-expression of myc-Robo1-CIT and myc-Robo1-CIT-Robo1 respectively. Construct co-
localisation was analysed by merging relevant images pseudo-coloured in red (FLAG-Robo1-CER and 
FLAG-Robo1-CER-Robo1) and green (myc-Robo1-CIT and myc-Robo1-CIT-Robo1). Scatter plots 
show co-localisation between differently tagged Robo1 constructs, r is Pearson's correlation 
coefficient. 
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Figure 3.9 Differential membrane distribution of truncated and full-length Robo1 constructs 
HEK 293 Flp-In T-REX cells were incubated with 10 ng/ml of doxycycline for 24 hours to induce 
expression of myc-Robo1-CIT or myc-Robo1-CIT-Robo1 construct. Cells then were fixed and 
fluorescence of Citrine examined using a confocal microscope. Three different view fields are presented 
for each construct.  
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Figure 3.10 Slit2-Robo1 interactions 
HEK 293T cells were transfected with mock DNA or the FLAG-Robo1-CER-Robo1 construct. 24 
hours after transfection Slit2 (R&D systems) was added to the cell medium to a final concentration of 
100 ng/ml. An equal volume of PBS was used as a negative control. Cells were incubated with Slit2 
for 15 minutes, washed with ice cold PBS and lysed with RIPA buffer. The Robo1 construct was 
immunoprecipitated using anti-FLAG antibody-coated agarose beads. Slit2 co-precipitation was 
detected using an anti-His antibody, since commercial Slit2 from R&D contains this tag. A sample 
containing 50 ng of Slit2 (R&D systems) was loaded as a positive control for Slit2 detection. Blots are 
representative of two independent experiments. 
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Figure 3.11 Modulation of Rac1 activity 
HEK 293 Flp-In T-REX cells were treated with 10 ng/ml of doxycycline for 24 hours to induce 
expression of myc-Robo1-CIT-Robo1. Cells then were treated with 100 nM of TPA or 100 ng/ml of 
Slit2 (R&D systems) for 5 minutes. Alternatively, cells were initially treated with Slit2 for 5 minutes 
and then TPA for an additional 5 minutes. Rac1 activity was measured by precipitating active, GTP-
bound Rac1 from cell lysates with PAK protein-coated beads and immunoblotting samples with anti-
Rac1 antibody (A). The blot is representative of three independent experiments. The optical density of 
bands on the blot was measured using ImageQuantTL (GE Healthcare) software, normalised to the non 
treated sample and expressed as a mean of three independent experiments ± SEM (n.s.–statistically not 
significant as determined by one way ANOVA with Bonferroni’s post test). 
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Figure 3.12 Lack of detectable Robo1-srGAP1 interactions 
HEK 293 Flp-In T-REX cells constitutively expressing the FLAG-Robo1-CER-Robo1 construct 
(induced with 10 ng/ml of doxycycline for 24 hours) were treated with 100 ng/ml of Slit2 (R&D) for 
15 minutes. Cells were lysed and the Robo1 construct precipitated using anti-FLAG antibody 
conjugated beads. Co-precipitation of srGAP1 was probed with an anti-srGAP1 antibody. Non-
induced and induced but not treated with Slit2 cells were used as negative controls. Blots are 
representative of two independent experiments. 
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Figure 3.13 Slit2-Robo1 interactions fail to modulate ERK 1/2 activity 
HEK 293 Flp-In T-REX cells constitutively expressing the myc-Robo1-CIT-Robo1 construct were used 
to assess Slit2 ability to activate (A) or inhibit (B) ERK1/2 kinase. Expression of the myc-Robo1-CIT-
Robo1 construct was induced by incubating cells with 50 ng/ml of doxycycline for 24 hours. Non-
induced cells were used as a negative control. To assess ERK1/2 activation cells were treated with Slit2 
(R&D systems) or an equal volume of PBS for 5 and 15 minutes respectively (A). To assess potential 
Slit2-Robo1 inhibitory effects on ERK1/2 activation cells were pre-treated with 100 ng/ml of Slit2 for 
15 minutes and then treated with 10% FBS for 1 or 5 minutes respectively (B). After treatment cells 
were lysed and the extent of ERK1/2 phosphorylation determined using immunoblotting with antibodies 
specific for phosphorylated and total ERK1/2. Blots are representative of two independent experiments. 
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Figure 3.14 The molecular basis of FRET imaging experiments 
Schematic illustration of a FRET imaging experiment. If Robo1 in the resting state exists as a dimer, 
receptor association would bring fluorescent proteins into close proximity allowing energy transfer 
between the fluorophores (A). If Slit2 causes the Robo1 dimer to dissociate, that would increase 
average distances between the receptors and their incorporated fluorescent protein thus reducing 
FRET signal (B). The same principles are valid for an opposite mechanism, i.e. ligand induced 
association, only here one initially would observe a low FRET signal which would be increased by 
the addition of the ligand. 
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Figure 3.15 FRET analysis of Robo1 oligomerisation in transiently transfected HEK 293T cells 
Live HEK 293T cells transiently expressing truncated or full-length Robo1 constructs were visualised 
and the FRET signal quantified as described in section 2.10. Figure A shows a typical data set for 
FRET quantification. In order to assess Slit2 effects on FRET signal, prior to visualisation cells were 
incubated with 90 ng/ml of Slit2 (in house) for 30 minutes. RFRET index for truncated (B) and full-
length (C) Robo1 constructs is expressed as a mean of six independent experiments ±SEM (n.s. –
statistically not significant as determined by t-test). One independent experiment represents the mean 
obtained from averaging RFRET index values of hundreds of ROI in eight different fields of view 
containing the same batch of transfected cells. The entire dataset was collected over the course of 
several days. 
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Figure 3.16 Generation of potentially oligomerisation-deficient Robo1 constructs 
To attempt to abolish Robo1 oligomerisation, the extracellular part of the receptor was truncated 
removing Ig domains or Ig and FnIII domains together (A). In order to verify expression and cell 
surface delivery of newly created constructs, nonpermeabilized HEK 293T cells transiently expressing 
each of those proteins were fixed and stained with primary anti-FLAG and secondary Alexa594 
conjugated antibodies (B and C). Samples without primary antibody served as a negative control. Cells 
were imaged with inverted an epifluorescence microscope for Cerulean and Alexa594 fluorescence.  
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Figure 3.17 FRET analysis of potentially oligomerisation-deficient Robo1 constructs 
Live HEK 293T cells transiently co-expressing myc-Robo1-CIT and FLAG-Robo1-CER, FLAG-
Robo1ΔIg-CER, FLAG-Robo1ΔIgΔFnIII-CER or Robo1 unrelated human muscarinic acetylcholine 
receptor M3 tagged with Cerulean were visualised and the FRET signal quantified as described in 
section 2.10. The RFRET index is expressed as a mean of six independent experiments ±SEM (*** 
p<0.0001, for differences in the FRET means between an intact protein and N-terminally truncated 
constructs as determined by one way ANOVA with Dunnett’s post test). One independent experiment 
represents the mean obtained from averaging RFRET index values of hundreds of ROI in eight 
different fields of view containing the same batch of transfected cells. The entire dataset was collected 
over the course of several days. FRET index values for myc-Robo1-CIT and FLAG-Robo1-CER pair 
are taken from Figure 3.15.  
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Figure 3.18 FRET analysis of Robo1 oligomerisation in HEK 293 Flp-In T-REX cells 
Stable expression of truncated or full-length Robo1 constructs was induced by incubating HEK 293 
Flp-In T-REX cells with 50 ng/ml of doxycycline for 24 hours. Donor and acceptor fluorescence was 
visualised and FRET quantified as described in section 2.10. Figure A shows a typical data set for 
FRET quantification. In order to assess Slit2 effects on FRET signal, prior to visualisation cells were 
incubated with 100 ng/ml of Slit2 (R&D systems) for 30 minutes. The RFRET index for truncated (B) 
and full-length (C) Robo1 constructs is expressed as a mean of six independent experiments ±SEM 
(n.s. –statistically not significant as determined with t-test). One independent experiment represents the 
mean obtained from averaging RFRET index values of hundreds of ROI in eight different fields of 
view containing the same batch of induced cells. The entire dataset was collected over the course of 
several days. 
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Figure 3.19 Basis of a TR-FRET experiment 
Fluorescent labels necessary for a TR-FRET experiment were added to Robo1 constructs using a 
SNAP labelling system (A, an image reprinted from www.neb.com (2012) with permission from New 
England Biolabs, http://tinyurl.com/7oj2o97). In order to make the existing Robo1 construct 
compatible with it, a SNAP tag was inserted between an epitope tag and a Robo1 sequence for both 
truncated and full-length Robo1 constructs. TM stands for transmembrane region (B). Putative Robo1 
oligomerisation would bring the fluorescent labels into close proximity yielding a high FRET signal 
(C). If the addition of Slit2 causes Robo1 oligomer dissociation, a decrease in the FRET signal would 
be observed (D).  
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Figure 3.20 Expression of SNAP-tagged Robo1 constructs 
HEK 293T cells were transiently transfected with truncated (A) or full-length (B) SNAP-tagged Robo1 
constructs or appropriate controls. Cells were lysed, samples of lysates were resolved by SDS-PAGE 
and then immunoblotted with anti-SNAP and anti-myc antibodies. Blots are representative of two 
independent experiments.  
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Figure 3.21 SNAP tagged Robo1 construct validation 
HEK 293T cells were transiently transfected with truncated (myc-SNAP-Robo1-CIT), full-length (myc-
SNAP-Robo1-CIT-Robo1) or SNAP tag lacking (myc-Robo1-CIT, negative control) Robo1 constructs. 
Nonpermeabilized cells were fixed and stained with Hoechst and SNAP-Surface 549, a cell impermeant, 
fluorescent SNAP substrate. Fixed cells were imaged with an inverted epifluorescence microscope. 
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Figure 3.22 TR-FRET measurements 
HEK 293T cells were transiently transfected with truncated (myc-SNAP-Robo1-CIT) or full-length 
(myc-SNAP-Robo1-CIT-Robo1) constructs. Alternatively, mock DNA was used for transfection as a 
vehicle control. The cells were labelled with a mixture of donor and acceptor SNAP substrate 
conjugates. The concentration of donor was kept constant at 50 nM, while the concentration of an 
acceptor was varied between 15 nM and 2 μM. The raw TR-FRET signal was measured at 665 nm 
following excitation at 340 nm and expressed as a function of acceptor concentration (A). In order to 
evaluate expression levels of the Robo1 construct Citrine fluorescence was measured at 520 nm 
following excitation at 485 nm (B). HEK 293T cells were transiently transfected with truncated (myc-
SNAP-Robo1-CIT) or full-length (myc-SNAP-Robo1-CIT-Robo1) Robo1 constructs and labelled with 
donor and acceptor SNAP substrate conjugates (50 nM Lumi4-Tb, 115 nM RED). 100 ng/ml of Slit2 
(R&D systems) or an equal volume of PBS was added to the cells and TR-FRET signal, assessed as 
the 665/620 nm ratio, was measured over a time course of 45 minutes. Signal values are expressed as a 
mean of two independent experiments ± SEM. No statistically significant differences were observed 
between Slit2 treated and non-treated samples as determined by two-way ANOVA (C).  
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Figure 3.23 Co-immunoprecipitation of differently tagged Robo1 constructs 
HEK293T cells were transiently co-transfected with differently tagged truncated or full-length 
constructs (myc-Robo1-CIT and FLAG-Robo1-CER or myc-Robo1-CIT-Robo1 and FLAG-Robo1-
CER-Robo1), maintained for 24 hours and treated with 100 ng/ml of Slit2 (R&D systems) for 30 
minutes or PBS as a negative control. The treated cells were lysed and the FLAG-tagged Robo1 
constructs were immunoprecipitated from the lysate using anti-FLAG antibody conjugated beads. Co-
precipitation of the myc tagged Robo1 constructs was probed using an anti-myc antibody.  
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Figure 3.24 Crosslinking and co-immunoprecipitation of differently tagged Robo1 constructs 
A schematic illustration of the crosslinking based assessment of the Robo1 oligomeric state (A). 
HEK293T cells were transiently co-transfected with differently tagged truncated or full-length 
constructs (myc-Robo1-CIT and FLAG-Robo1-CER or myc-Robo1-CIT-Robo1 and FLAG-Robo1-
CER-Robo1), incubated for 24 hours and treated with 100 ng/ml of Slit2 (R&D systems) or PBS as a 
negative control. The cells were then crosslinked with DTSP reagent, lysed and the FLAG-tagged 
Robo1 constructs were immunoprecipitated from the lysate using anti-FLAG antibody conjugated 
beads. Co-precipitation of the myc-tagged Robo1 constructs was probed using an anti-myc antibody. 
The blot is representative of three independent experiments. (B). In order to assess crosslinking 
effects on a Robo1 cytoplasmic tail HEK 293T cells were transiently transfected with a construct 
representing a mouse Robo1 cytoplasmic domain N-terminally tagged with a FLAG tag, crosslinked 
with different concentrations of DTSP reagent, lysed and analysed with Western blot (C).  
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Figure 3.25 Mapping the sites of Robo1 oligomerisation 
Peptide arrays were used to screen the complete sequence of the rat Robo1 extracellular domain for sites 
of association with the soluble rat Robo1 extracellular domain (Robo1-Fc). Two separately produced 
membranes with identical peptide spots were used in this experiment (A and B). In both cases the same 
membrane was used both for negative control (anti-Fc antibody only) and Robo1 overlay (Robo1-Fc 
incubation followed by blotting with anti-Fc antibody). Peptides identified in both experiments are listed 
in table, where numbers represent spot coordinates on the grid (C). Identified putative Robo1-Robo1 
interaction sites (spot ids are listed according to Figure A) are also schematically mapped on to the 
Robo1 structure (D).  
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Figure 3.26 Structural conservation of putative Robo1 oligomerisation sites 
Putative Robo1 oligomerisation sites were mapped (colour coded pink) on to the sequence alignment of 
rat Robo1 Ig domains (A) and Robo1 Ig2 [pdb id: 2V9Q] and Ig5 [pdb id: 2EO9]   structures (B) 
revealing a possible common structural element of surface exposed loops surrounded by two β-sheets. 
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Figure 3.27 Dimerisation interfaces of I-set Ig proteins 
Putative Robo1 dimerisation sites were mapped (coloured in red) on to Robo1 related proteins with 
known dimer structures: NCAM [pdb id: 1QZ1] (A) and PTPRσ [pdb id: 2YD9] (B). 
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4 Study	of	Slit‐Robo	role	in	the	immune	system	
4.1 Introduction	
Substantial evidence indicates that the Slit-Robo signalling axis is utilised by the immune 
system. Published data show Robo1 expression in various populations of white blood cells. 
Correspondingly, Slit2 is able to inhibit chemotactic leukocyte movement both in vitro and 
in vivo (see section 1.5.8). Moreover, treatment with Slit2 reduces immune responses in 
various inflammation models. The opposite is true as well, as studies show that 
inflammatory responses usually coincide with changing expression levels of Slit proteins 
(Guan et al, 2003; Kanellis et al, 2004; Ye et al, 2010). In summary, Slit and Robo proteins 
are expressed by various immune system cells and related tissues, they affect progress of 
inflammation and, conversely inflammation regulates their expression levels. All this 
indicates that the Slit-Robo signalling axis is coupled to the immune system, however the 
precise role of these proteins within it remains unknown. Elucidation of Slit-Robo role 
within the immune system is of fundamental biological importance. Functional interplay 
between the nervous and immune systems is now well established as additional evidence 
accumulates and expands in scope (Steinman, 2004; Sternberg, 2006). Many common 
themes, patterns and organisational principles can be found among these two systems on 
different levels ranging from organs to molecules (Kioussis & Pachnis, 2009). In fact, all 
major neuronal guidance molecule families (Slit-Robo, Netrin-DCC, Semaphorin-Plexin, 
Eph-Ephrin) interact with the immune system in one or other way (Kumanogoh & 
Kikutani, 2010; Ly et al, 2005; Pasquale, 2008). Thus research into Slit-Robo role within 
the immune system could potentially advance our understanding of connections between 
the immune and nervous systems. Besides, possible practical applications are no less 
important. Broad inhibitory effects of Slit on leukocyte migration might be of value in 
fighting uncontrolled or chronic inflammation. All together this makes the role of the Slit-
Robo signalling axis in the immune system a compelling research object. 
Although published data clearly show links between the Slit-Robo signalling axis and the 
immune system, currently available information is not sufficient to suggest initial 
hypotheses. One of the possible ways to establish a working hypothesis is a systematic and 
thorough expression profiling of Slit-Robo protein expression in various mouse tissues. 
Identification of Slit or Robo expressing leukocyte populations would be especially useful. 
Different leukocyte subtypes perform different functions and knowing which of them are 
expressing Slit or Robo proteins may help suggest Slit-Robo functions as well. Moreover, 
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as mentioned above, various studies indicate that expression levels of Slit proteins are 
dynamic and regulated in accordance with immune responses. Bioinformatic analysis of 
transcription factor binding sites (TFBS) could help to elucidate mechanisms underlying 
this regulation and, by extension, connections between the Slit-Robo signalling axis and 
the immune system. 
4.2 Slit‐Robo	expression	profiling	
4.2.1 Slit‐Robo	expression	in	mouse	organs	and	tissues	
Initially, a broad Slit-Robo expression profile was determined in mouse organs and tissues. 
Two female C57BL/6 mice were sacrificed and samples of various tissues and organs were 
collected. Tissues then were flash frozen with liquid nitrogen and ground to a fine powder 
using a mortar and pestle. Total RNA was extracted and cDNA synthesised as described in 
sections 2.2.1 and 2.22. In parallel, as a control for genomic DNA contamination, identical 
cDNA synthesis reactions were performed without reverse transcriptase. Finally, Slit-Robo 
paralogue or GAPDH (Glyceraldehyde 3-phosphate dehydrogenase, housekeeping gene, 
positive control) specific primers were used in routine PCR assays. Representative gels for 
Robo2 and GAPDH are shown in Figure 4.1A and 4.1B and all results are summarised in 
Figure 4.1C. In agreement with published data, these experiments showed that Slit-Robo 
mRNA is expressed in a wide range of different tissues and organs. The only exceptions 
are Slit1 and Robo3, expression of which is confined to the brain and the brain and the 
kidney respectively. Brain was found to express all family members, which is in keeping 
with known expression data. Leukocyte rich lymph nodes and spleen have similar 
expression patterns - strong expression of Robo1, Robo2, Robo4, Slit3 and traces of Slit2. 
Interestingly, no Slit or Robo expression was detected in bone marrow (BM). This was a 
surprising result and subsequent publications have shown that BM stromal cells do express 
Slit2 while hematopoietic stem cells express Robo4 (Shibata et al, 2008; Smith-Berdan et 
al, 2011). This contradiction most likely is caused by different sensitivity of the 
experiments in question. Shibata and colleagues failed to notice Slit2 expression in whole 
BM samples as well and it became detectable only after BM stromal cells were purified 
and the RT-PCR cycle number was increased to 40 (Shibata et al, 2008). This example 
illustrates the innate limitation of qualitative RT-PCR with whole organs and tissues. 
Often, especially when the signal is low, it is not clear which cells express the transcript of 
interest, as low signal can be explained by low expression in all cells, a small fraction of 
transcript-rich cells mixed with non-expressers or anything in between. General profiling at 
the organ level provides a useful general picture, but since observed expression patterns for 
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Slit-Robo proteins are really broad, more specific tools and approaches are necessary to 
further “zoom in” on Slit-Robo functions within the immune system.  
4.2.2 Slit‐Robo	expression	in	cell	lines	
In addition to mouse tissues, Slit-Robo mRNA expression was assessed in different 
immortalised cell lines. This experiment had several purposes. The first goal was to reveal 
any correlation between Slit-Robo expression patterns and cell type which could indicate 
Slit-Robo role within the immune system. Second, Slit or Robo expressing immortalised 
cell lines could be employed as a standard for further experiments, for example flow 
cytometry assays with ex vivo hematopoietic cells.  
Cells were lysed and total RNA extracted as described in section 2.2.1. cDNA was 
synthesised and used as a template for PCR with Slit or Robo orthologue-specific primers. 
Expression of the housekeeping gene GAPDH was used as a positive control, while 
samples lacking reverse transcriptase served as a negative control for genomic DNA 
contamination. All results are summarised in Figure 4.2. In general, highly variable 
expression profiles of Slit and Robo proteins can be observed. It seems that cells of 
myeloid origin (monocytes, macrophages, megakaryocytes, mast cells) tend to express 
Robo1 more uniformly then other populations, but apart from that, expression profiles do 
not follow easily identifiable cell type-related patterns. Interestingly, many cells express 
both Slit and Robo proteins raising the possibility of autocrine regulation. Another 
interesting observation relates to Slit1 expression. Mouse tissue profiling described above, 
and published data, show that Slit1 expression is usually limited to neuronal tissues only. 
However several hematopoietic cell lines (HUT-78, Jurkat, THP-1) showed strong Slit1 
expression at least at the mRNA level (Figure 4.2). It has been reported previously that 
expression of Slit-Robo proteins can be both silenced and activated during tumour 
development (see section 1.5.7) so care must be taken when interpreting expression data 
from oncogenically transformed cell lines, as they not necessarily represent native cells 
they originated from. Nevertheless, these experiments revealed widespread and highly 
variable expression of Slit and Robo mRNA in immortalised cell lines. 
4.2.3 Slit‐Robo	expression	in	ex	vivo	leukocytes	
While information about Slit-Robo expression in immortalised cell lines is useful, the most 
important question to address is Slit-Robo expression in live tissues at the cellular level. 
Flow cytometry is a standard tool to analyse protein expression in hematopoietic cells and 
since experimental data and published information show that these cells tend to express 
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Robo1, it was employed to phenotypically characterise Robo1 expressing leukocyte 
populations.  
Initially, THP-1 cells which express endogenous Robo1 (Figure 4.2) were used as a 
standard to verify the assay. Cells were labelled with biotinylated anti-Robo1 antibody 
(R&D Systems), stained with avidin-APC (allophycocyanin) conjugate and analysed using 
flow cytometry as described in section 2.2.33. This experiment revealed a signal which 
was definite but weak in comparison to isotype antibody control (Figure 4.3A). These 
results indicate that either the levels of endogenous Robo1 protein in THP-1 cells are 
extremely low or that the antibody used is not specific enough. In order to address this 
issue the assay was repeated using HEK 293 Flp-In T-REX cells able to express a myc-
Robo1-CIT construct. Expression of the construct was induced by incubating cells with 50 
ng/ml of doxycycline overnight. Cells were then labelled with anti-Robo1 antibody as 
described above. In parallel, non induced cells were used as a negative control. 
Fluorescence of the Citrine fluorescence protein present in the Robo1 construct was readily 
detectable upon incubation with doxycycline, independently demonstrating expression of 
this protein (Figure 4.3B). In agreement, the anti-Robo1 antibody was able to detect strong 
and ubiquitous expression of Robo1 (Figure 4.3C). These data show that the flow 
cytometry assay is functional and the observed week Robo1 signal in THP-1 cells is most 
likely caused by low expression levels of the receptor. Consequently, it was used to assess 
Robo1 expression in hematopoietic cells. Human peripheral blood mononuclear cells 
(PBMC) were labelled with the anti-Robo1 antibody as described above and analysed 
using flow cytometry, however, no differences between isotype control and anti-Robo1 
antibody were observed (Figure 4.3D). It seems that protein levels of endogenous Robo1 
on the surface of human PBMC are extremely low or it is not expressed at all.  
An alternative anti-Robo1 antibody from Developmental Studies Hybridoma Bank (DSHB, 
University of Iowa, Iowa City, USA) was examined in an attempt to optimise detection of 
endogenous Robo1 by flow cytometry. Hybridomas producing this antibody were acquired 
from DSHB and cells were grown as described in section 2.2.30. Initially, attempts were 
made to purify the anti-Robo1 antibody from hybridoma supernatant in order to conjugate 
it with fluorescent dye. Because this particular antibody is of an IgM isotype, standard 
antibody purification techniques based on protein G binding could not be applied and a 
HiTrap IgM Purification HP Column (GE Healthcare) was used instead according to 
manufacturer’s instructions (Figure 4.4A). Collected fractions were analysed by SDS-
PAGE revealing protein mixtures without any apparent enrichment of Ig chains (Figure 
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4.4B). Fractions were combined and the eluate was further tested using Western blot. Cell 
lines natively expressing Robo1 or HEK 293T cells transiently transfected with myc-
Robo1-CIT or FLAG-Robo1-CER constructs were lysed, samples were resolved by SDS-
PAGE and immunoblotted with purified anti-Robo1 antibody (DSHB), anti-Robo1 
antibody (DSHB) hybridoma supernatant, Robo1 antibody from R&D Systems or anti-myc 
and anti-FLAG antibodies (Figure 4.5). Expression of what appears to be full-length 
Robo1 was detected in THP-1 cell lysates by supernatant but not by purified Robo1 
antibody (DSHB) (Figure 4.5A). Surprisingly, an identical band was also detected in Jurkat 
cell lysates which, according to RT-PCR experiments, contain no detectable Robo1 mRNA 
(Figure 4.5A). Moreover, expression of the myc-Robo1-CIT or FLAG-Robo1-CER 
constructs was not detected with DSHB antibody even though it was readily visualised 
with anti-myc, anti-FLAG or anti-Robo1 antibody from R&D Systems (Figure 4.5B). The 
epitope detected by the DSHB antibody maps to the first FNIII domain and is not affected 
by known splicing or other modifications. Given this uncertainty about the specificity of 
the DSHB antibody it was not used for further studies. 
Overall, attempts to employ flow cytometry and determine the phenotype of Robo1 
expressing hematopoietic cells failed because of lack of suitable anti-Robo1 antibodies. 
Low levels of endogenous expression might also be a contributing factor as the example 
with THP-1 cells demonstrates. 
4.3 Transcription	factor	binding	site	analysis		
Various studies indicate that expression levels of Slit and Robo proteins are dynamic and 
can be regulated in response to external stimuli (Guan et al, 2003; Kanellis et al, 2004; Ye 
et al, 2010). Therefore it can be reasoned that bioinformatic analysis of transcription factor 
binding sites (TFBS) in putative Slit-Robo promoter regions might help to elucidate 
mechanisms underlying this regulation and, by extension, connections between the Slit-
Robo signalling axis and other cellular circuits. In other words, knowing the transcription 
factors involved in Slit-Robo regulation, one may be able to suggest testable hypotheses 
about the role of Slit-Robo within the immune system. 
Identification of regulatory TFBS is not a trivial task. Simple DNA sequence matching 
with known transcription factor binding sites is not a productive strategy. TFBS usually are 
ambiguous and loosely defined and a straightforward search for known binding sequences 
would reveal hundreds of putative sites even in randomly generated DNA. Moreover, 
promoters vary greatly in terms of their overall structure and defining features and even the 
current abundance of genomic data have failed to provide meaningful generalisations. 
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Currently suggested classification, which even by the authors is considered “work in 
progress”, defines three broad classes of metazoan promoters (Lenhard et al, 2012). Type I 
"sharp" promoters are easier to analyse since regulatory TFBS tend to cluster in groups 
relatively close to core promoter elements (like the TATA box) and transcription start sites. 
Meanwhile, type II and III "broad" promoters span relatively long sequences, lack 
identifiable core elements and contain multiple transcription start sites which further 
burdens their analysis (Lenhard et al, 2012). Because of all this variability false-positive 
errors plague in silico promoter analysis and additional methods are needed to remove 
them. A method called phylogenetic footprinting is usually employed for this purpose 
(Qiu, 2003). It is based on the principle that functionally important sequences tend to be 
conserved among multiple species and putative TFBS shared by several different species 
are more likely to be biologically relevant. 
Table 4.1 Transcription factors potentially involved in regulation of Slit-Robo expression 
Transcription factor Biological relevance 
EGR1 (early growth response gene 1)  Monocyte/macrophage lineage commitment 
control 
LEF-1/TCF 
 
Wnt signalling axis, cell invasion, matrix 
protease expression.  
Myc/Max/Mad network 
 
Cell proliferation, growth and apoptosis 
KLFS (Kruppel like zinc fingers) 
 
Various aspects of development 
ETS1 (E26 transformation specific sequence) 
 
Differentiation of haematopoietic cells, invasive 
cell behavior, hypoxia 
NFAT (Nuclear factor of activated T cells) 
 
Developmental cell-cell interactions, cytokine 
production in T cells, neuronal growth 
PAX5 Cell differentiation, nerve system development 
STAT  
 
Various aspects of growth, survival and 
differentiation in cell 
IKR Ikaros zinc finger family, potential regulator of 
lymphocyte differentiation 
MYT1 Myelin transcription factor 1 
 
Differentiation of neurons 
NF-κB 
 
Cell survival, immune response, neuronal 
plasticity  
 
Slit-Robo promoter analysis was started by identifying 5000 bp of upstream sequence for 
Slit1, Slit2, Slit3, Robo1 and Robo2 orthologues from different mammals in NCBI Entrez 
Genome database (http://www.ncbi.nlm.nih.gov/sites/genome). Robo1 and Robo2 proteins 
exist as two isoforms which employ different signal peptides. It appears that they arise 
from alternative transcription sites which are separated by hundreds of kilobases of 
genomic DNA and therefore most likely are controlled by different promoters (Nural et al, 
2007). The shorter isoform (Robo1B/Dutty or Robo2B) is expressed more widely and 
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strongly than the longer version (Robo1A and Robo2A) (Clark et al, 2002; Yue et al, 
2006), thus its upstream sequence was used for promoter analysis. Slit and Robo upstream 
sequences from different mammalian species were collected and systematically inspected 
for core promoter elements and CpG islands using MatInspector (Cartharius et al, 2005) 
and CpG Island Searcher (Takai & Jones, 2003) respectively. This analysis revealed that 
putative promoters of all examined genes lack identifiable core promoter sequences but 
clearly contain relatively large CpG islands extending into the coding region (Figure 4.6). 
According to the nomenclature suggested by Lenhard and colleagues, the Slit-Robo thus 
are regulated by "broad" Type III promoters which usually have multiple transcription start 
sites and are associated with developmentally regulated genes (Lenhard et al, 2012).  
Identification of CpG islands strongly indicates the presence of biologically relevant TFBS 
therefore the same upstream sequences of Slit1, Slit2, Slit3, Robo1 and Robo2 orthologues 
from different species were aligned and analyzed for TFBS using DiaAlign software 
(fragment of DiaAlign output is exemplified in Figure 4.7) (Cartharius et al, 2005). Only 
transcription factor binding sites conserved across multiple species were considered for 
further analysis. Nevertheless, even then, dozens of putative transcription factors 
potentially involved in regulation were identified for each gene. Some of the more 
prominent hits are listed in Table 4.1. As one might expect, a lot of the identified 
transcription factors are related to development. Others have a variety of different 
functions depending on cellular or tissue context. This reduced the potential usefulness of 
the promoter analysis since functional pleiotropy meant that no specific connection 
between Slit-Robo and other particular signalling circuits could be made. The exception 
was the transcription factor Foxn1 whose binding site was identified in both Slit2 and Slit3 
promoters (Figure 4.8). More interestingly, in both cases the distance between putative 
Foxn1 DNA binding site and the open reading frame of the gene was similar. Positions of 
transcription start sites, mapped by genome-wide cap analysis of gene expression (CAGE) 
also indicate biological relevance of Foxn1 site as several transcription start sites (TSS) are 
located downstream of putative Foxn1 binding site in human and mouse genomes (Figure 
4.8). Interestingly, human and mouse Slit2 genes potentially contain an alternative 
promoter approximately 1500 bp upstream of the Foxn1 site, as a cluster of TFBS 
identified by DiaAlign overlaps with TSS identified by CAGE (Figure 4.8). This particular 
TSS seems to be used preferentially in many mouse tissues, as numerous expressed 
sequence tags (EST, sequenced short random fragments of cDNA), confirm the existence 
of a Slit2 transcript with a long 5' untranslated region. Nevertheless, the Slit2 upstream 
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region containing the Foxn1 binding site also includes TSS identified by CAGE both in 
mouse and human and therefore constitutes a valid putative promoter. All together these 
CpG, TFBS and TSS patterns strongly indicate biological relevance of Foxn1 binding site 
and hence all further studies were focused on it.  
This spatial conservation serves as additional evidence of biological relevance and hence 
all further studies were focused on this bioinformatics hit. The transcription factor Foxn1 is 
a well established master regulator of thymus development. Disruption of this gene leads to 
a non-functional thymus and severe immunodeficiency since the thymus is crucial for 
development of T cells and adaptive immunity (Nehls et al, 1994). Given the well 
established ability of Slit-Robo to regulate cell movement in general, and leukocyte 
chemotaxis in particular, it is tempting to speculate that these proteins also act as “traffic” 
regulators in thymus. 
4.4 Slit	function	in	thymus	
The thymus is a primary lymphoid organ that is found in almost all vertebrates and is 
responsible for differentiation and development of T lymphocytes. Hematopoietic 
precursor cells, whose precise linage is still debatable, migrate into thymus from bone 
marrow (Desanti et al, 2011; Luc et al, 2012). Then these maturing hematopoietic cells, 
also called thymocytes, move between different thymic compartments depending on the 
stage of their development. The thymic cortical region harbours thymocytes during their 
early stages of development. Cells here undergo T cell receptor (TCR) rearrangement and 
positive selection which ensures their functionality. They then move into the medullary 
region of the organ where negative selection takes place and cells not able to “ignore” 
innate antigens of the organism are destroyed. Finally, mature and functionally competent 
T cells migrate from the thymus into the periphery where they take part in many different 
aspects of the adaptive immune response (Love & Bhandoola, 2011). 
Thymocyte development completely depends on the interactions with thymic epithelial 
cells (TEC). Based on their localisation and expressed markers TECs can be subdivided 
into two populations - cortical (cTEC) and medullary (mTEC). Neither cTEC nor mTEC 
are homogenous populations and additional subdivisions were suggested by various 
authors (Gray et al, 2006; Hamazaki et al, 2007). TECs interact with thymocytes both 
directly, and via secreted molecules, and are indispensable for T cell development within 
the thymus (Love & Bhandoola, 2011). This dependency is very obvious in some naturally 
occurring mutations. One classical example is so called the "nude phenotype" which 
appears both in humans and mice and is characterised by lack of hair, athymia and severe 
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immunodeficiency (Flanagan, 1966; Frank et al, 1999). It is caused by the mutation in the 
transcription factor Foxn1 which belongs to the forkhead box transcription factor family 
(Kaestner et al, 2000). Foxn1 is a master controller of TEC development. Its expression is 
switched on 11.5 days post coitum (E11.5) in mice enforcing differentiation of the 
endodermic anlage into thymic epithelium (Rodewald, 2008). Factors controlling Foxn1 
expression are currently unknown, so this transcription factor is the earliest known marker 
of TEC. Lack of Foxn1 becomes apparent as early as E13; TEC progenitors fail to 
proliferate and differentiate into medullary and cortical compartments and hematopoietic 
cells are virtually absent in the formed rudimentary thymus (Rodewald, 2008). Studies also 
demonstrated that Foxn1 retains its functional importance after the birth, as postnatal 
disruption of Foxn1 leads to histological and functional degeneration of the thymus (Chen 
et al, 2009; Cheng et al, 2010).  
On a molecular level Foxn1 appears to be a transcriptional activator which switches on a 
set of TEC-related genes, although its targets remain somewhat obscure despite more than 
a decade of research. Only one gene, FGF2 (fibroblast growth factor), using chromatin 
immunoprecipitation was directly shown to be regulated by Foxn1 (Weiner et al, 2007). 
Others, like the Notch ligand DLL4, the chemokine CCL25, the transcription factor Pax-1 
or the PD-1 ligand PD-L1 are indicated by circumstantial evidence (Bleul & Boehm, 2001; 
Liu et al, 2006; Nowell et al, 2011). Identification of positionally conserved Foxn1 binding 
sites within the putative Slit2 and Slit3 promoters raises the possibility that the Slit-Robo 
signalling axis is involved in thymic function. The absence of a putative Foxn1 binding site 
in the upstream Slit1 sequence agrees well with the fact that Slit2 and Slit3 are expressed 
widely around the body, while Slit1 is generally restricted to the nervous system. In fact, 
relatively high Slit3 expression in human thymus was reported previously (Dickinson et al, 
2004). Similarly, Robo1 expression was reported in thymus as well (Wu et al, 2001). In 
both cases whole thymus was used for expression analysis and it is impossible to know 
which cells express the proteins in question. Given the fact that hematopoietic cells mainly 
express Robo1 it is reasonable to assume that Robo1 is present on thymocytes, while Slit2 
is expressed by thymic stromal cells. Foxn1 is known to regulate expression of the CCL25 
chemokine in TECs, which is a guidance cue for CCR9-expressing leukocyte migration 
into the thymus. Using this as a parallel one can speculate that Slits also contribute to the 
regulation of Robo1 expressing cell movement in the thymus. This hypothesis primarily 
rests on the prediction that Slit2 and Slit3 are regulated by Foxn1 thus verifying this 
prediction experimentally was the first step in testing the overall hypothesis. 
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4.4.1 Slit2	and	Slit3	expression	in	TECs	
The Foxn1 knockout mouse is a standard, and readily available, animal model, which 
could be used to assess Foxn1 effects on Slit2 and Slit3 expression. Unfortunately it is not 
useful in this particular situation because the thymus in these animals is reduced to a 
rudiment and therefore comparison of thymic Slit expression between wild type and Foxn1 
knockout mice is not practical (Dooley et al, 2005). Instead, Slit2 and Slit3 expression 
levels were measured in TEC cells isolated from embryonic thymus at different 
developmental stages. If Slit2 or Slit3 are regulated by Foxn1, and have functions in 
thymic development, their expression levels should vary accordingly.  
Timed pregnant C57BL/6 mice were sacrificed and embryos representing developmental 
stages E12-E14 (the day when the vaginal plug was detected was considered as E0) were 
harvested. Embryonic thymi were dissected, pooled and disaggregated into single cell 
suspensions (Figure 4.9). Cells were stained with antibodies specific for CD45 and 
EpCAM and the CD45- EpCAM+ population purified from the cell mixture using cell 
sorting by Dr A. White. CD45 is a general leukocyte marker while EpCAM denotes cells 
of epithelial origin and TECs therefore have a CD45- EpCAM+ phenotype. Purified cells 
were lysed and RNA was extracted as described in section 2.2.1. cDNA was synthesized 
using total RNA as a template and the copy number of Slit2 and Slit3 mRNA was 
quantified using QPCR based on SYBR Green chemistry (Figure 4.10). 
Due to the laborious nature of the experiment and scarcity of samples only two 
independent biological replicates (different mothers) were acquired for Slit2 and only one 
for Slit3. However, Slit2 replicate experiments were performed in different laboratories 
and each time two different housekeeping genes (GAPDH and TATA binding protein) 
were used for normalisation with the same outcome. Moreover, QPCR threshold cycle 
values were reasonably high (Ct 20-25) and no non-specific products were detected using 
melting curves. Overall data show a clear downregulation of Slit2 and Slit3 mRNA starting 
at embryonic stage E13 (Figure 4.10). Foxn1 generally is a transcriptional activator so the 
observed reduction in expression levels is not necessarily related to Foxn1 and might be 
caused by other regulatory factors. While this experiment failed to prove a causal link 
between Foxn1 and Slit2 or Slit3 expression, it does not contradict it either, as Slit 
induction by Foxn1 might happen before E12. Nevertheless, altered Slit2 and Slit3 mRNA 
levels in TECs show that expression of these proteins is actively regulated during thymic 
development and suggests that products of these genes may have a role in thymic ontogeny 
or function.  
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4.4.2 Analysis	of	Slit2	knockout	mice	
The most straightforward way to identify Slit function in the thymus is to determine what 
effects Slit2 or Slit3 deletion has on the thymus and the immune system in knockout mice. 
Both Slit2 and Slit3 knockout mice have been reported in the literature. Homozygous Slit2 
deletion is perinatally lethal and therefore no effects of this mutation on the immune 
system have been reported (Plump et al, 2002). Meanwhile, mice lacking functional Slit3, 
in fact, were created by two independent groups with both reporting closely similar 
phenotypes. Homozygous Slit3 knockout animals survive into adulthood although they 
have lower weight, shorter life span and generally are less viable because of an abnormal 
diaphragm (Liu et al, 2003; Yuan et al, 2003). Major malfunctions of the immune system 
most likely would have been detected and reported if present, however the authors mention 
none. Moreover, a figure in one of the original publications describing Slit3 knockout mice 
shows the open chest cavity, where an apparently normal thymus can be identified (Liu et 
al, 2003). It is reasonable to assume, therefore, that T cell development in these animals is 
not severely compromised.  
Redundancy between Slit2 and Slit3 genes is possible, as sequence differences between 
these proteins are relatively small (see section 1.2). If Slit2 and Slit3 can complement each 
other in thymic development or function, a single knockout would fail to reveal the effects 
of gene deficiency. Adult double knockout animals (Slit2+/-, Slit3-/-) have been reported 
in the literature and would have been the most useful model for the studies described here 
(Jaworski et al, 2010). Unfortunately these mice were not available. It is possible to create 
a double knockout animal strain by crossing Slit2 and Slit3 deficient mouse strains, but 
again Slit3 knockout animal were not available and only Slit2 knockout animals were 
accessible for this study. This therefore leaves the potential issue of Slit2 and Slit3 
redundancy unaddressed. However, Slit2 knockout effects are marked and much more 
obvious than those of Slit3 deletion. While it does not prove absence of redundancy in 
thymus specifically, it shows that at the general level Slit2 and Slit3 are not completely 
redundant and that Slit2 knockout mice alone potentially can be useful in providing 
information about Slit functions.  
The perinatal lethality of homozygous Slit2 deletion would not allow assessment of adult 
animal immune function, but does not interfere with analysis of possible knockout effect 
on thymic development. One additional problem related to knockout lethality is that it 
complicates animal breeding. Animal stocks must be kept and bred as heterozygotes 
(Slit2+/-) which, according to Mendelian laws, results in genotypically mixed litters (in 
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this particular case final Mendelian ratios will be skewed by early death of homozygous 
knockout animals). This means that upon dissection every single embryo must be 
genotyped separately before further analysis of embryonic thymic structure and 
composition. On the other hand, both wild type and knockout embryos are acquired under 
almost identical conditions, allowing effective comparison of thymic cellular composition. 
A scheme illustrating the overall experiment is depicted in Figure 4.11.  
Heterozygous (Slit2+/-) animals were mated and female mice were inspected for vaginal 
plugs each morning. The day when the vaginal plug was detected was considered as E0. 
Pregnant mice were sacrificed and E15 embryos were removed from the adult animal and 
decapitated. Embryonic thymus, and separate tissue samples for genotyping, were then 
taken from each individual embryo. Genomic DNA was extracted using Qiagen DNeasy 
Blood and Tissue kit according to manufacturer’s instructions and used as a template in a 
PCR reaction for genotyping as described in section 2.2.5. Representative genotyping 
results are shown in Figure 4.12. During the course of the studies described here 88 
embryos were genotyped with following results: 28 wt, 37 heterozygous and 23 
homozygous Slit2 knockout animals. Similarly, 56 adult animals were genotyped in total: 
19 wt, 37 heterozygous and 0 homozygous. Observed ratios between different genotypes 
follow the expected Mendelian distribution and confirm previous reports that Slit2 
knockout is perinatally lethal.  
In parallel to genotyping, each individual embryonic thymus was disaggregated into a 
single cell suspension and analysed for cellular composition using flow cytometry. Two 
different antibody panels were used for this analysis, one to assess composition of 
thymocytes, the other - composition of TECs. 
T cell development and populations present in thymus are relatively well defined. The 
thymocyte population representing the earliest developmental stage is called double 
negative (DN) and has the immunotype CD45+ CD4- CD8-. Following β-selection, which 
ensures a functional T cell receptor (TCR), thymocytes express CD4 and CD8 leading to 
the so-called double positive (DP; CD45+ CD4+ CD8+) stage. These cells then undergo 
positive and negative selection and differentiate into single positive cells (SP; CD45+ CD4- 
CD8+ or CD45+ CD4+ CD8-) which represent the last stage of T cell development within 
the thymus before emigration. By no means all thymocyte populations were listed here as 
many others can be identified (Love & Bhandoola, 2011). DN, DP and SP cells, however, 
represent major milestones in T cell development and thus an immunotyping panel 
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containing antibodies specific to CD45, CD4 and CD8 is sufficient to assess general 
thymocyte composition and to detect major changes induced by Slit2 knockout if they are 
present. 
Initially, the selected antibody panel was verified using thymocytes from adult mice. Adult 
C57BL/6 female mice were sacrificed, thymus dissected and thymocytes collected as 
described in section 2.2.32. Cells were stained with antibodies specific for CD45, CD4 and 
CD8 markers and analysed using flow cytometry. Dead cells were excluded from further 
analysis using the viability dye Viaprobe (BD). As expected, four different cell populations 
were detected (DN, DP and both SPs) confirming the validity of the antibody panel (Figure 
4.13A). In contrast to the adult thymocytes, the majority of thymocytes in stage E15 
embryos had a “double negative” phenotype. The observed additional “CD4 high” 
population most likely represents the first stages of “double negative” T cells 
differentiating into “double positive” (Figure 4.13B). Each population was quantified as a 
fraction of the parent population to normalize differences between samples caused by 
uneven tissue disaggregation. Eleven embryos were analyzed this way (2 wt, 5 
heterozygote and 4 homozygote Slit2 knockout), but no genotype-related differences in 
cell populations were observed (Figure 4.13C and D). 
Identical analysis was carried out on thymic epithelial cells using antibodies specific for 
EpCAM, Ly51 and MHC II markers. Dead cells were excluded using Viaprobe dye, TECs 
were selected by gating on the CD45- EpCAM+ population and then analyzed for MHC II 
and Ly51 expression (Figure 4.14A). cTEC, unlike mTEC, express Ly51 so they can be 
discriminated based on this marker. Some of the published studies describe several 
additional subpopulations for TEC cells based on MHC II expression (Chen et al, 2009), so 
this marker was included into the panel as well. Fifteen E15 embryos were analyzed this 
way (3 wt, 8 heterozygote and 4 homozygote Slit2 knockouts). The quantity of CD45- 
EpCAM+ cells was not genotype dependant (Figure 4.14B) and on average constituted 3% 
of total live cells, which closely matches numbers reported elsewhere (Gray et al, 2006). 
Comparison of the results also failed to reveal any genotype-related differences in MHC II 
or Ly51 expression demonstrating that mTEC and cTEC composition most likely was not 
affected by Slit2 knockout (Figure 4.14B).  
In summary, analysis of embryonic thymus composition by flow cytometry failed to reveal 
any effects of Slit2 deletion in leukocyte or TEC compartments. This means that either 
Slit2 has no role in thymus development or that Slit3 functionally compensates its deletion. 
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Slit2 knockout mice were created by disrupting the Slit2 gene with insertion of a DNA 
cassette containing a coding sequence of the Tau-GFP fusion protein (GFP fused to a 
microtubule binding protein Tau) (Plump et al, 2002). Expression of this construct falls 
under control of native Slit2 promoter and therefore cells of the knockout animal which 
normally express Slit2 are marked with GFP fluorescence. This reporter system was 
employed in order to establish thymic cell populations expressing Slit2 protein and to 
complement previous PCR-based expression studies. Moreover, it served as an additional 
verification of animal phenotypes.  
Individual embryonic thymi were dissected at stage E15 and disaggregated into single cell 
suspensions. Cells then were stained with fluorescent dye conjugated antibodies specific 
for EpCAM, CD45 or Ly51 markers and analysed using flow cytometry. Expression of the 
Tau-GFP construct was monitored directly by GFP fluorescence. An apparent GFP+ cell 
population was observed in some, but not all, samples (Figure 4.15A and B). 
Correspondingly, when these results were matched with genotyping data, a strong 
correlation was revealed between genotype and abundance of GFP fluorescent cells, 
confirming their identity (Figure 4.15C). In order to establish their phenotype the GFP+ 
population was gated and analysed for expression of EpCAM, CD45 and Ly51 markers 
(Figure 4.15D and E). Unexpectedly it turned out that GFP is mainly expressed by CD45- 
EpCAM- Ly51+ cells that are neither thymocytes (lack of CD45 marker) nor TECs (lack of 
EpCAM marker). This is a surprising finding and at first glance contradicts previous 
results which indicated TECs as a source of Slit2 expression in thymus. However, GFP 
fluorescence is somewhat difficult to detect using FACS because the GFP emission 
spectrum overlap with the autofluorescence of cells causing a poor signal-to-noise ratio. 
Relatively high GFP expression is necessary for a cell to be unambiguously detected as 
GFP+ in flow cytometry. Transcription of Tau-GFP is controlled by the native Slit2 
promoter and expression levels of the construct in different cells are proportional to those 
of Slit2. So it is not unexpected that some native cell populations might have considerably 
higher GFP fluorescence then others. The appearance of CD45- EpCAM- Ly51+ cells as the 
only GFP+ population may therefore simply mean that these cells have much higher 
Tau-GFP (and potentially Slit2) expression levels than TECs.  
This experiment shows that TECs are not the only source of Slit2 in the thymus. In fact, it 
seems that CD45- EpCAM- Ly51+ cells, whose population size equals that of TECs, 
express it at higher levels then TECs. Cells with an identical CD45- EpCAM- Ly51+ 
phenotype were described in the literature as pericyte-type mesenchymal cells which 
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surround blood vessels (Muller et al, 2008). While conjunction of three markers alone does 
not completely prove that the observed GFP+ population is pericytes in nature, matching of 
the phenotype and the size of the populations is highly suggestive.  
Slit2 expressed by pericytes potentially might have different physiological functions than 
Slit2 expressed by TECs as size and affinity for heparin sulphate most likely restricts Slit2 
diffusion localising its activity close to the source. 
4.5 Discussion	
The main purpose of the experiments described in this chapter was to establish the 
functions of the Slit-Robo signalling axis in the immune system. Plenty of evidence exists 
that connects these proteins to the immune system: they are expressed by immune cells, 
they affect immune responses, and vice versa, immune responses affect their expression 
levels. Available published data were not sufficient to suggest a testable hypothesis 
explaining these connections, so initially all efforts were directed towards establishing a 
working hypothesis.  
Analysis of Slit and Robo expression profiles in mouse tissues, and immortalised cell lines, 
failed to reveal any identifiable function related expression patterns. Slit and Robo 
proteins, with the exception of Slit1 and Robo3, are widely expressed across the whole 
animal body and in the majority of tested in vitro cell lines. Quite often immortalised cell 
lines express both Slit and Robo proteins together indicating possible autocrine regulation 
through the Sllit-Robo signalling axis. However, these findings need to be treated with 
caution as cancerous transformation, which these cells underwent, might affect Slit-Robo 
transcription. Unfortunately, the most promising experimental approach, Robo1 receptor 
expression analysis by flow cytometry, was not successful either. Low endogenous Robo1 
expression levels, and lack of suitable antibodies, made Robo1 detection in hematopoietic 
cells technically impractical. Overall, the attempt to generate an initial hypothesis about 
Slit-Robo function in the immune system via expression profiling was not successful. 
An alternative bioinformatics approach was taken and Slit-Robo promoters were analysed 
with the aim of identifying regulatory mechanisms controlling expression of these proteins 
as this information might reveal functional connections between the Slit-Robo axis and 
other systems including the immune system. Initial analysis showed that Slit-Robo 
promoters lack “classical” core elements but contain other hallmark promoter feature – 
CpG islands. This means that Slit and Robo promoters belong to Type III promoters 
according to the classification suggested by Lenhard (Lenhard et al, 2012). These results 
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closely match known information about Slit-Robo as Type III promoters are usually found 
in developmentally regulated genes, expression of which is precisely coordinated across 
different cells and tissues.  
Further analysis revealed scores of potential transcription factor binding sites, even though 
results were "filtered" using phylogenetic footprinting and only binding sites conserved 
across multiple species were considered. As can be expected, many of the identified 
transcription factors were related to development, neuron growth and differentiation. Some 
others, like EGR1, ETS1 and IKR, have roles related to the immune system. However, 
their functions are very general and thus it was impossible to draw specific conclusions 
about a potential Slit-Robo role. The exception was the transcription factor Foxn1, binding 
sites for which were detected both in the Slit2 and Slit3 upstream sequence in 
approximately the same position. Foxn1 has relatively specific and narrow functions within 
the immune system and because of that further studies were focused on this particular 
transcription factor.  
Foxn1 generally is a transcriptional activator which controls differentiation of thymic 
epithelial cells so the presence of its binding sites in the Slit2 and Slit3 promoters 
suggested that TECs may express Slit proteins. This prediction was tested by measuring 
Slit2 and Slit3 expression levels in the developing embryonic thymus at different stages. 
The experiment revealed that TECs do express Slit2 and Slit3 mRNA which is 
downregulated four-fold starting at E13. It is difficult to suggest a straightforward 
explanation for these data. The observed downregulation of Slit proteins is not necessarily 
related to Foxn1. Foxn1 primarily is a transcription activator, although it might act as a 
repressor under certain circumstances (Bazzi et al, 2009). The possibility exists that Foxn1 
switches on early Slit2 and/or Slit3 expression, while downregulation at E13 is triggered 
by other transcription factors. Interestingly, reduced expression levels roughly coincide 
with the first entry of thymocyte precursors into the thymus (Hollander et al, 2006). It was 
observed that, during first wave of immigration, leukocytes initially accumulate in thymic 
periphery and only later move into the thymus itself (Itoi et al, 2001). It is possible that 
Slit2 and Slit3, expressed by TECs, contribute to initial immigration restriction which is 
later removed by downregulation of these proteins. Reduction of Slit expression might also 
be part of the TEC differentiation programme and protein expression is switched off 
because it is no longer required for cell function. In general, these data confirm Slit2 and 
Slit3 expression by TECs and show active regulation of their expression during different 
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developmental stages, suggesting a functional relevance of Slit2 and Slit3 in thymic 
development. 
In order to elucidate the role for Slit2 in thymic development the cellular composition of 
the embryonic thymus in wild type and Slit2 knockout mice was compared, but no 
differences were observed. It seems that deletion of Slit2 alone is not sufficient to affect 
the thymus, so either Slit2 has no function in thymic development or the remaining 
functional Slit3 gene compensates for it. Unfortunately, Slit3 knockout mice were not 
available and issues of Slit2-Slit3 redundancy remain unaddressed. 
On the other hand, analysis of Slit2 knockout thymus revealed that TECs are not the main 
population expressing Slit2. The GFP reporter system present in Slit2 knockout animals 
showed the highest GFP signal in cells with CD45- EpCAM- Ly51+ phenotype which are 
neither thymocytes nor TECs. An identical CD45- EpCAM- Ly51+ population is reported in 
the literature and corresponds to mesenchymal cells (Muller et al, 2008). These pericyte-
type cells, also called NC-Mes, cover the entire thymic vasculature and separate TECs and 
blood vessel-forming endothelial cells (Foster et al, 2008; Muller et al, 2008). NC-Mes 
have a completely different developmental programme from that of TECs. They originate 
from Neural Crest, migrate into the thymus during development and are not dependent on 
Foxn1. Physiological functions of NC-Mes remain somewhat obscure. In other parts of the 
body pericytes support blood vessels and regulate their permeability. For example, 
pericytes are a crucial component of the blood-brain barrier. Like brain, thymus also 
appears to be highly selective for entering and leaving cells and some authors even suggest 
the existence of a blood-thymus barrier (Kato, 1997; Raviola & Karnovsky, 1972). It is 
tempting, therefore, to speculate that NC-Mes are part of the "gate keeping" system in 
thymus. Indeed, recently it was demonstrated that egress of mature leukocytes from 
thymus is regulated by NC-Mes cells via sphingosine-1-phosphate signalling (Zachariah & 
Cyster, 2010). It was also shown that NC-Mes regulate cTEC homeostasis via retinoic acid 
(Sitnik et al, 2012). So it looks like these pericyte-like mesenchymal cells have important 
and diverse roles in thymus which we are only beginning to uncover. 
What functions Slit2 might fulfil within TECs or NC-Mes remains an open question. Given 
evidence that pericytes control thymocyte emigration from thymus one might speculate 
that Slit2 contributes to the regulation of migration. On the other hand, it is worth noting 
that pericytes and smooth muscle cells, from other organs and tissues, also express Slit2 or 
Slit3 proteins (Marlow et al, 2010), so it is possible that they play a general role in 
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maintenance or functions of vasculature which is not thymus specific. Even less can be 
said about Slit2 or Slit3 role in TECs. Two different aspects of possible Foxn1 and Slit2-
Slit3 functions in thymus needs to be recognised here - thymic development and adult 
functions. The possibility exists that Slit2-Slit3 functions in thymus are purely 
developmental. These proteins might be involved in intensive TEC precursor migration 
which predates formation of an anatomically distinct thymus (E10-E11), later expression 
simply being a remnant of this developmental history (Hollander et al, 2006). The 
observed Slit2 and Slit3 downregulation at E13 supports this idea. Later development and 
function of embryonic thymus are also considerably different from that of the fully 
developed organ. For example, the first waves of leukocytes enter the developing thymus 
before functional blood vessels are formed, while the mature organ is seeded via blood 
vessels located at the cortico-medullary junction (Lind et al, 2001; Rodewald, 2008). The 
phenotype of thymocyte progenitors seeding thymus during development and in adult 
organism also might be different (Luc et al, 2012). So even if Slit2-Slit3 expressed by 
TECs are related to leukocyte traffic regulation these functions might be restricted to 
embryonic stages.  
The biggest issue for future research in this area is possible redundancy between Slit2 and 
Slit3 and ideally embryonic thymus composition needs to be reassessed using double Slit2-
Slit3 knockout. This animal model is compatible with embryonic studies thus flow 
cytometry and immnohystochemistry could be employed to evaluate mutation effects on 
thymic development and early function. On the other hand, perinatal lethality of Slit2-/- 
Slit3-/- animals prevents studies of the adult animal and additional “tricks” might be 
necessary in order to address possible Slit roles in them. Marlow and colleagues, for 
example, successfully used a transplantation technique where embryonic Slit2-/- Slit3-/- 
mammary gland tissues were transplanted into Slit+/+ animals, allowing their analysis in 
the background of an fully developed animal (Marlow et al, 2010). Similarly, a technique 
which allows transplantation of fetal thymus under the kidney capsule of an adult animal 
might be also of great use (Jenkinson et al, 2007). An alternative approach is to generate 
conditional Slit2 knockout animals, however this animal model has not been reported in 
the literature so far. Overall, Slit-Robo biology perfectly exemplifies that incredible level 
of integration and connectivity inherent to biological systems, making its studies 
technically and methodologically demanding. Nevertheless, it is a worthy challenge as it 
addresses the deepest principles of development and functions of multicellular organisms. 
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Figure 4.1 Slit-Robo expression in mouse organs and tissues 
Expression of Slit and Robo orthologues in mouse tissues was assessed using RT-PCR. Representative 
gels show PCR with cDNA from various tissues with primers for Robo2 (A) and GAPDH (B) genes. 
GAPDH detection was used as a positive control (RT+) or  control for genomic DNA contamination 
(RT-). General expression profile was determined from two female C57BL/6 female mice (C). LN - 
lymph nodes, SI - small intestine, BM - bone marrow. ++ - detected, ± - traces detected, - -not detected. 
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Figure 4.2 Slit-Robo expression in cell lines 
Assessment of Slit and Robo expression in various cell lines by RT-PCR. All cell lines are of human 
origin exept 3T3 and B16 which originate from mice. 
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Figure 4.3 Robo1 expression assessment by flow cytometry 
THP-1 cells were labelled with biotin conjugated anti-Robo1 antibody (R&D Systems) or biotin 
conjugated isotype control, stained with avidin-APC conjugate and analysed using flow cytometry (A). 
Alternatively, expression of myc-Robo1-CIT construct was induced in HEK 293 Flp-In cells by 
incubating them with 50 ng/ml of doxycycline overnight and myc-Robo1-CIT expression was assessed 
either directly measuring Citrine fluorescence (B) or labelling cells with biotin conjugated anti-Robo1 
antibody and avidin-APC conjugate. Doxycycline induced HEK 293 Flp-In cells labelled with isotype 
control or non-induced and unstained cells served as negative controls (C). Human PBMC were 
labelled with biotin conjugated anti-Robo1 antibody or biotin conjugated isotype control, stained with 
avidin-APC conjugate and analysed using flow cytometry (D). Number indicates median fluorescence 
intensity of populations. Images B and C are single independent experiments, images A and D are 
representative of two independent experiments.  
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Figure 4.4 Purification of Robo1 (DSHB) antibody 
HiTrap IgM Purification HP Column (GE Healthcare) was used to purify Robo1 antibody from 
hybridoma supernatant (A). Fractions 2 and 3 were selected based on UV adsorbtion and analyzed 
using SDS-PAGE (B). HC and LC marks expected positions of heavy and light chain of purified 
antibody.  
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Figure 4.5 Verification of Robo1 (DSHB) antibody function 
Anti-Robo1 antibody from Developmental Studies Hybridoma Bank was tested  by immunoblotting 
lysates of hematopoietic cells (A) or HEK 293 Flp-In T-REX cells expressing myc-Robo1-CIT or 
FLAG-Robo1-CER constructs (B). 
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Figure 4.6 CpG islands in the putative Slit2 promoter 
Upstream DNA sequences of Slit2 orthologues from different species were analyzed for CpG content. 
Each vertical tick corresponds to a CpG dinucleotide. ATG marks start of the open reading frame. 
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Figure 4.7 Phylogenetic footprinting 
Fragment of upstream sequence alignment for Slit1 gene exemplifying output of DiaAlign software. 
Different colours mark identified conserved transcription factor binding sites. 
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Figure 4.8 Putative Foxn1 binding site 
Putative conserved transcription factor binding sites in upstream sequences of Slit2 and Slit3 
mammalian genes. Foxn1 is marked in red. Transcription start sites listed in a CAGE database are 
marked with green (mouse) and blue (human) arrows. A number next to the arrow is a tag cluster 
identifier within the CAGE database.  
. 
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Figure 4.9 Dissection of embryonic thymus 
E12 mouse embryo with dissected thymus. Image contributed by Dr. A. White. 
Chapter 4  156 
 
 
 
  
Figure 4.10 Slit2 and Slit3 expression in TECs during thymic development 
Relative expression levels of Slit2 (A) and Slit3 (B) in TECs isolated from embryonic thymus at 
different developmental stages.For Slit2, results are represented as mean±SEM, n=2. Slit3 data were 
acquired from single independent experiment. ** p<0.01 as determined by one way ANOVA with 
Tukey’s post test. Cell isolation was performed by Dr. A. White 
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Figure 4.11 Embryonic thymus analysis in Slit2 knockout mice 
Diagram illustrating the workflow of embryonic thymus analysis in Slit2 knockout mice. Stage E15 
embryos were dissected and decapitated. Embryonic thymus and separate tissue sample for genotyping 
were taken from each individual embryo. The embryonic thymi were individually disaggregated into a 
single cell suspension and analysed for cellular composition using flow cytometry. In parallel, each 
embryo was genotyped using PCR. Finally, flow cytometry and genotyping data were combined and 
analysed together  
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Figure 4.12 Genotyping of Slit2 knockout mouse embryos 
Representative results of Slit2 knockout mouse genotyping. Each line represents genotype of different 
embryo. NC and PC stands for negative control (no template) and positive control (sample of an adult 
animal tissues) respectively. 
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Figure 4.13 Comparison of thymocyte composition in wild type and Slit2 knockout embryos 
Thymocytes from adult animal (A) or disaggregated embryonic (E15) thymi (B) were analyzed using 
flow cytometry. Live cells were selected based on viability dye exclusion, CD45 positive cells were 
gated and analyzed for CD8 and CD4 expression. CD45 and CD4 positive populations were quantified 
as a fraction of the parent population and compared according to genotype (C and D). Each dot 
represents the value for an individual embryo. No statistically significant differences were detected by 
one way ANOVA. SP stands for single positive, DP – double positive, DN – double negative. 
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Figure 4.14 Comparison of TEC composition in wild type and Slit2 knockout embryos 
TEC composition in embryonic (E15) thymi was analyses using flow cytometry. Live cells were 
selected based on viability dye exclusion, EpCAM positive cells were gated and analyzed for Ly51and 
MHC II expression (A). EpCAM+ and Ly51+MHC II+ population were quantified as a fraction of the 
parent population and compared according to genotype (B and C). Each dot represents the value for an 
individual embryo. No statistically significant differences were detected by one way ANOVA. 
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Figure 4.15 Identification of GFP+ cell population in embryonic thymus 
Size of the putative GFP+ population of embryonic thymus cells varied greatly between individual E15 
embryos (A and B). This variation had strong correlation with genotype of embryo (p=0.004 as 
determined by one way ANOVA) confirming that it is caused by endogenous expression of GFP in 
knockout animals (C). Further analysis of marker expression showed that GFP+ cells have a CD45-
EpCAM-Ly51+ phenotype (D and E). 
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5 Final	discussions	
The aim of this study was to investigate two different aspects of the Slit-Robo signalling 
axis – its transmembrane signalling mechanism and its functional role in the immune 
system. These two topics have little in common in terms of standard classification and 
subdivision of life sciences, however, arbitrary boundaries created by the need to organise 
knowledge should not limit understanding of a subject. It is especially true for Slit-Robo 
proteins which are perfect showcases of complex, hierarchical and seamlessly integrated 
organisation of biological systems. And as it happens, genuine connections between Robo 
transmembrane signalling mechanism and physiological functions, including that of the 
immune system, can be envisaged.  
Type I receptors containing a single transmembrane helix are incapable of transmitting 
signal across the membrane within one receptor molecule and therefore they need to recruit 
the help of other proteins. Consequently, many type I receptors associate into homo or 
heterooligomers, formation or dissociation of which can be controlled by ligand as a way 
to transfer signal across the membrane. Compelling pilot evidence had indicated that Robo 
receptors use a similar mechanism, however experiments described in Chapter 3 strongly 
contradicts this model. No Slit2 induced changes in Robo1 oligomeric state were observed 
using FRET imaging or TR-FRET assays even though these experiments clearly show that 
Robo1 exists as an oligomer in vivo. So how does Robo1 transmit signals across the 
membrane? As discussed in section 3.7, conceptually it is possible to envision several 
alternative mechanisms. Robo1 might form stable protein complexes which react to Slit2 
binding by changes in conformation but not in oligomerisation. Alternately, or even in 
cooperation with conformational changes, Slit2 binding might induce Robo proteolysis 
which sheds the C-terminal cytoplasmic tail releasing its signalling capabilities. An even 
better understanding of transmembrane Robo1 signalling might be gained if one considers 
it in the context of biological function. The best described, and probably evolutionary most 
conserved, Slit-Robo role is axon guidance during development. Axon wiring is led by the 
so called growth cone – a specialised sprout at the tip of the axon which pushes forward 
using adhesion (Vitriol & Zheng, 2012). Published data show that at least in Drosophila 
Robo receptors are actively and specifically delivered to the growth cones and largely 
remain in that neuronal compartment (Kidd et al, 1998). Many other receptors responsible 
for neuronal guidance are present here as well and as the growth cone squeezes through the 
tissues it simultaneously encounters many different guidance cues which sometimes might 
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bear opposite directives. Therefore growth cones have a remarkable signal integration 
capability where final response is determined by amalgamation of many different 
instructions (Vitriol & Zheng, 2012). Coincidently, the Slit-Robo signalling axis shows a 
strong dependence on cellular context not only in neurons but in other cells as well (see 
section 1.6). Other aspect of growth cone worth noticing is its reliance on adhesion, short 
range guidance cues and juxtacrine regulation (Lowery & Van Vactor, 2009). At least two 
major signalling axes are responsible for axon guidance, Eph kinases/ephrin and 
Semaphorin/Plexin, are juxtacrine in nature i.e. ligands are tethered to the membrane of 
another cell and physical contact between two cells is necessary for ligand-receptor 
interactions. Slits are secreted proteins but their size and affinity for heparan sulphate most 
likely severely restricts their diffusion and Robo receptors encounter most of the Slit 
molecules embedded into extracellular matrix or adsorbed on the cellular surfaces. In other 
words Slits might be considered as solid phase ligands acting as haptotactic guidance cues. 
Moreover, Robo4 recently was shown to serve as a ligand for the UNC5B receptor and 
while the authors failed to detect Robo4 downstream signalling in response to UNC5B 
binding, it does not completely exclude the possibility that this signalling axis is 
bidirectional and Robo4 can be activated by UNC5B receptor under different cellular 
context (Koch et al, 2011). Taking all these circumstances into account it is reasonable to 
argue that the Slit-Robo signalling axis is largely juxtacrine in its nature as well. This 
arrangement might have important implications for transmembrane signalling as it is no 
longer a matter of two interacting molecules, but that of two interacting surfaces tethered 
together by ligand-receptor interactions with mechanical tension and shear forces coming 
in to the play. This theoretical consideration is supported by recent data showing that 
signalling of EphA2 kinase is affected by mechanical force (Salaita et al, 2010). 
Interestingly, EphA2 forms clusters consisting of hundreds of molecules, and mechanical 
force seems to affect their composition and cytoskeleton-based transport which in turn 
modulates actual effects of downstream signalling (Salaita et al, 2010). This mechanism 
reminds us of that of T cell receptor activation, another juxtacrine signalling system where 
TCR is activated by interactions with antigen peptide presented in trans by MHC complex 
on antigen-presenting cells triggering formation of complex macromolecular assemblies, 
the size and organisation of which controls downstream signalling (van der Merwe & 
Dushek, 2011). Most interestingly, an increasing number of studies indicate that 
biomechanical force may trigger and modulate TCR activation (Allard et al, 2012; Husson 
et al, 2011; Li et al, 2010). Yet another group of receptors interacting with "solid state" 
ligands are integrins whose ability to form clusters and their sensitivity to biomechanical 
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force are now well established (Arnaout et al, 2005). So, an interesting pattern emerges 
from this analysis as it appears that many juxtacrine systems share numerous common 
properties – receptor cluster formation, sensitivity to mechanical force and close functional 
cooperation with the cytoskeleton. So called "cis inhibition" potentially is another 
emerging trait of juxtacrine signalling. It describes the situation when ligand presented in 
cis (on the same cell surface) inhibits effects of the same ligand presented in trans (on the 
surface of the other cell). This peculiar phenomenon was observed for the Notch/DSL, 
Eph/ephrin and Semaphorin/Plexin juxtacrine signalling axes (Yaron & Sprinzak, 2012). 
Given all these coincidences it is tempting to speculate that juxtacrine signalling systems 
might share a common transmembrane signalling mechanism based on interplay between 
the cell-cell mechanical interactions, receptor clustering and cytoskeleton. Obviously, this 
idea is highly speculative and much more work needs to be done before it gains any 
credibility. Nevertheless, in its light many "eccentricities" of Slit-Robo signalling system 
become somewhat less puzzling. Contradictive and highly variable effects of recombinant 
Slit in in vitro models might be related to the fact that Slit instead of being a "solid state 
ligand" is presented as a soluble molecule. Cis inhibition is another possible explanation 
for highly variable in vitro assays, as recombinant Slit is likely to adsorb on the surface of 
assayed cells which theoretically might lead to inhibition of signal in trans. Similarly, a 
long lasting debate about existence of Slit2-Robo4 signalling, where functional assays 
show signals being transmitted by Slit2-Robo4 axis, but evidence of direct interactions are 
vague and elusive, might also benefit from mechanistical considerations outlined above. 
Interestingly, adhesive and juxtacrine Slit2-Robo4 properties appear to be utilised by 
hematopoietic stem cells in bone marrow. Smith-Berdan and colleagues observed that 
Robo4 knockout caused increased efflux of hematopoietic stem cells into the circulation. 
Surprisingly, neither Robo4 deletion, nor treatment with soluble Slit2 caused observable 
changes in cell proliferation or in vitro migration capabilities of hematopoietic cells, so 
authors argue that Slit2 expressed by bone marrow stromal cells acts as an adhesive cue for 
Robo4 expressing hematopoietic cells (Smith-Berdan et al, 2011). Studies described in 
Chapter 4 indicate that Slit2 and Slit3 are expressed by TECs and that Foxn1 likely 
contributes to the regulation of these genes. Both bone marrow and thymus stroma have 
similar roles – formation of niches for hematopoietic cells. It is tempting to speculate 
therefore that Slit-Robo thymic niches are also defined by Slit2-Robo4 interactions. On the 
other hand Robo4 is downregulated after hematopoietic stem cells leave the bone marrow 
(Smith-Berdan et al, 2011). Moreover, TECs are not the only source of Slit2 in thymus as 
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it is also expressed by pericytes surrounding the vasculature, so these similarities might be 
only superficial. Nevertheless, these data echo previous conclusions, that Slit-Robo is 
primarily a juxtacrine signalling axis and one needs to think about two interacting cells or 
cell - ECM interactions when considering Slit-Robo functions within the immune system.  
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